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Thesis Abstract 
 This thesis applied spectroscopy and molecular dynamics simulation to study the 
structural biology of actin-binding domains (ABDs) from the spectrin superfamily of 
proteins as well as an intrinsically disordered region (IDR) of an integral membrane 
protein called synaptotagmin 1. In the former case, the structural hypothesis being tested 
was that actin-binding domains exist in distinct conformational states that are either 
permissive to or inhibitory towards binding of actin filaments. This question was probed 
using pulsed-EPR, which measured distances between the calponin homology (CH) 
domains that make up the ABD as proxy for conformation in the presence or absence of 
actin or with and without disease-causing mutation. The initial hypothesis of a closed 
compact state being unable to bind actin and an open extended state being binding-
competent was largely supported by the data. However, the hypothesis was ultimately 
refined to conclude that an “open” state is likely to still be a fairly collapsed structure that 
is dynamically disordered. With this model, future efforts will be able use the model to 
look for small molecules that perturb the conformational equilibrium of ABDs harboring 
disease-causing mutations in potentially therapeutically efficacious ways. Moreover, the 
model can be tested in other ABDs of the protein superfamily to assess similarities and 
differences in mechanism. 
In the case of the intrinsically disordered region of synaptotagmin 1, it was 
hypothesized that a post-translational modification, specifically phosphorylation of a 
threonine residue, caused a structural change in the IDR that then results in a change in 
neurotransmitter release. This hypothesis was also tested with spectroscopic methods, 
mainly FRET and circular dichroism, but also with molecular dynamics. It was found that 
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mimicking the low dielectric environment of the membrane with co-solvents in solution 
and artificially in silico caused the synaptotagmin 1 IDR to fold into helical structure. 
The post-translational modification, however, was found to interfere with the formation 
of helical structure, providing a still incomplete but novel molecular explanation for the 
effect it has on potentiation of neurotransmitter release observed in vivo. At the very 
least, the structural model provides a working hypothesis that can be further explored in 
further work. 
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 study, is also indicated. 
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Sampling of a structurally collapsed state by the Syt 1 IDR in aqueous solution. 
 (A) Determining the number of lifetimes needed to fit tryptophan decays without 
 (blue) and with (red) acceptor dyes. In both cases, two lifetimes were considered 
 necessary and sufficient (asterisk). (B) Time-resolved FRET measurement of Syt 
 1 IDR synthesized peptide showing Trp-dansyl undergoing energy transfer in 10 
 mM sodium phosphate buffered to a pH of 7.4. Blue: donor-only.  Red: donor-
 acceptor. Error bars: SD of 4 replicates. Black: instrument response function 
 (IRF). The distance derived from the change in average lifetime (τD = 
 1.53±0.11, τDA = 1.06±0.10) is 2.40±0.05 nm (Eq. 4.4). Shown below the time-
 resolved data are residuals of fitting to bi-exponential functions. (C) A similar 
 FRET result was obtained from a recombinantly expressed Syt 1 IDR construct 
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 that was labeled with AEDANS acceptor. The slight increase in FRET in the 
 recombinant IDR is thought to be due to inclusion of a his-tag, which tend to 
 promote compaction in IDPs. 
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MD simulation of the full-length Syt 1 IDR (residues 80-141) with an implicit 
 solvent (ε=80) and salt concentration of 10 mM. (A) Radius of gyration (Rg) as a 
 function of simulation time indicates the IDR sequence samples both extended 
 and compact states. Dotted line indicates average Rg. (B) Inter-residue distance 
 (<Rj-i>) between first (i) and each subsequent (j) residue (Cαj-Cαi) in the Syt 1 
 IDR plotted as a function of simulation time. Plots suggest weak long-range 
 interactions promote sampling of more compact conformations. However, 
 compact conformers are not the dominant structural species in an aqueous 
 environment as indicated by the location of the average inter-residue distances 
 (black diamonds). (C) Representative conformers of different Rg. Structures, N- to 
 C-terminus, are color-coded blue to red. 
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Impact of Thr112 phosphorylation on Syt 1 IDR core region 
 (GKNAINMKDVKDLGKTMKDQALKDDDAETGLTDG). (A) MRE of 
 unphosphorylated Syt 1 IDR core and (B) MRE of phosphorylated Syt 1 IDR core 
 as a function of increasing TFE (0-60% v/v going from red to violet) in 10 mM 
 sodium phosphate at a pH of 7.4. (C) Fitting of absorption profiles to linear 
 combinations of α-helix, β-sheet and random coil in each IDR construct at a 
 maximal TFE concentration of 60% v/v. (D) Simultaneous fitting of the 198 nm 
 coil minimum (solid circles, dark line) and 222 nm (open circles, lighter line) 
 signals during folding transition for unphosphorylated (purple), phosphorylated 
 (green) and full-length (orange) peptides. (E) Comparison of 222 nm/200 nm ratio 
 from full-length (orange), unphosphorylated core (purple) and phosphorylated 
 core (green). Removal of flanking charge shifts IDR from a pre-molten globule-
 like (PMG-like) state to a more coil-like state and phosphorylation accentuates 
 this effect. Figure modified from reference 164. 
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Simulated structural ensemble of unphosphorylated Syt 1 IDR core region. (A) 
 Representative conformers of the peptide at a dielectric constant of 80 with 
 secondary structure probability per residue is shown below (histogram). (B) 
 Representative conformers of the peptide at a dielectric constant of 20 and 
 secondary structure probability per residue shown below (histogram). Note 
 increase in helical probability. (C) Close-up of example salt bridge that forms to 
 stabilize helix in low dielectric environment. (D) IDR core region sequence 
 showing sample salt bridge interactions found in helices at a dielectric constant of 
 ε=20. Residues highlighted in purple occupy helical secondary structure. (E) Heat 
 map showing change in all salt bridge interactions in going from dielectric 80 to 
 dielectric 20. An increased frequency of interaction between two charged residues 
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 is indicated by gradations of blue whereas decreased interactions are indicated by 
 gradations of red. Note increased frequency of i, i+3 and i, i+4 contacts. 
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 compared to unphosphorylated peptide. (B) Representative conformers of the 
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 salt bridge that distorts peptide backbone and limits helix formation in low 
 dielectric environment. (D) IDR core region sequence showing salt bridge 
 interactions inhibitory toward helices at a dielectric constant of ε=20. Green 
 residues are those that occupy helical conformers during the trajectory. (E) Heat 
 map showing change in salt bridge interactions in going from dielectric 80 to 
 dielectric 20. An increased frequency of interaction between two charged residues 
 is indicated by gradations of blue whereas decreased interactions are indicated by 
 gradations of red. 
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Simulation-derived thermodynamic cycle of structural states adopted by Syt 1 
 IDR core region (residues 97-129). Folding free energies of each structural state 
 (Unphos80, Phos80, Unphos20, Phos20) were determined by applying the 
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 of helical content is shown parenthetically below each structural state. At a given 
 dielectric constant, phosphorylation is generally unfavorable toward helix 
 formation. Note that the apparent ∆∆G computed from MD structural data is of 
 similar magnitude to that derived from CD. 
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xviii 
 
Figure 4.9  ……………………………………………………………….………...…..147 
Position of Syt 1 IDR in sequence charge-dependent phase diagram of structural 
 states. Note that location of the Syt 1 IDR, indicated by Seq 1 data point, suggests 
 it likely samples coil and/or hairpin-like structural states in an environment whose 
 dielectric constant is similar to water. 
 
Figure 4.10  …………………………………………………..………….………...…..148 
RMSD of Syt 1 IDR constructs used in MD simulations. Core region peptides 
 (residues 97-129) in unphosphorylated (purple) and phosphorylated (green) states 
 and at dielectric constants of both ε=80 and ε=20 are shown in top four panels. 
 The full-length peptides (residues 80-141) at dielectric constant and salt 
 concentration of ε=80 and 10 mM (blue), ε=80 and 100 mM (green), ε=20 and 10 
 mM (red), ε=20 and 100 mM (orange) are shown in the bottom four panels. Note 
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 transition. The middle column shows partial folding of IDR core residues (97-
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 recombinantly expressed IDR that includes a C-terminal his-tag. Violet to red 
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Helix probability histograms (determined as described in main text) for full-length 
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Potential factors influencing full-length IDR compaction. (A) FRET efficiency 
 was not significantly affected by salt. (B) Core region Syt 1 IDR (representative 
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 terminus, in addition to transiently interacting with the acidic C-terminus of the 
 IDR sequence, also interacts with acidic lipids in a synaptic vesicle membrane 
 and likely has two competing interactions (lipid – intermolecular; acidic C-
 terminus – intramolecular) that could influence propensity to exist in compact 
 structural state. 
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CHAPTER 1: PROTEIN STRUCTURAL DYNAMICS AND METHODS TO 
STUDY THEM 
 
1.1 - Protein folding, structure and conformational change in relation to function  
1.1.1 – Traditional structure-function relationship of proteins 
Proteins are a class of biomolecules that generally serve as major workhorses for 
molecular processes that underlie cellular function. This includes processes such as the 
catalysis of metabolism, ion transport of second messenger signaling and alteration of 
membrane potential, maintenance of cell shape and integrity with cytoskeletal protein 
filaments, and regulation of gene expression. Typically, proteins are able to carry out 
these distinct functions by virtue of having unique three-dimensional folded structures 
that are dictated by their primary amino acid sequence. A newly synthesized chain of 
amino acids folds into secondary structural elements that generally include α-helices, β-
sheets, and turns, which then form additional intramolecular contacts to stabilize a more 
globular, tertiary structure. In some cases, a protein in its tertiary structure combines with 
others to form a larger protein molecule that is then referred to as being in its quaternary 
structure. This then represents the final form of the molecule that consists of multiple 
subunits. Ultimately, these final unique three-dimensional structures are then able interact 
with specific ligands, ions, or macromolecule binding partners such as other proteins, 
nucleic acids, or lipids as a way of carrying out their functions.  
The three-dimensional structures of proteins are, however, not static. Proteins can 
exist in multiple conformational states. In many instances, distinct conformational subsets 
of a protein’s overall ensemble are what actually enable execution of functional activity 
and the transitioning between these conformations is what imparts regulation of function. 
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As a classic example, the ubiquitous class of motor proteins known as myosins generate 
the mechanical force of many molecular movements carried out in cells, but most 
famously movement in muscle cell contraction. Myosins undergo large-scale changes in 
their conformation that are tightly coupled to the binding, hydrolysis and subsequent 
release of an ATP molecule, ultimately allowing them to convert the chemical potential 
energy of a phosphodiester bond into mechanical energy that enables ratchetting along 
the length of actin filaments. 1-3 Another classic example where conformation of a protein 
regulates function is hemoglobin. Hemoglobin has a quaternary structure consisting of 
four subunits, each of which contains an iron-containing heme prosthetic group for 
binding molecular oxygen. Hemoglobin protein structure is designed to promote efficient 
loading and unloading of O2 as the red blood cell shuttling it passes from alveolar to 
tissue capillaries. This loading and unloading is mediated by binding cooperativity and 
allostery that are linked to each subunit’s conformation.4 When a molecule of O2 binds to 
one subunit, it causes small structural distortions to that subunit’s secondary and tertiary 
structure. Those distortions propagate to the adjacent subunits, altering their 
conformations in such a way that their subsequent binding of molecular O2 becomes 
easier. These O2 binding-induced changes that increase regional affinity for the ligand in 
adjacent subunits continue until hemoglobin is saturated at all four sites. In both 
examples, myosin and hemoglobin, changes in protein conformation ultimately change 
the way in which each molecule can bind their chemical substrate, which in turn enables 
execution of their molecular-level function. 
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1.1.2 – Intrinsically disordered proteins and protein regions 
 While the above examples illustrate roles of conformational change in regulating 
protein function, it is important to note that not all protein molecules exist in a stable and 
well-folded three-dimensional structure under native conditions. About 30-40% of 
eukaryotic genomes encode for proteins that are categorized as being intrinsically 
disordered or partially intrinsically disordered5, meaning their entire amino acid sequence 
or significant parts of their sequence lack stable tertiary and/or secondary structure most 
of their cellular lifetime and instead they more frequently occupy random coil-like 
conformations. When intrinsically disordered proteins (IDPs) and intrinsically disordered 
regions (IDRs) were first recognized as a separate entity within this class of bio-
molecule6, 7, it brought up several important questions. How do IDPs interact with their 
target macromolecule if they don’t have a well-folded surface that can form residue 
contacts at a molecule-molecule interface? Can something that mostly lacks three-
dimensional structure participate in important protein behaviors like allostery if there 
isn’t a clear occupation of discrete conformations in their ensemble? In the roughly two 
decades development of the IDP field, generalized answers to the above questions have 
begun to emerge. Consequently, our view of the protein structure-function relationship 
has expanded. What constitutes a functional protein “fold” is now viewed as a broader 
continuum ranging from highly stable ordered structure to complete disorder.8, 9  
A large determinant of why one protein molecule adopts a stable, folded state and 
another does not is the amino acid composition of the primary sequence. Typically, 
proteins that are intrinsically disordered have a notably low frequency of bulky, 
hydrophobic or aromatic amino acids and an enrichment in polar, charged or structure-
4 
 
breaking amino acids.10 A large driving force for protein folding is the burial of bulky, 
hydrophobic residues, where burial of residue side chains shields hydrophobic side chains 
from the surrounding polar solvent. Amino acid sequences of IDPs do not typically have 
this driving force because of their bias towards charged and polar residues. This does not 
mean, however, that disordered proteins never fold. Quite the contrary, IDPs will often 
undergo folding as part of the biological function they carry out in the cell.8 For example, 
IDPs often serve as hub proteins where they use short linear motifs in their primary 
sequence to bind multiple different folded proteins and, in doing so, help to organize the 
folded proteins into one central location.11, 12 The interaction of these short linear motifs 
with their target protein partners can often associated with regional folding into short 
helices or sheets. In this regard, the unfolded-to-folded transition frequently seen in IDPs 
is similar to the examples described above for well-folded proteins in that it is just 
another type of conformational transition that regulates function.  
In this thesis, research questions on the two ends of the protein structure-function 
continuum are examined. On one end, the very well-folded but conformationally flexible 
actin-binding domains from two representative members of the spectrin superfamily are 
probed to understand how conformation regulates their binding to filamentous actin 
(Chapters 2 and 3). On the other end, an intrinsically disordered linker region in the 
integral membrane protein synaptotagmin is examined, asking a more fundamental 
question about molecular determinants of secondary structure formation (Chapters 4). 
The relevance of these distinct avenues of research are further introduced in two 
subsequent sections below, but first methods for measuring folding and conformational 
change will be discussed. 
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1.2 – Spectroscopy as a measure of protein structure and conformation 
1.2.1 – Fluorescence and resonance energy transfer 
The conformational change of a protein is often studied through use of 
spectroscopy, a discipline primarily concerned with how different types of 
electromagnetic (EM) radiation interacts with matter. In the case of this thesis, we’re 
specifically concerned about the interaction of EM radiation (particularly ultraviolet and 
microwave regions of the spectrum) with protein molecules or probes that we attach to 
the protein molecules. Spectroscopy can be broadly categorized as being absorption-
based or emission-based. One of the main absorption-based spectroscopies used in 
Chapter 4 is circular dichroism. While perhaps simpler compared to other spectroscopies, 
circular dichroism is quite useful for studying folding reactions of IDPs and is always a 
good place to start study of an IDP before moving on to more laborious methods.  
EM radiation used in spectroscopy consists of waves that have electric (E) and 
magnetic (B) field components that oscillate in magnitude perpendicularly to each other 
and the direction of the wave’s propagation.  
 
Figure 1.1. Different polarizations of light used in this thesis.  
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Most EM radiation sources will emit waves whose oscillations occur in any direction 
about the axis of propagation and these waves are said to be unpolarized. When waves 
have their electric field component constrained to a single plane, they are said to be 
linearly polarized (Figure 1.1, left). In the circular dichroism spectrometer used in 
Chapter 4, waves have a constant electric field vector that rotates around the axis of wave 
propagation. These light waves are circularly polarized (Figure 1.1, right). The 
directionality of circular polarization can be either clockwise or counterclockwise. 
Ultimately, the relevance of light polarization in examining protein structure is 
that protein molecules differentially absorb right and left circularly polarized light. This 
stems from several factors including the chirality of their amino acids, the folded 
secondary structure of those amino acids and the wavelength of the incident light. Both 
right and left forms are directed at solutions containing the protein of interest. In the 
absence of any absorption of either form of circularly polarized light, the waves sum to a 
linearly polarized wave because each electric field component is unmodified. However, 
when greater absorption of one polarization occurs relative to the other, summation of 
right and left results in elliptically polarized light because of the difference in electric 
field component magnitudes resulting from differential absorption. This leads to the 
degree of ellipticity, θ, that is measured in the experiment as a function of wavelength: 
    tan(θ) = (El + Er)/(El - Er)    Eq. 1.1 
where El and Er represent the magnitudes of the electric field vectors in left and right 
circularly polarized light, respectively. Measurement of θ as a function of wavelength 
spanning from approximately 190-260 nm results in characteristic absorption profiles 
depending on the type of secondary structure present in the protein molecule (Figure 1.2).  
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Figure 1.2. Basis absorption spectra for random coil (purple), β-sheet (orange) and α-
helical protein secondary structures, where raw ellipticity is in degrees. 
 
Different types of secondary structure result in unique absorption profiles; this forms the 
basis for quantifying the relative amounts of secondary structure in regular protein 
samples. If a protein has a mixture of secondary structures, the absorption profile is just a 
linear combination of the individual components. Using basis data sets of purely α-
helical, purely β-sheet and purely random coil as references, a non-linear least squares fit 
of experimental data can be performed using coefficients for each form of secondary 
structure as the floating parameters: 
   θλ = ∑ fα*Sλα + fβ*Sλβ + frc*Sλrc    Eq. 1.2 
where θλ is ellipticity at a given wavelength in the spectrum, Sλα, Sλβ, Sλrc are the α-helix, 
β-sheet, and random coil basis spectra at that given wavelength, and fα, fβ, frc are the 
weighting factors for the basis spectra. Fitting data sets in this manner allows for the 
relative percentages of structure to be estimated in a sample.13 
Ultimately, this form of spectroscopy was used to study folding of an intrinsically 
disordered protein region in Chapter 4. Because of the absorption profile shifts with 
changes in protein secondary structure, addition of co-solvents or other chemical reagents 
that perturb the folding equilibrium of an IDP allows for this form of spectroscopy to 
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extract equilibrium thermodynamics parameters. These are useful for learning about 
global protein behavior and energetic barriers to folding and further details on how free 
energies are obtained from circular dichroism data is detailed in the supporting materials 
of Chapter 4. 
Aside from circular dichroism, another major type of spectroscopy used in this 
work is fluorescence, a form of emission spectroscopy. In fluorescence, EM radiation is 
directed at a protein molecule to excite an electronic transition that will soon after result 
in emission of a detectable photon of longer wavelength (Figure 1.3, blue and green 
transitions).  
 
Figure 1.3. Jablonski diagram of electronic states important for fluorescence and 
resonance energy transfer in distance measurements. 
 
The type of radiation used for fluorescence could be UV in origin if, for example, the 
intent is to excite natural fluorophores within the protein like tryptophan. Alternatively, it 
could come from the visible part of the electromagnetic spectrum if excitation of an 
extrinsic fluorophore is intended. In either case, the applied radiation excites an electron 
from its ground state within the fluorophore to a higher energy electronic state. 
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Occupancy of this higher energy level is short lived, due to loss of energy through 
vibrational relaxation which eventually brings the electron down to its lowest energy 
excited state. From here, the electron relaxes back to ground state and emits a photon in 
the process (Figure 1.3). The length of time the electron spends in an excited state is 
referred to as its lifetime, τ, which is typically only a few nanoseconds.  
 Fluorescence spectroscopy can ultimately be used for studying protein 
conformation because it is capable of making distance measurements through the process 
of resonance energy transfer. Fluorescence resonance energy transfer or Förster 
resonance energy transfer (FRET) is a form of spectroscopy that uses two fluorophores to 
make molecular measurements on the order of a few nanometers, a scale suitable for 
protein molecules. In FRET, these two fluorophores can be attached to the same molecule 
if the goal is to make intramolecular distance measurements, or they can be attached on 
two separate molecules to measure intermolecular distance. In either case, one 
fluorophore acts as a donor, the fluorescent probe being excited with some wavelength of 
light and then either emitting a photon or transferring energy non-radiatively to a second 
chromophore that acts as an acceptor. An acceptor is a molecule whose spectroscopic 
properties allow it to undergo electronic excitation to a higher energy level by non-
radiatively receiving transferred energy from the first fluorophore’s excited state (Figure 
1.3, gray transitions). This non-radiative transfer of energy has a strong dependence on 
distance between the two fluorophores, as defined by the Förster equation: 
   kT/kD= (R/R0)
-6      Eq. 1.3 
Here kT is the rate of non-radiative energy transfer from donor fluorophore to acceptor 
chromophore, kD is the natural rate of relaxation of the donor excited state to ground 
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state, R is the interprobe distance, and R0 is the Förster distance or the distance at which 
the two fluorophores in question have an energy transfer efficiency of 50%. The rate of 
donor relaxation when in the presence of an acceptor (kDA) can be represented as the sum 
of the intrinsic donor relaxation rate and the rate of non-radiative energy transfer as both 
processes contribute to depletion of the excited state: 
  kDA = kD + kT        Eq. 1.4 
Both the donor relaxation rate without (kD) and with (kDA) acceptor are inversely 
proportional to their respective excited-state lifetimes, which are readily measurable 
experimental parameters: 
  kD = 1/τD        Eq. 1.5 
  kDA = 1/τDA        Eq. 1.6 
If we substitute a rearranged Eq. 1.4 into Eq. 1.3 and move the exponent, 
  (kDA - kD/kD)
-1/6 = (R/R0)      Eq. 1.7 
Based on Eq. 1.5 and Eq. 1.6, Eq. 1.7 becomes an expression for interprobe distance as a 
function of experimentally measurable donor lifetimes: 
  [(1/τDA – 1/τD)/(1/τD)]-1/6 = (R/R0)     Eq. 1.8 
Factoring out 1/τD and simplifying results in a more accessible expression: 
  [(τD /τDA) – 1]-1/6 = (R/R0)      Eq. 1.9 
Eq. 1.9 shows that a simple measurement of donor lifetime in the presence and absence 
of  acceptor should enable determination of R, the interprobe distance. The only other 
factor in Eq. 1.9 that must be determined is the Förster distance R0, which relies on 
several factors, as shown below: 
  R0 = (9.78 x 10
3)*(κ2n-4ϕDJ(λ))1/6              Eq. 1.10 
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Here κ is the relative orientation of fluorophore transition dipoles, n is the solution’s 
refractive index, ϕD is the quantum yield of the donor fluorophore, and J(λ) is the overlap 
integral, which is mathematically shown below and conceptually illustrated in Figure 1.4: 
  J(λ) = ∫ FD(λ)εA(λ)λ4dλ / ∫ FD(λ)dλ              Eq. 1.11 
 
Figure 1.4. Use of excitation and emission spectra of donor and acceptor fluorophores in 
the design of FRET experiments. Note regional overlap of donor emission and acceptor 
excitation spectrums. 
 
When all factors contributing to R0 are known, measurements of fluorescence lifetimes 
with and without an acceptor probe can be made for the purpose of inferring 
conformational change in a protein. If we consider an example of intramolecular FRET 
(Figure 1.5), where the protein of interest has two folded domains and a donor probe in 
one of those domains and an acceptor in the other, we can predict the expected outcome 
based on a structural hypothesis. If the example protein binds actin and, upon doing so, 
its domains become further separated from one another compared to the unbound state, 
then the interprobe distance will increase, resulting in both a decrease in energy transfer 
efficiency and an increase in the apparent donor lifetime (Figure 1.5). From these lifetime 
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measurements, a distance change can be determined using Eq. 1.9, and conformation 
change can subsequently be inferred. 
 
Figure 1.5. Use of lifetime-based FRET for measuring conformational change in a 
protein upon binding its target. 
 
1.2.2 – Electron paramagnetic resonance 
While both circular dichroism and FRET are using UV light (at least, in the 
chapter where these methods are relevant, Chapter 4), radiation from other regions of the 
electromagnetic spectrum can be used to assess protein conformation. The other major 
form of spectroscopy used in this thesis (Chapters 2 and 3) is a form of electron 
paramagnetic resonance (EPR). In this form of spectroscopy, rather than using high-
energy UV waves for exciting an electronic transition, low-energy microwaves are used 
to excite a spin transition of a free radical.  
 Since most proteins do not have an unpaired valence electron that would make 
them EPR active, we instead use an attachable probe that contains a stable free radical. 
These probes are referred to as “spin labels” and are covalently linked to a specific region 
of interest in the protein under study. Spin labels generally consist of a heterocyclic ring 
that contains a nitroxide bond (Figure 1.6). On the carbon atoms adjacent to the nitroxide 
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nitrogen are methyl groups that flank and help stabilize the free radical when in solution.  
Opposite the nitroxide is some type of reactive functional group such as maleimide (as 
used in MSL), iodoacetamide (as used in IASL) or methanesulfonothioate (as used in 
MTSSL) that serves the role of chemically attaching the probe to the protein’s sulfhydryl 
side chains found in cysteine residues. Once a spin label is attached to the protein, EPR 
spectroscopy can be performed. 
 
Figure 1.6. Commonly used nitroxide spin labels. The two left-most labels, MSL and 
IASL, are spin labels that become irreversibly covalently attached to the target protein. 
The right-most label, MTSSL, forms a disulfide linkage that can be reversed with 
reducing agent. MSL is the label used in this thesis. 
 
 In EPR, the end goal is to excite a spin transition in the nitroxide radical. These 
types of transitions have lower energy differences between states and thus require lower 
frequency radiation for excitation. This same reasoning dictates use of even lower 
frequency radiation in nuclear magnetic resonance (NMR), where the energy gap 
between nuclear spin states is smaller still compared to electron spin states. In either form 
of magnetic resonance, however, before you can excite the spin transition the sample 
must be subjected to an external magnetic field (B0). In the absence of this applied 
external magnetic field, the spin quantum states available for the nitroxide’s electron (ms 
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= +½, ms = -½) are degenerate, meaning there is no energy gap for excitation. However, 
in the presence of the external magnetic field, the Zeeman Effect causes splitting of spin 
state energy levels so that one becomes higher in energy. This occurs because one of the 
spin aligns parallel with B0 (resulting in lower energy) whereas the other aligns 
antiparallel (resulting in higher energy) (Figure 1.7). With this newly generated energy 
gap, application of microwaves can then excite the spin transition if the conditions for 
resonance are met:  
   ΔE = hν = geμBB0               Eq. 1.12 
ΔE is the energy difference between spin states, h is Planck’s constant (6.626 x 10-34 
m2kg/s), ν is the applied microwave frequency, ge is the g-factor (2.0023 for a free 
electron), μB is the Bohr magneton (9.274 x 10-24 J/T) and B0 is the external magnetic 
field strength. Absorption of incident microwaves that are being continuously applied in 
the EPR experiment (frequency of microwaves is usually ~9.5 GHz) only occurs at 
specific magnetic field strengths that generate energy gaps that exactly match that of the 
applied radiation frequency. 
One of the consequences of using a nitroxide as the source of a stable electron, 
however, is that the nuclear spin states of the 14N nucleus in the nitroxide bond influence 
the local magnetic field of the electron. This influence of the nitrogen’s nuclear spin on 
the electron magnetic field is referred as the hyperfine interaction and ultimately results 
in further splitting of the electron spin energy levels generating the characteristic three 
resonances typically seen in nitroxide spin label’s field swept spectrum (Figure 1.7). 
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Figure 1.7. Spin transitions of the nitroxide radical. Degeneracy of spin states is 
eliminated with application of an external magnetic field. The two spin states become 
further split by the local field of the nitrogen nucleus whose spin is I=1, resulting in 
possible mI spin states of -1, 0, and +1 which interact with the field experienced by the 
electron that causes hyperfine splitting. 
 
 While the resulting spectra described above can provide information on protein 
structure and dynamics14, the work in this thesis was focused more on use of a pulsed 
EPR experiment called double electron-electron resonance (DEER), rather than the 
continuous wave EPR experiment. In DEER experiments, the goal is to measure 
interprobe distance just like FRET in fluorescence spectroscopy. While making the same 
kind of distance measurement and inferring conformational change in a protein from it, 
DEER has a few advantages over FRET that make it an attractive spectroscopy to utilize. 
(1) DEER only requires use of a single label type, which makes labeling a protein, 
particularly for intramolecular distance measurements, considerably more 
straightforward. (2) A spin label is generally much smaller than a fluorescent probe, 
which usually makes it less perturbing to the protein’s structure and function. (3) DEER 
is more sensitive to conformational heterogeneity in the sample and can quantify degree 
of static disorder in the sample. And lastly, DEER can be done on more complex 
samples. DEER does have two principal disadvantages relative to FRET: (1) It is less 
sensitive, requiring much higher concentrations (micromolar vs nanomolar) and 
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acquisition time (hours vs seconds). (2) It’s distance dependence is less steep (R-3 vs R-6), 
making background correction a more significant problem.  
The way DEER measures an interprobe distance ultimately stems from a dipolar 
interaction between two spins that are in close proximity (R<10nm, as in FRET). The 
interaction is generated with a series of microwave pulses applied at different 
frequencies. The main pulse sequence used in the DEER experiment is a spin echo 
sequence.15 The spin echo pulse sequence first applies a 90° pulse to the sample to shift 
the net magnetization vector into the transverse plane. Since the sample is once again in 
an external magnetic field so that the Zeeman Effect can provide the necessary splitting 
for excitation of the spin transition, the net magnetization vector is initially going to be 
aligned with the external field. After the 90° pulse places the net magnetization vector in 
the transverse plane, different spins with different chemical environments begin to 
precess at different frequencies, and coherence is lost. This represents transverse, T2, 
relaxation. After some period of time, τ, has passed, a second pulse is applied at the same 
frequency though this time it’s a 180° pulse that inverts magnetization vectors. After the 
180° flip, each spin’s precession results in a building up and subsequent loss of 
magnetization along the axis of detection in the transverse plane, which constitutes the 
echo (Figure 1.8, top). This spin echo pulse sequence is only applied to a subpopulation 
of spins in the sample and the frequency at which it is applied is referred to as the observe 
frequency, νobs. However, as this observe frequency pulse sequence is being applied, a 
second frequency referred to as the pump frequency, νpump, is being used for application 
of additional pulses that invert spins of a different subpopulation of spins in the sample. 
This spin inversion is accomplished through application of a 180° pulse at νpump. If the 
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inverted spins are in close proximity to the spins being subjected to the spin echo pulse 
sequence, the precession of the spin echo spins is altered through the dipolar interaction, 
ultimately resulting in a decrease in the amplitude of the measured spin echo. The 
strength of the dipolar interaction is inversely proportional to the cube of the distance 
between spins, which is where interprobe distance will be derived. To ultimately extract 
the distance between spins from the change in echo amplitude, however, the νpump 180° 
pulse has to be applied at varied time points during the spin echo pulse sequence to 
assemble a DEER waveform. The DEER waveform is a plot of the echo amplitude as a 
function of time at which the 180° pump pulse is applied. As the time at which the pump 
pulse is increased, disruption of spin precession eventually reaches a maximum 
modulation depth at which point subsequent increases in the time at which the pump 
pulse is applied only promotes echo amplitude oscillation about a mean value (Figure 
1.8). The initial rate of echo amplitude decay and the frequency of its modulation are 
directly related to distance between two spins. The closer two spins are, the faster the 
decay and the higher the frequency of oscillations. The oscillations in the waveform are 
also a readout on order within the protein. If a protein is conformationally heterogeneous, 
the oscillations are dampened out. If the protein is highly ordered, oscillations are more 
prominent. 
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Figure 1.8. Four pulse DEER experiment.15 The observe frequency (νobs) moves the net 
magnetization vector of a subpopulation of spins to the transverse plane and during time 
τ1, coherence is lost. A refocusing pulse is then applied such that coherence transiently 
returns to generate a spin echo. It is during this period that the pump pulse at νpump is 
applied to invert spins in a second subpopulation of spins in the sample. Varying the time 
at which the pump pulse is applied during time period τ2 results in differing degrees of 
dipolar disruption to observe spin precession, resulting in loss of echo amplitude that 
generates the DEER waveform. 
 
 When a protein sample is labeled with two spin labels, performing DEER to 
obtain a waveform allows for a distance measurement to be made and for conformational 
changes to be subsequently inferred. In we consider the same example discussed above 
for FRET, if our two-domain protein exists in a compact conformation when not bound to 
actin filaments, the two spins will be in close proximity resulting in stronger dipolar 
interactions. This will lead to a DEER waveform with a faster decay and higher 
frequency oscillations (Figure 1.9). If the protein’s two domain then undergo separation 
upon binding actin, the distance between spins will increase and the dipolar interaction 
strength will decrease. Consequently, the rate of echo amplitude decay will slow and 
oscillations will have a lower frequency (Figure 1.9). 
 
Figure 1.9. Example of DEER-based distance measurement to determine conformation 
of a protein and the amount of conformational heterogeneity. 
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1.3 – Structural biology questions relevant to this thesis 
1.3.1 – The spectrin superfamily of proteins and their actin-binding domains 
 Actin-binding domains (ABDs) are found in several different cytoskeletal 
proteins found throughout many different cell types. Some notable examples of such 
proteins include dystrophin, utrophin, α-actinin, β-spectrin, fimbrin, plectin and nesprin.16 
These proteins all generally function as cytoskeletal integrators, meaning they bind some 
cytoskeletal structure such as actin or microtubules and link them to either other 
filaments or to membrane-embedded proteins which could be localized to either the 
plasma or nuclear membrane.16 The relevance of such linkages depends on the protein in 
question. In the case of dystrophin, its linkage of the muscle actin cytoskeleton to the 
dystroglycan complex in the sarcolemma17, 18 aids in the transmission of force from the 
sarcomere to the extracellular matrix through its indirect linkage to proteins like 
laminin.19, 20 The importance of this dystrophin linkage is readily apparent in the types of 
muscular dystrophy known as Duchenne and Becker muscular dystrophy (DMD and 
BMD, respectively), where missense or nonsense mutations lead to a loss of functional 
dystrophin resulting in loss of sarcolemma integrity and ultimately muscle fiber 
degeneration.21 In the case of β-spectrin (particularly βIII-spectrin), the protein links 
cortical actin to the plasma membrane of Purkinje cells in the cerebellum. Spectrin plays 
a similar membrane stabilizing role that, when disrupted, leads to fragility of membrane 
structures.22 Within Purkinje cells specifically, βIII-spectrin seems to be particularly 
important for maintenance of dendrite membrane structures, as an in-cell deletion of the 
protein results in dendrite degeneration.23 This functional role, similar the observation 
made for loss of dystrophin, is also readily appreciated in a disease context. Mutations 
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that alter βIII-spectrin’s interaction with actin change its ability to maintain dendrite 
processes24, resulting in spinocerebellar ataxia type 5 (SCA-5), a condition where motor 
coordination mediated by the cerebellum is impaired. Without the Purkinje cell’s normal 
expansive dendrite tree, the capacity for integration of motor sensory inputs is 
significantly diminished. In the case of the protein α-actinin, two α-actinin protein 
molecules form antiparallel dimers so that both ends of the molecule have ABDs that can 
bind actin filaments. This allows for α-actinin to act as an actin filament cross linker in 
several cell types.25 
Each of the proteins mentioned above ultimately binds to actin by utilizing 
calponin-homology (CH) domains termed CH1 (most N-terminal in sequence) and CH2 
(more C-terminal in sequence) which are located in tandem. The tandem CH domains 
thus comprise all ABDs found in the spectrin superfamily and are found at the N-
terminus of their filamentous structures. While other regions of certain spectrin 
superfamily proteins (particularly dystrophin and utrophin) do have other segments 
capable of binding actin despite not being made up of CH domains26, 27, these regions are 
found within the spectrin-like repeats that make up the rod domain of each protein and 
are not the focus of the thesis research. The focus of Chapters 2 and 3 will only be on the 
ABDs composed of tandem CH domains.  
Given their ubiquity and diverse roles in cytoskeletal functions, ABDs became of 
significant interest to biochemists and structural biologists and the mechanism by which 
these protein domains bound actin became the focus of intense research. In some of the 
earliest studies elucidating the mechanism of interaction between ABDs and actin, 
solution state NMR was the method of choice and it used small peptide fragments from 
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the putative ABD under study to define regions that associate with F-actin. These studies 
focused on dystrophin’s ABD and came up with the initial identification of residues that 
seemed important for association.28, 29 However, binding studies that systematically 
deleted these potential binding interface residues showed that not all residue regions 
contributed to binding and it was instead suggested that segments within the first 90-
residues were most important for the interaction with actin.30 When one of the first 
crystal structures of an ABD was solved from the protein fimbrin31 (Figure 1.10, left), the 
regions identified in these earlier peptide and regional deletion studies did not form a 
particularly obvious binding surface on the ABD molecule. The implicated regions were 
somewhat discontinuous and few of the residue segments were either contributing to the 
core fold of a CH domain or were partially buried at the interface between CH1 and CH2.  
 
 
Figure 1.10. Earlier crystal structures of ABDs showing possible variability in 
conformation of tandem CH domains. Fimbrin on the left (1AOA) and utrophin  on the 
right (1QAG) are shown as examples. 
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Not long after this structure, however, came the crystal structure of utrophin’s 
first ABD (Figure 1.10, right).32 Unlike fimbrin’s ABD, which crystalized as a compact 
monomer, utrophin’s ABD crystalized as a domain-swapped dimer where the two CH 
domains were in an extended conformation. Interestingly, the CH1 and CH2 domain 
interface identified in fimbrin was also found in the utrophin structure, it just involved 
CH1 and CH2 from different ABD molecules within the dimer. The structural 
comparison between fimbrin and utrophin lead to the hypothesis that utrophin’s ABD, 
and possibly dystrophin’s which crystalized in a similar manner33, might be more flexible 
compared to fimbrin and undergo some sort of conformational change in solution. What 
was not clear, however, was whether or not a more “open” extended conformation was 
what bound actin filaments or if the original, more compact “closed” conformation (as 
represented by fimbrin’s crystal structure) was binding competent. To answer this 
question, electron microscopy reconstructions of ABD-actin complexes were performed 
for a few ABDs. The results varied depending on the ABD studied with fimbrin 
appearing to bind in its “closed” conformation34 whereas utrophin exhibited a greater 
degree of diversity in its binding mode, though binding in an “open” conformation 
appeared to possible.35 As information accumulated on other ABDs, particularly disease-
causing mutations in α-actinin, electron microscopy was revisited to get a better 
mechanistic picture of binding and led to the proposal that CH2 sterically hinders binding 
and thus requires opening of the ABD for CH1-association.36 This was later supported by 
DEER experiments that, like the example depicted in Figure 1.9, used spin labels to 
measure inter-CH domain distance in utrophin’s ABD as a function of actin binding.37 It 
was found that, in the absence of actin, the interprobe distance was short, consistent with 
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CH1 and CH2 being in a “closed” state. However, when increasing concentrations of 
actin were added, the interprobe distance increased indicating separation of CH domains 
upon binding filaments. 
While the DEER experiments on utrophin’s ABD started to contribute more to the 
binding mechanism and were consistent with the CH domain-opening hypothesis, it was 
still unclear whether or not the binding mechanism was universal for all ABDs or even 
just similar to some ABDs. A continuation of this research question is what constitutes 
Chapter 3 of this thesis. DEER spectroscopy is once again used examine the ABD-actin 
binding mechanism but this time for utrophin’s homologue, dystrophin. 
The other element of the CH domain-opening hypothesis proposed from cryo-EM 
structures36 was in relation to the mechanism of disease-causing missense mutations. In 
α-actinin and many other ABDs of other spectrin superfamily of proteins38-40, several 
missense mutations are localized to the CH2 subdomain, the domain that was proposed to 
be a negative regulator of CH1 domain forming its binding interface with actin through 
steric hindrance. Importantly, most of these mutations result in a gain-of-function, where 
their affinity for actin is increased. Given this high frequency of mutations in CH2 and 
their common pattern of increasing ABD affinity for actin in vitro, it was proposed that 
these mutations promote opening of the CH domains, such that CH2 is less of a steric 
hindrance to CH1’s binding of actin.  
The content of Chapter 2 in this thesis contributes to the mechanistic 
understanding of these CH2-localized mutations. This missense-mutation opening 
hypothesis did not seem to match well with what crystallographers were seeing in their 
structural models. In α-actinin, for example, one of its gain-of-function mutations 
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(K255E) was shown to still crystalize in the canonical “closed” conformation41, 
ultimately being at odds with the proposed mechanism of disease.36 In Chapter 2, we try 
to help resolve this question by examining a different gain-of-function mutation but one 
that is from βIII-spectrin. This disease-causing mutation is localized CH2 and results in 
dramatically increased affinity for actin42, making it a good test subject for structural 
hypothesis testing. A combination of DEER spectroscopy, cryo-EM, and circular 
dichroism are all used synergistically in an attempt to elucidate the mechanism of CH2 
mutation-induced disease. 
 
1.3.2 – Synaptotagmins in exocytosis 
 Synaptotagmins are a class of integral membrane proteins that regulate vesicle 
trafficking events. The best-studied isoform of the family, synaptotagmin 1 (Syt 1), is 
specifically responsible for regulating synchronicity of neuronal exocytosis. Neuronal 
exocytosis of neurotransmitters is a complex process involving numerous synaptic 
proteins. Chief among the dozen or so proteins that promote docking, priming and 
ultimately fusion of a synaptic vesicle with the plasma membrane are synaptobrevin, 
SNAP-25, syntaxin, Munc18-1, Munc13, synaptotagmin 1 and complexin.43 The first 
three proteins mentioned are all SNARE proteins (soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor) which zipper together into a four-helix bundle that’s 
thought to bring membranes into close proximity for fusion (Figure 1.11).44 Munc18-1 is 
crucial for helping the proper assembly of the SNARE complex and it works together 
with Munc13 to help position the docked vesicle. Complexin is a small IDP that contains 
regions that fold upon binding various targets (including other proteins and also 
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membranes). In part of its central sequence is a SNARE complex-binding region that 
tightly associates with assembled SNARE complexes and is thought to stabilize it before 
it progresses to its completely zippered state that promotes membrane merger.45 
Complexin works in some fashion with Syt 1 such that complexin becomes displaced 
when Syt 1 binds calcium ions (Ca2+).46  
 
Figure 1.11. Simplified model of SNARE-synaptotagmin-mediated fusion of a synaptic 
vesicle with the plasma membrane. As the vesicle docks (left) the v-SNARE 
synaptobrevin (Syb) folds upon binding syntaxin(Syn)-SNAP-25 complexes that were 
assembled through use of Munc proteins. Complete zippering of the SNARE complex to 
its state of promoting membrane fusion is promoted upon action potential-induced influx 
of Ca2+ (right). 
 
Syt 1 itself seems to play a role in sensing the Ca2+ influx that ultimately triggers 
complete fusion of vesicle and plasma membranes, but the mechanism is not entirely 
clear. Syt 1 contains a single-pass transmembrane helix that anchors tandem C2 domains, 
Ca2+ and lipid-binding β-sandwiches, to the vesicle membrane (structure detailed further 
in Chapter 4). Binding lipids seems to be promoted by Ca2+ association to each C2 
domain, so one hypothesis for Syt 1’s promotion of fusion is that each of its two C2 
domains binds to opposing membrane surfaces and helps pull them closer together for 
SNARE-mediated fusion. In conjunction with lipid interactions, several structural studies 
suggest that the C2 domain, specifically the C2B domain, can bind to SNARE complexes 
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directly and that this interaction works together with membrane bridging to promote 
fusion.47, 48 
While much work has been done on the structural biology of Syt 1 C2 domains, 
considerably less effort has been put into studying the structure and function of the ~60 
residues that span between the transmembrane helix and the tandem C2 domains. The 
main assumption in the field is that the sequence is inert and just a flexible tether. This 
region is intrinsically disordered in solution, but initial studies that looked at its 
interaction with synthetic membrane suggest structural potential.49 Chapter 4 of this 
thesis aims to address the question of what this 60-residue Syt 1 IDR might be doing for 
function by examining the structural biology of a post-translational modification that 
occurs in its central region of sequence.  
*This chapter was reproduced in its entirety with permissions from the following article: 
Avery AW, Fealey ME, Wang F, Orlova A, Thompson AR, Thomas DD, Hays TS, 
Egelman EH. Structural basis for high affinity actin binding revealed by a β-III spectrin 
SCA-5 missense mutation. Nat Comm. 2017 8:1350.  
 
CHAPTER 2: STRUCTURAL BASIS FOR HIGH-AFFINITY ACTIN BINDING 
REVEALED BY A Β-III-SPECTRIN SCA5 MISSENSE MUTATION* 
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2.1 – Section Summary  
Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by 
mutations in the cytoskeletal protein β-III-spectrin. Previously, a SCA5 mutation 
resulting in a leucine-to-proline substitution (L253P) in the actin-binding domain (ABD) 
was shown to cause a 1000-fold increase in actin-binding affinity. However, the 
structural basis for this increase is unknown. Here we report a 6.9 Å cryo-EM structure of 
F-actin complexed with the L253P ABD. This structure, along with co-sedimentation and 
pulsed-EPR measurements, demonstrates that high-affinity binding caused by the CH2-
localized mutation is due to opening of the two CH domains. This enables CH1 to bind 
actin aided by an unstructured N-terminal region that becomes α-helical upon binding. 
This helix is required for association with actin as truncation eliminates binding. 
Collectively, these results shed light on the mechanism by which β-III-spectrin, and likely 
similar actin-binding proteins, interact with actin, and how this mechanism can be 
perturbed to cause disease.  
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2.2 – Introduction 
Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease that stems 
from autosomal dominant mutations in the cytoskeletal protein β-III-spectrin.50, 51 SCA5 
pathogenesis results from a functional deficit in Purkinje cells, in which the expression of 
β-III-spectrin is required for normal cerebellar control of motor coordination.52 β-III-
spectrin is thought to form a heterotetrameric complex with α-II-spectrin, and to cross-
link actin filaments to form a cytoskeleton localizing to the shafts and spines of Purkinje 
cell dendrites. β-III-spectrin is required for normal dendrite structure23 and synpatic 
transmission53, 54. Recently, our group reported that a SCA5 missense mutation, L253P, 
localized to the β-III-spectrin N-terminal actin-binding domain (ABD), causes a ~1000-
fold increase in actin-binding affinity.42 Here, we probe the structural mechanism of this 
mutation by studying the ABD with complementary biophysical techniques. 
The β-III-spectrin ABD is comprised of tandem calponin homology (CH) 
domains and the L253P mutation is localized to the second subdomain (CH2). Very little 
is known about the structural biology of β-III-spectrin’s ABD, with the closest related 
atomic model being the isolated CH2 domain of β-II-spectrin.55 Crystal structures of N-
terminal ABDs from the spectrin superfamily, including α-actinin, dystrophin and 
utrophin, invariably show that extensive contacts are made between CH1 and CH2, 
suggesting a tendency to exist in a “closed” conformation without actin.32, 33, 56, 57 A cryo-
EM structure of the fimbrin ABD shows that it associates with actin in a closed structural 
state.58 In contrast, cryo-EM showed that α-actinin associates with actin in an “open” 
structural state in which only a single CH domain is bound to the filament and the second 
domain is structurally disordered on account of it being dissociated from the interacting 
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CH domain.36 A similar conclusion was reached for filamin59, another member of the 
spectrin superfamily. Binding studies suggested that the CH1 domain of α-actinin has 
greater intrinsic affinity for actin in isolation60 and this suggested that it was CH1 bound 
in the cryo-EM structure. This led to the hypothesis that the CH2 domain functions to 
regulate the actin-binding function of CH1 through steric hindrance when the two 
domains are associated. Consistent with this, many mutations in the CH2 domains of both 
α-actinin and filamin impart modest gains in ABD affinity for actin.39, 61 Collectively, 
these studies suggest that the L253P mutation of β-III-spectrin, which is similarly 
localized to CH2, causes high-affinity actin binding by disrupting a regulatory 
mechanism that shifts the ABD structural equilibrium from a closed to more open 
binding-competent state. Here, we report cyro-EM, co-sedimentation and pulsed EPR 
data consistent with such a mechanism. 
 
2.3 – Results 
2.3.1 – Structure of L253P β-III-spectrin ABD bound to actin  
To begin testing our hypothesis, we first performed cryo-EM on the β-III-spectrin 
ABD bound to actin filaments. The actin-binding affinity of the wild-type (WT) β-III-
spectrin ABD is low (Kd =75µM), resulting in poorly decorated actin filaments that were 
of insufficient quality for analysis (Fig. 2.4a). The L253P ABD yielded high quality 
complexes of decorated filaments (Fig. 2.4b,c), enabling a three-dimensional 
reconstruction (Fig. 2.1a) of the mutant ABD-actin complex at 6.9  Å resolution (Fig. 
2.5). This represents a substantial improvement over previous ABD-actin 
reconstructions36, 58, 62, the best of which was 12 Å. The reconstruction and resulting 
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atomic model provide several mechanistic insights. First, the density map reveals that 
only a single CH domain is bound to actin, as observed previously for the α-actinin ABD. 
Second, the bound CH domain has an additional N-terminal helix that is tightly 
associated with actin (Fig. 2.1b, red). This helix was not identified in other ABD-actin 
cryo-EM complexes. However, reexamination of the α-actinin-actin reconstruction36 
suggests that extra density is present, consistent with such an N-terminal helical 
extension. By comparison, the higher resolution fimbrin-actin reconstruction58, 
containing closed CH domains, shows no extra density. The presence of this contiguous 
N-terminal helix unambiguously identifies the bound domain as CH1. Thus, high-affinity 
actin binding, caused by the L253P mutation in the CH2 domain, is mediated through the 
CH1 domain. The L253P mutation does not expose or generate a de novo high-affinity 
actin binding site in the CH2 domain, as has been suggested previously.63  
All N-terminal ABDs contain amino acid sequences of variable length and 
composition preceding the conserved CH1 domain. However, a structured N-terminal 
region preceding the globular fold of a CH domain has not been previously observed in 
most reported ABD crystal structures. This reflects either disorder in this region or the 
intentional truncation of the region based on predicted intrinsic disorder.64 However, 
when calmodulin was crystallized with the plectin ABD, calmodulin was bound to the N-
terminal region which had become α-helical.64 Solution studies confirmed that in the 
absence of calmodulin, the plectin N-terminal region is unstructured. The β-III-spectrin 
CH1 domain with the extended N-terminal helix built into the cryo-EM map 
superimposes very well with the corresponding plectin CH1 domain with calmodulin 
(Fig. 2.6), and shows that calmodulin would be involved in massive clashes with actin. 
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As proposed this explains how calmodulin, in the presence of Ca2+, dissociates the plectin 
ABD from actin since the binding of actin and calmodulin is competitive.65  
 
 
Figure 2.1. Cryo-EM map and model of L253P β-III-spectrin ABD bound to actin. (a) 
The map (left, gray transparent surface) has been fit with a model for actin (cyan) and the 
β-III-spectrin ABD (magenta). On the right, the surface of the reconstruction has been 
color coded for the two actin strands (blue and green) and the β-III-spectrin ABD 
(magenta). (b) Close-up view of (a) showing that the CH1 domain has an additional N-
terminal helix (red) interacting with F-actin. The actin subdomains (SD1, SD2, SD3 and 
SD4) have been labeled on one actin subunit, while SD1’ and SD2’ are labeled on a 
different subunit. 
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Figure 2.2. The β-III-spectrin N-terminus is required for actin binding. (a) Coomassie 
blue stained gel of purified wild-type ABD or wild-type ABD without the N-terminal 51 
amino acids (A52).  (b) F-actin co-sedimentation assays showing that the N-terminal 
truncation abolishes actin affinity.  (c) CD spectra demonstrating α-helical absorption 
profiles. The A52 ABD has a statistically significant increase in helicity (n=3). (d)  CD 
denaturation at 222nm.  The A52 ABD has a statistically significant increase in Tm (n=3). 
 
 
 
2.3.2 – N-terminal residues of β-III-spectrin ABD are essential for actin binding  
The β-III-spectrin cryo-EM structure showing the N-terminal helix bound to actin 
suggests that the helix must contribute to binding affinity. To test this, we measured 
affinity of WT ABD with and without the first 51 amino acids (A52). Strikingly, 
truncation of the N-terminal sequence abolished binding of the ABD to actin (Fig. 
2.2a,b). Circular dichroism (CD) indicates that this loss in binding is not due to 
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misfolding (Fig. 2.2c,d). On the contrary, the A52 ABD showed small but reproducible 
increases in helicity and stability, suggesting that the N-terminal residues contain intrinsic 
disorder, which we verified by CD (Fig. 2.7). Collectively, these data sets, combined with 
the cryo-EM structural model, indicate that the N-terminal sequence is critical to binding, 
both directly by interacting with actin and potentially indirectly through allosteric 
destabilization of the ABD, the latter of which may alter the ABD conformational 
ensemble to impact binding. Evidence supporting an allosteric contribution comes from 
recent folding and binding studies on the utrophin ABD1 which showed that the utrophin 
N-terminal residues destabilize ABD1 and are required for full ABD1 binding activity.  
The utrophin N-terminal residues alone do not bind actin.66 
 
Figure 2.3. DEER measurement showing the L253P mutation opens the β-III-spectrin 
ABD structure. Echo amplitude decays of WT ABD (blue) and L253P ABD (purple) 
along with their corresponding Tikhonov fits are shown on the left. The inter-probe 
distances derived from Tikhonov regularization (Fig. 2.9) for both WT and L253P ABDs 
are shown on the right. The WT ABD distance distribution is centered at 4.8 nm, 
consistent with the distance predicted in the homology model of the closed state shown in 
Fig. 2.8. Upon introduction of the L253P mutation, the distance distribution undergoes a 
shift to populate a longer inter-probe distance, visible as a shoulder to the right of the 4.8 
nm peak, consistent with structural opening of the ABD.  
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2.3.3 – L253P mutation in β-III-spectrin ABD promotes structural opening of CH 
domains  
Previously we demonstrated that the L253P mutation substantially destabilizes the 
ABD (ΔTm = -14.8 C).  If the open structural state of the ABD is responsible for high-
affinity actin binding, then decreased stability may facilitate opening of the CH domains 
from a closed state. In our previous structural homology model of the β-III-spectrin ABD 
in the closed structural state42, L253 is positioned at the CH domain interface (Fig. 2.8), 
suggesting that the L253P mutation could also perturb CH1-CH2 interactions that 
stabilize the closed structural state. To test this hypothesis, we used double electron-
electron resonance (DEER) to measure inter-CH domain distance with and without the 
L253P mutation. We exploited the native cysteine residues at positions 76 and 231 for 
irreversible attachment of spin labels. 
For WT ABD in the absence of actin, clear oscillations were present in the echo 
amplitude decay (Fig. 2.3). Analysis (Fig. 2.9) revealed an inter-probe distance centered 
at 4.8 nm (Fig. 2.3) which agrees well with the distance predicted for the closed structural 
state (Fig. 2.8). Upon introduction of the L253P mutation, the distance distribution 
undergoes a shift to populate a longer inter-probe distance, visible as a shoulder to the 
right of the 4.8 nm peak. This indicates that the ABD undergoes an opening as a result of 
the mutation (Fig. 2.3), consistent with the cryo-EM structure showing that CH1 
separates from CH2 upon associating with actin (Fig. 2.1). 
In the context of other ABDs harboring disease-causing mutations, a similar 
structural mechanism has been proposed for the K255E mutation of α-actinin-4, a 
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missense mutation also located at the CH domain interface. This mutation caused 
increased affinity for actin, but the crystal structure showed the ABD of mutant α-actinin-
4 to be in a closed state.41 While seemingly counter to our proposed mechanism here, the 
DEER-derived distance distributions indicate that the shift to an open conformer is not 
complete (Fig. 2.3). Only a small portion of the population exists in the more open state 
in the absence of actin, with the remaining ensemble occupying the closed conformer. 
Given that crystallographic conditions favor more stable conformers, the K255E mutant 
may open, similar to L253P β-III-spectrin, but crystallize in its more stable closed state 
because it is more significantly populated.  
 
2.4 – Discussion 
SCA5 pathology is characterized by atrophy of the cerebellum67, likely reflecting 
degeneration of dendritic arbors extended by Purkinje cells. Within dendrites, β-III-
spectrin binds to actin filaments to form a spectrin-actin skeleton underlying the plasma 
membrane.68 The low affinity of WT β-III-spectrin for actin suggests that normal 
membrane function requires a dynamic spectrin-actin cytoskeleton in which spectrin-
actin linkages form and dissociate. We suggest that the high affinity of L253P β-III-
spectrin for actin decreases dynamics of spectrin-actin linkages, resulting in reduced 
plasticity of the spectrin-actin cytoskeleton. We speculate that spectrin-actin cytoskeleton 
plasticity is important for the cytoskeleton to expand or retract within structurally 
dynamic regions of the dendritic arbor, such as growing or remodeling dendrites and 
spines. Recent work has highlighted the requirement of β-III-spectrin to support dynamic 
spine structure and post-synaptic signaling.54 In addition, disrupted microtubule-based 
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transport has been reported for the L253P mutation69, and these transport defects may 
disrupt arborization and contribute to SCA5 pathogenesis. Disrupted transport may be 
secondary to defects in microtubule tracts that are organized by the spectrin-actin 
cytoskeleton70-73, and/or result from the direct impact of high-affinity binding of L253P 
β-III-spectrin to the actin-related protein, ARP174, a component of the dynactin complex 
that facilitates cargo transport by microtubule motor proteins.75, 76 
Collectively, the 6.9 Å cryo-EM structure, binding studies, and DEER distance 
distributions converge on a structural mechanism for disease. The CH2 domain-localized 
L253P mutation perturbs a closed-open structural equilibrium in β-III-spectrin’s ABD by 
lowering the energetic barrier between structural states. The ABD is then relieved of its 
regulatory mechanism allowing for the CH1 domain to interact with actin filaments, 
aided by an additional N-terminal unstructured region that becomes helical upon binding 
actin. 
 
2.5 – Materials and Methods 
2.5.1 – Protein Purification 
For cryo-EM analyses, the wild-type or L253P human β-III-spectrin ABD coding 
sequences contained in pET-30a-ABD WT or pET-30a-ABD L253P vectors were 
expressed in E. coli BL21(DE3) (Novagen). ABD proteins were both purified using a 
HiTrap Q 5 mL ion-exchange column followed by a Superdex 200 size exclusion column 
(GE Healthcare Life Sciences).42   Elution fractions of the Superdex 200 column 
containing pure ABD proteins as assessed by SDS-PAGE were pooled and concentrated 
(Amicon Ultra-4 Centrifugal Filter, 10 K MWCO). A Bradford assay (Biorad) was then 
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used to determine protein concentrations which equaled 44.0 and 40.6 µM for wild-type 
and L253P, respectively. ABD proteins were stored on ice until preparation of ABD-F-
actin complexes.  
To test the contribution of the N-terminus to actin-binding affinity, the coding 
sequences for wild-type ABD (amino acids 1-284) or truncated wild-type ABD (amino 
acids 52-284) were PCR amplified using the forward primer 
AAACACCTGCAAAAAGGTATGAGCAGCACGCTGTCACCC or 
AAACACCTGCAAAAAGGTGCAGATGAACGAGAAGCTGTGC and reverse primer 
AAATCTAGACTACTTCATCTTGGAGAAGTAATGGTAGTAAG.  PCR products 
were digested with AarI and Xba1 restriction enzymes and ligated into the BsaI site of 
pE-SUMOpro (LifeSensors) containing His and SUMO tags.  The final constructs pE-
SUMO-ABD WT and pE-SUMO-A52-ABD WT were sequence verified and transformed 
into E. coli BL21 (DE3)pLysS (Agilent).  Transformed bacteria were incubated with 
rotation at 27C in flasks containing 1L LB media with 100 µg per mL ampicillin and 50 
µg per mL chloramphenicol until an absorbance of 0.5 at 550 nm was reached. Then 
flasks were placed in ice for 10 min before addition of IPTG to 0.5 mM final.  The flasks 
were then incubated with rotation for 4 h in a 22C water bath.  Bacteria were harvested 
at 5,000 x g and pellets stored at -20C.  Bacteria were lysed with lysozyme (Sigma) for 1 
h at 4C in buffer containing 50 mM Tris, pH 7.5, 300 mM NaCl, and 25% sucrose with 
protease inhibitors (Complete Protease Inhibitor tablet, EDTA-free, Roche), followed by 
a freeze-thaw cycle using an isopropanol-dry ice bath.  Then MgCl2 to 10 mM final and 
DNase1 (Roche) to 7.5 U per mL final were added and lysate incubated for 1 h at 4C.  
Lysate was clarified at 40,000 x g at 4C for 30 min.  Supernatants were collected and 
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passed through a 0.45 µm syringe filter before loaded onto a Poly-Prep (Biorad) 
chromatography column containing 1 mL Ni-NTA agarose (Qiagen) equilibrated in 
buffer containing 50 mM Tris, pH 7.5, 300 mM NaCl and 20 mM imidazole.  The 
column was washed with buffer containing 50 mM Tris, pH 7.5, 300 mM NaCl and 20 
mM imidazole, and proteins eluted in buffer containing 50 mM Tris, pH 7.5, 300 mM 
NaCl and 150 mM imidazole.  Fractions containing ABD proteins were pooled and 
loaded into a Slide-a-Lyzer, 10K MWCO, dialysis cassette (ThermoScientific), and 
dialysis performed at 4C in buffer containing 25 mM Tris, pH 7.5, 150 mM NaCl and 5 
mM β-mercaptoethanol.  To cleave off the SUMO tag, Ulp1 SUMO protease was added 
to dialyzed ABD proteins at a 1:14 (protease:ABD) mass ratio,  and digests incubated for 
1.5 h at 4C. To separate ABD proteins from the cleaved His-SUMO tag and His-tagged 
SUMO protease, ABD proteins were loaded onto a Poly-Prep chromatography column 
containing 0.5 mL Ni-NTA agarose equilibrated in 25 mM Tris, pH 7.5, 150 mM NaCl, 
and 5 mM β-mercaptoethanol.  Elution fractions containing ABD proteins were collected 
and then loaded onto a gel filtration column (Sephadex S100, GE) equilibrated in buffer 
containing 10 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2 and 1 mM DTT at 4C.  
Fractions were analyzed by SDS-PAGE and Coomassie blue staining, and fractions 
enriched with ABD proteins were pooled and concentrated (Amicon Ultra-15 Centrifugal 
Filter, 10 K MWCO). 
For DEER analyses, the wild-type and L253P ABD proteins were modified to 
substitute a serine residue in place of cysteine 115.   Spin labeling was performed using 
native cysteines of which the β-III-spectrin ABD contains four (C76, C115, C186, C231), 
and C76, C115 and C231 are all solvent exposed.  Residues C76 and C231 were best 
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suited for DEER distance measurements, so C115 was mutated to serine to prevent non-
specific labeling at that site. The C186 site did not require mutagenesis because it is 
naturally buried in the core of CH2 and would thus not be accessible to free spin label in 
solution. PCR site-directed mutagenesis was performed on pET-30a-ABD WT and pET-
30a-ABD L253P vector templates using the oligonucleotides CATGCGGATCCACTC-
CCTGGAGAACGTG and CACGTTCTCCAGGGAGTGGATCCGCATG. The resulting 
constructs pET-30a-ABD WT C115S and pET-30a-ABD L253P C115S were sequence 
verified, and then transformed into E. coli BL21(DE3).  The ABD C115S proteins were 
purified as described above.42 For structural studies of the β-III-spectrin N-terminal 
residues, a small peptide corresponding to residues 
SSTLSPTDFDSLEIQGQYSDINNRWDLPDSDWDNDSSSARLFERSRIKALA was 
produced via solid-state synthesis through Selleck Chemicals LLC. 
 
2.5.2 – Cryo-EM ABD-actin  
5 µM of rabbit skeletal muscle G-actin was polymerized in 15 mM Hepes-HCl 
buffer, pH 7.5, 75 mM KCl, 1 mM MgCl2, and 0.5 mM ATP for 2 h at room temperature. 
For negatively stained samples 2 µM F-actin was incubated with 5-10 µM wild-type β-
III-spectrin or with 2-5µM β-III-spectrin mutant L253P for 2-20 min. For cryo-samples 
1.5 - 2µL of the mixture was applied to lacey carbon grids that were plasma cleaned 
(Gatan Solarus) and vitrified in a Vitrobot Mark IV (FEI, Inc.). Grids were imaged in a 
Titan Krios at 300 keV, and recorded with a Falcon II direct electron detector at 1.05 Å 
per pixel, with seven “chunks” per image. Each chunk, containing multiple frames, 
represented a dose of ~ 20 electrons per Å2. A total of 586 images (each 4k x 4k) were 
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selected that were free from drift or astigmatism, and had a defocus less than 3.0 μm. The 
program CTFFIND377 was used for determining the Contrast Transfer Function (CTF) 
and the range used was from 0.6 to 3.0 μm. The SPIDER software package78 was used for 
most subsequent steps. The CTF was corrected by multiplying each image by the 
theoretical CTF, both reversing phases where they need to be reversed and improving the 
Signal-to-Noise ratio. The program e2helixboxer within EMAN279 was used for boxing 
long filaments from the micrographs. Overlapping boxes, 384 px long with a 40 px shift 
between adjacent boxes (~ 1.5 times the axial rise per subunit) were extracted from these 
long filaments, yielding ~ 60,000 segments that were padded to 384 x 384 px. The CTF 
determination and particle picking came from the integrated images (all seven chunks), 
while the segments used for the initial alignments and reconstruction came from the first 
two chunks. 
An initial reconstruction using the IHRSR method80 showed clear decoration of 
actin, but the mass density due to β-III-spectrin was lower than that from the actin. This 
appeared to arise from incomplete occupation. We therefore used atomic models of pure 
actin and actin decorated with α-actinin36 to sort the segments. Only ~ one-third of the 
segments showed a higher cross-correlation with the decorated filament, and 20,340 
segments were used for further processing. The IHRSR cycles converged to a rotation of 
-166.9° and an axial rise of 27.3 Å per subunit. After excluding segments with a large 
out-of-plane tilt or poor orientation against the reference, 12,443 segments were used in 
the final reconstruction. 
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2.5.3 – Model building  
An actin-spectrin asymmetric unit was segmented from the filament map in 
Chimera.81 Model building began by docking cryo-EM structure of actin (5JLH)82 and a 
predicted model of spectrin CH1 domain into the experimental density data. This 
predicted spectrin model was generated by I-TASSER83 based on a crystal structure of 
plectin (1MB8)84. Then the actin-spectrin complex was rebuilt with RosettaCM 
protocols.85 A total of 1,500 models were generated, and the 10 best models (selected 
based on Rosetta’s energy function) were combined into one model by manual editing in 
Coot86 to yield the best overall fit to the density map. A filament model was subsequently 
generated from this and refined by Phenix real-space refinement.87 MolProbity88 was 
used to evaluate the quality of the model (Table 2.1). The MolProbity scores for the 
actin-spectrin filament models compare favorably (99th percentile) with structures of 
similar resolution. 
Although segments were sorted to exclude naked actin, Phenix refinement of the 
actin-spectrin reconstruction clearly shows that the occupancy by spectrin is not 100% 
percent, and the actual occupancy is ~ 75%. Therefore, the threshold chosen for the 
filament needed to show the full volume for spectrin shows a somewhat larger and lower 
resolution actin. 
 
2.5.4 – Co-sedimentation assays 
Actin was purified from acetone powder derived from the psoas muscle of New 
Zealand white rabbit.89 Acetone powder was hydrated in 4°C water for 30 minutes to 
extract actin. The resultant slurry was passed through a Whatman filter paper and 30 mM 
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KCl was added to the filtrate to polymerize actin for a period of 1 hr at room temperature.  
Filamentous actin was then pelleted by 30 minute centrifugation at 80,000 rpm in a TLA 
100.3 rotor. The actin pellet was resuspended in buffer containing 5 mM Tris pH 7.6, 0.5 
mM ATP, 0.2 mM MgCl2 and homogenized on ice. A 10 minute clarifying spin at 70,000 
rpm was then performed to pellet aggregate proteins. The G-actin containing supernatant 
was then isolated and polymerization was initiated by addition of 2 mM MgCl2 with a 30 
minute incubation at room temperature. The purified ABD proteins were clarified at 
100,000 x g at 4C for 30 min prior to setting up binding assays.  A Bradford assay was 
performed to determine F-actin and clarified ABD protein concentrations.  Binding 
assays were performed in F-buffer containing 10 mM Tris, pH 7.5, 150 mM NaCl, 0.5 
mM ATP, 2 mM MgCl2 and 1 mM DTT.  Binding reactions contained 3 µM ABD protein 
and F-actin ranging from 0 to 140 µM in a total volume of 60 µL.  Binding reactions 
were incubated at room temperature (23-24C) for 30 min to reach equilibrium, and then 
F-actin pelleted by centrifugation at 100,000 x g at 25C for 30 min.  Unbound ABD was 
measured by combining 45 µL of binding reaction supernatant with 15 µL 4x Laemmli 
sample buffer and performing SDS-PAGE followed by Coomassie blue staining.  After 
destaining, gels were scanned using the 700 nm channel in an Odyssey Imager (LI-COR 
Biosciences). The fluorescence intensities of the ABD protein bands were quantified in 
Image Studio Lite Ver 5.2 software (LI-COR Biosciences).90 Individual ABD band 
fluorescence intensities were converted to amount ABD protein.  This conversion was 
performed using a standard curve generated by linear regression (Prism 5 software) on 
ABD Coomassie blue fluorescence intensity values attained from a SDS-PAGE gel 
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loaded with varying amounts of ABD in F-buffer.  To determine the dissociation constant 
(Kd) value, data were fit by non-linear regression in Prism 5 software to the equation: 
 
 Y = X/(Kd +X)         Eq. 2.1 
 
Where Y equals fraction ABD bound and X equals free F-actin concentration.   
 
2.5.5 – Circular dichroism  
ABD proteins were clarified at 100,000 x g for 20 min at 4C.  A Bradford assay 
was performed to determine ABD protein concentrations, and ABD proteins were diluted 
to 250 ng/µL in buffer containing 10 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2, 1 
mM DTT.  CD spectra were acquired in a Jasco J-815 Spectropolarimeter equipped with 
a Peltier temperature controller.  Immediately before analysis, the instrument was 
baseline-corrected using ABD protein buffer.  For secondary structure analyses, CD 
spectra were measured from 200 nm and 260 nm at 25C.  Thermal unfolding of the 
ABD protein sample was analyzed by recording CD spectra at 222 nm over the 
temperature range of 20C-85C.  CD analyses were performed three times for each ABD 
protein.  Non-linear regression analysis was performed in Prism 5 (GraphPad Software, 
Inc.) to determine the melting temperature using the following equation for a two-state 
transition, as reported previously91: 
 
Y = (αN + βNT)/(1 + e4T)        Eq. 2.2 
 
44 
 
 
For secondary structure analysis of the N-terminal peptide, a lyophilized powder was 
reconstituted in the same buffer system as that described for the ABD proteins. The 
reconstituted peptide was then diluted to a concentration of 99 ng per µL and 
subsequently scanned over the same wavelength range described above. In the case of 
both ABDs and peptide, raw ellipticity was normalized to each sample’s respective 
concentrations according to the following equation: 
 
MRE = [θ(MW/N – 1)]/(lc)        Eq. 2.3 
 
Where θ represents the raw ellipticity, MW represents the protein molecular weight, N is 
the number of amino acids, l is the path length, and c is the concentration in milligrams 
per milliliter. 
 
2.5.6 – Statistical analyses  
Unpaired t-tests were performed in Prism 5 software to determine whether 
significant differences existed in ABD protein melting temperatures or 222 nm/208 nm 
absorbance ratios determined by CD.  The n value was equal to three in all cases. 
 
2.5.7 – Spin labeling  
In the β-III-spectrin ABD constructs, 500 µM of the spin label 4-maleimido-
TEMPO (MSL, 4-maleimido-2,2,6,6-tetramethyl-1-piperidinyloxy; Sigma-Aldrich) was 
added to 25 µM protein and equilibrated on a rocker for 3 hours at 4 °C. Prior to addition 
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of MSL, the protein solution had been run over a Zeba desalting column pre-equilibrated 
with 10 mM Tris pH 7.5 and 150 mM NaCl to remove most of the 1 mM DTT left over 
from size exclusion. After the spin-label incubation period, the protein was once again 
subjected to a Zeba desalting column to remove any unreacted spin label. To ensure 
complete removal, however, the spin labeled protein was then subjected to three 4 h 
rounds of dialysis in 4 liter solutions contain 10 mM Tris pH 7.5, 150 mM NaCl and 1 
mM DTT. MSL was ultimately chosen over the more commonly used (1-oxyl-2,2,5,5,-
tetramethylpyrroline-3-methyl) methanethiosulfonate (MTSSL) because spin labeling of 
the β-III-spectrin ABD constructs was incomplete, requiring inclusion of DTT reducing 
agent post-labeling to prevent undesired ABD cross-linking. Incubation of the ABD 
constructs with spin label for periods longer than 3 hours resulted in significant protein 
loss due to precipitation. The spin labeled WT and L253P β-III-spectrin ABD constructs 
were concentrated down to 230 μM and 175 μM, respectively, prior to spin counting and 
DEER sample preparation. 
 
2.5.8 – EPR spectroscopy  
To verify labeling, a continuous wave (CW) electron paramagnetic resonance 
(EPR) spectrum was acquired with sample temperature of 296 K on the E500 Bruker 
EPR spectrometer operating at X-band (9.5 GHz) and equipped with a super high Q 
(SHQ) cavity. The derivative spectrum was then doubly integrated to determine spin 
concentration by comparing with the double integral of a 100 µM TEMPOL standard 
(Fig. 2.8b and 2.8c). For WT and L253P β-III-spectrin ABD constructs, spin 
concentrations were determined to be 98 μM and 75 μM, respectively, indicating a 
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labeling efficiency of ~43% for both. After spin counting, we performed double electron-
electron resonance (DEER) on β-III-spectrin ABD constructs doubly labeled with MSL. 
ABD samples were prepared by adding 7% v/v glycerol (as a cryoprotectant), loading 
samples into quartz capillaries (1.1 mm i.d., 1.6 mm o.d., 15 µL sample volume) and 
subsequently flash freezing samples in liquid nitrogen after which samples were stored at 
-80 °C until use. A Bruker E580 spectrometer operating at Q-band (34 GHz) with an 
EN5107 resonator was then used to implement a four-pulse DEER protocol with a π/2 
pulse width of 12 ns and an electron double resonance (ELDOR) pulse width of 24 ns.15 
The ELDOR frequency was set to the absolute maximum of the field swept nitroxide 
absorption spectrum and the observe position was set 24 G up-field. Experiments were 
run at a temperature 65 K. After data acquisition, background-corrected DEER decays 
were analyzed using the Tikhonov regularization method provided in DeerAnalysis2016 
to extract distance distributions encoded in the waveform (Fig. 2.9).92 To determine the 
stable components in the resulting Tikhonov distributions, we examined the impact of a 
range background models whose starting fit positions varied from 0.5 μs to 2.4 μs on the 
uncorrected waveform. The components that were invariable were used for structural 
interpretation of the ABD constructs. The component that was not stable (the peak at >7.0 
nm) was excluded from structural interpretation as it represents an artifact of background 
subtraction. 
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2.6 – Supporting Information 
 
a b
 
 
Figure 2.4. Electron microscopy of β-III-spectrin ABD-actin complexes. Negative 
staining of (a) WT ABD-actin showing poor decoration of filaments and (b) L253P 
ABD-actin. Cryo-EM was used (c) for the 3D reconstruction of the L253P ABD 
decorated actin filaments. Lacey carbon grids were used, with the filaments suspended in 
the holes within this carbon film. The carbon film is seen near the center of the image, 
with holes on both sides of it. The space bars in (a), (b) and (c) are 1,000 Å. 
 
c 
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Figure 2.5. Resolution of the Actin-spectrin filament reconstruction, estimated two 
different ways. (a) The resolution was derived from Fourier Shell Correlation (FSC) 
calculation between the refined atomic model and the map. (b) A “gold-standard” FSC is 
also calculated between two half maps. Given the relatively small number of segments 
used in the final reconstruction (~12k), splitting this into two halves to generate a 
conventional “gold standard” map:map FSC can be problematic, as the result from the 
half-maps is biased to a lower resolution than the full map.93 Nevertheless, this method 
yielded an estimate of 6.9 Å resolution at FSC=0.143. For the map:model comparison, 
we used FSC=0.38 where 0.38=√0.143. 
 
 
Figure 2.6. Comparison with calmodulin-bound plectin structure (4Q57). F-actin (gray), 
β-III-spectrin (pink), plectin (brown) and calmodulin (orange) are shown. Plectin model 
is aligned with spectrin using only the N-terminal helices (rmsd=0.8 Å), and a major 
clash would result between calmodulin and F-actin.    
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Figure 2.7. Circular dichroism spectra on a peptide corresponding to the β-III-spectrin N-
terminus.  The absorption profile is consistent with a disordered structure. 
 
 
Figure 2.8. Site-directed spin labeling of β-III-spectrin ABD. (a) Homology model 
generated for β-III-spectrin ABD from crystal structure of the closed state of α-actinin, 
indicating the approximate inter-probe distance (side chain-side chain distance of 4.5 nm, 
yellow dotted line) between two native cysteine residues (C76 and C231, magenta 
residues) and highlighting L253 in orange at the CH domain interface. (b and c) CW EPR 
spectrum (left) of MSL-labeled β-III-spectrin ABD and example spin count (right) for 
WT (blue) and L253P mutant (purple). Note probe mobility is as expected for cysteine 
residues located in loops. 
 
 
 
50 
 
 
Figure 2.9. DEER analysis of WT (blue) and L253P (purple) β-III-spectrin ABDs. (top 
row) Raw echo amplitude decays with optimal background. (middle rows) L-curve 
analysis indicating smoothing parameter chosen from Tikhonov fit of the echo amplitude 
decay. As the distance distributions from fitting the DEER waveform are highly sensitive 
to the choice of the background component, we examined the impact of a range 
background fits (varying the start of the fit from 0.5 μsec to 2.4 μsec on the uncorrected 
waveform). The components that were invariable with respect to choice of background 
were used for structural interpretation of the ABD constructs. The component that was 
not stable, and in some cases disappeared entirely (the peak(s) at >7.0 nm), was excluded 
from structural interpretation as it represents an artifact of background subtraction. 
(bottom row) Normalized echo amplitude decays fit with the Tikhonov model 
corresponding to the lowest RMSD.  
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 Actin-spectrin filament 
Clash score, all atoms  6.6 
Protein geometry  
  Ramachandran favored (%) 92.7 
  Ramachandran outliers (%) 0 
  Rotamer outliers (%) 0 
  Cβ deviations > 0.25 Å (%) 0 
RMS deviations  
  Bonds (Å) 0.01 
  Angles (°) 1.00 
MolProbity score 1.82 (99th, 3.25 Å – 7.25 Å) 
PDB ID 6ANU 
 
Table 2.1 – Refinement statistics for the actin-spectrin filament model by MolProbity.88 
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3.1 – Section Summary  
We have used pulsed EPR, calorimetry, and molecular dynamics simulations to 
examine the structural mechanism of binding for dystrophin’s N-terminal actin-binding 
domain (ABD1) and compare it to utrophin’s ABD1. Like other members of the spectrin 
superfamily, dystrophin’s ABD1 consists of two calponin-homology domains, CH1 and 
CH2. Several mutations within dystrophin’s ABD1 are associated with development of 
severe degenerative muscle disorders Duchenne and Becker muscular dystrophies, 
highlighting the importance of understanding its structural biology. To investigate 
structural changes within dystrophin ABD1 upon binding to actin, we labeled the protein 
with spin probes and measured changes in inter-CH domain distance using double 
electron-electron resonance (DEER). Previous studies on the homologous protein 
utrophin showed that actin binding induces a complete structural opening of the CH 
domains, resulting in a highly ordered ABD1-actin complex. In the present study, DEER 
shows that dystrophin ABD1 also undergoes a conformational opening upon binding F-
actin, but this change is less complete and significantly more structurally disordered than 
observed for utrophin.  Using molecular dynamics simulations, we identified a hinge in 
the linker region between the two CH domains that grants conformational flexibility to 
ABD1. The conformational dynamics of both dystrophin’s and utrophin’s ABD1 showed 
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that compact conformations driven by hydrophobic interactions are preferred, and that 
extended conformations are energetically accessible through a flat free energy surface. 
Considering that the binding free energy of ABD1 to actin is on the order of 6-7 
kcal/mole, our data are compatible with a mechanism in which binding to actin is largely 
dictated by specific interactions with CH1, but fine tuning of the binding affinity is 
achieved by the overlap between conformational ensembles of ABD1 free and bound to 
actin. 
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3.2 – Introduction 
Dystrophin (Dys) is a large muscle cytoskeletal protein of 427 kDa. Structurally, 
Dys consists of an N-terminal actin-binding domain (ABD1), 24 spectrin-like repeats that 
form the rod domain and house the second actin binding domain (ABD2), and a C-
terminal region containing a cysteine-rich domain that binds the dystroglycan complex.94 
The N- and C-terminal ends of the protein provide a biochemical picture of how Dys can 
link the costameric F-actin network to both the sarcolemmal membrane and extracellular 
matrix via the dystroglycan complex. This location in the cytoskeletal network of muscle 
is crucial for maintaining membrane and costamere integrity, a fact that is best 
appreciated in the context of Duchenne and Becker muscular dystrophies (DMD and 
BMD, respectively).95 In DMD and BMD, a multitude of mutations (missense and 
nonsense alike) in Dys lead to the development of muscle tissue degeneration. Patients 
with these forms of muscular dystrophy have elevated cytosolic calcium levels, indicative 
of an extracellular leakage of the ion through the sarcolemma due to focal membrane 
tears. Similarly, Dys-deficient model organisms, particularly mdx mice, show the same 
elevated cytosolic calcium phenotype.96  
The biophysical mechanism by which Dys protects the sarcolemma from 
mechanical stress is still an active research question. Dys contains several spectrin-like 
repeat domains (triple helix bundles) between the N-terminal ABD1 and C-terminal ZZ 
domain that anchors it to the dystroglycan complex. Atomic force microscopy has been 
used to unfold these types of protein domains from spectrin, showing that they have a low 
energy barrier to unfolding, which probably serves as a mechanical means to dissipate 
transduced force propagating through the costamere.97 However, independent of such a 
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mechanism is the impact Dys has on the actin cytoskeleton alone. Previously, it was 
shown that the large-scale bending and twisting motions of F-actin are greatly restricted 
when both Dys and its homologous partner utrophin (Utr) bind.98, 99 Intriguingly, the 
amplitude of these large scale motions is reduced, but the rate of motion is increased 
indicating that both Dys and Utr binding impart resilience to the actin cytoskeleton. Such 
an effect could be another means by which the two proteins dampen the laterally 
transduced force of contraction within the costamere. 
 
 
Figure 3.1. Proposed structural model for Dys ABD1 upon binding F-actin. In the 
absence of actin, the two adjacent CH domains are closely packed (closed state, blue). In 
the presence of actin, CH1 and CH2 can become more separated (open state, red) and 
sample multiple structural states. To see figure in color go on-line. 
 
While both Dys and Utr were found to restrict the amplitude of motion, the 
proteins were found to do so differentially, with Utr being the more restrictive of the two 
proteins.98, 99 Although it is unclear how such functional differences arise, a possibility is 
that they originate from differences in the structural binding modes of each protein’s 
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actin-binding domains. Previously, the Utr ABD1 was shown to undergo a 
conformational opening upon association with F-actin; Utr ABD1’s adjacent calponin-
homology (CH) domains transitioned from a more closed compact state to an open 
extended state forming a well-ordered and stable complex with F-actin.37 We propose 
here that the Dys ABD1 can also undergo a similar structural transition (Fig. 3.1), but 
with distinct nuances that could contribute to a less stable ABD1-F-actin complex and, in 
turn, a smaller restrictive contribution to overall filament motions. Indeed, spectroscopic 
evidence in support of Dys ABD1 having a distinct binding mode has been reported.100 
Several ABDs from proteins in the spectrin superfamily have been characterized 
in both open32, 33 and closed38, 41, 56 conformations using x-ray crystallography. Solution 
studies have converged on a similar finding; analytical ultracentrifugation41 and pyrene 
excimer fluorescence studies100 have identified ABDs in a closed conformation whereas 
pulsed-EPR experiments show an equilibrium between closed and more open 
conformations, specifically for utrophin’s ABD. This open/closed dichotomy persists 
when ABDs are bound to actin.  Both mutation studies101 and cosedimentation assays102 
suggest a predominant role played by CH1 to binding affinity, with CH2 adopting a 
regulatory role. Excimer fluorescence suggests that Dys ABD1 binds to actin in a closed 
conformation100, but DEER shows clearly that Utr ABD1 binds to actin in an open 
conformation37, and cryo-EM models suggest an open conformation for actin-bound α-
actinin and β-III-spectrin ABDs.36, 103 These observations suggest that ABDs are 
malleable domains whose conformations are susceptible to actin binding and, potentially, 
even to the small perturbations introduced by different experimental techniques. It is thus 
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appealing to hypothesize that the observed differences in Dys and Utr ABD1 interactions 
with actin stem from their distinct structural dynamics. 
To test this hypothesis in the present study, we have used a combination of double 
electron-electron resonance (DEER) experiments and molecular dynamics (MD) 
simulations to examine the conformational dynamics of Dys ABD1. By applying these 
methods in parallel, we were able to define a mechanism of Dys ABD1 binding to actin 
that is distinct from that of Utr ABD1, providing insight into the different physical 
properties of these two proteins that may contribute to physiological function. 
 
3.3 – Materials and Methods 
3.3.1 – Protein mutagenesis, expression, purification, and labeling 
A plasmid encoding the mouse Dys ABD1 protein fragment (residues 8-246) was 
subjected to mutagenesis using a Q5 ® Site-Directed Mutagenesis Kit (New England 
BioLabs) to remove the protein’s native cysteines and incorporate new cysteines at 
positions 120 and 239. These positions were chosen to mimic our previous study on Utr 
ABD1 and also because they were suitable for measuring the proposed distance changes. 
The mutated plasmid was then transformed into BL21 DE3 E. coli and subsequently 
grown to an OD of 0.7, at which point protein expression was induced with 2 mM IPTG 
per liter of growth. Use of mouse Dys ABD1 was chosen so that we could compare 
spectroscopic measurements to that of Utr ABD1 published previously, which was also 
from mouse.37 Expression was allowed to occur overnight at room temperature. After 
expression, cells were pelleted at 10,000 rpm. Cells were subsequently lysed in 50 mM 
Tris pH 8, 20% w/v sucrose, 1 mM EDTA and 1 mM DTT by incubation with lysozyme 
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for 1 hour at 4 °C, followed by freeze-thaw cycling in a dry ice isopropanol bath. The 
resulting lysate was then incubated with DNase I for 1 hour at 4 °C. All cell debris was 
removed from solubilized protein by centrifugation at 18,500 rpm in a SS-34 Sorvall 
rotor and was subsequently sterile-filtered through a 0.2 μm filter to ensure complete 
removal of particulates. The lysate was then loaded onto a GE 5 mL SP ion-exchange 
column and eluted over a linear gradient (0-500 mM) of NaCl buffered by 10 mM Tris 
pH 7.5, 1 mM EGTA, and 1 mM DTT. Elution fractions containing the ABD1 fragment 
were then concentrated and further purified using an S100 sepharose gel-filtration 
column. Protein fractions pooled after size exclusion were then dialyzed in buffer 
containing 10 mM Tris, 100 mM NaCl, 2 mM MgCl2 and 1 mM DTT at pH 8, buffer 
conditions under which actin-bundling does not occur.104 Final protein purity was verified 
by SDS-PAGE. 
For DEER experiments, a 5-fold excess (to cysteine residue concentration) of 4-
maleimido-TEMPO (MSL, 4-maleimido-2,2,6,6-tetramethyl-1-piperinyloxy; Sigma-
Aldrich) was added to a DTT-free Dys ABD1 sample and allowed to incubate for 3 h at 
25 °C. Free label was subsequently removed by 4 rounds of dialysis in 4 liters of 10 mM 
Tris, 100 mM NaCl, 2 mM MgCl2 and 1 mM DTT at pH 7.5. The resultant labeled 
protein was spin counted to determine the label concentration which, when compared to 
the protein concentration, resulted in ~84% labeling efficiency (Fig. 3.6). Spin labeled 
samples were then loaded into quartz capillary tubes (1.1 mm ID, 1.6 mm OD, 15 μL 
sample volume) containing 7% v/v glycerol as a cryo-protectant and flash frozen in liquid 
nitrogen and subsequently stored at -80 °C until use. 
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3.3.2 – Double electron-electron paramagnetic resonance (DEER) 
We performed DEER experiments to measure interprobe distances in the range of 
2-6 nm. Measurements were made on a Bruker E580 spectrometer (Billerica, MA) 
operating at Q-band (34 GHz) with an EN5107 resonator. A four-pulse DEER protocol 
with a π/2 pulse width of 12 ns and an electron double resonance (ELDOR) pulse width 
of 24 ns was implemented. The ELDOR frequency was placed on the pump position 
which corresponded to the absolute maximum of the nitroxide absorption spectrum. The 
observe position was placed 24 Gauss higher than the pump position on the field-swept 
spectrum. Experiments were performed at 65 K. The resulting DEER waveform was 
analyzed using the model-independent Tikhonov fit provided in DeerAnaylsis2013.2. 
The Tikhonov distribution was then fit to multiple Gaussian distance distributions 
(equations 3.1 and 3.2) assuming the existence of discrete structural states as described 
previously105: 
 
ρ(r) = 1/(σ√2π) exp((r-R)2/(2σ2))       Eq. 3.1 
σ = (FWHM)/(2√ln(2))        Eq. 3.2 
 
3.3.3 – Differential scanning calorimetry (DSC) 
DSC experiments were performed on a NanoDSC (TA Instruments, New Castle, 
DE) at a scan rate of 1 °C/min using micromolar protein concentrations. Buffers 
consisted of 20 mM MOPS, 100 mM KCl at a pH of 7.5. Solutions were extensively 
degassed under vacuum with gentle stirring prior to loading into the calorimeter. This 
helps prevent release of air bubbles from solution during the experiment. From the 
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thermodynamics parameters enthalpy of unfolding (ΔH), melting temperature (Tm), and 
change in baseline heat capacity (ΔCp), we calculated a free energy of unfolding (ΔG) 
using the Gibbs-Helmholtz equation: 
 
ΔG = ΔH(1-T/Tm) + ΔCp(T-Tm-Tln(T/Tm)      Eq. 3.3 
 
Further details of our analysis using multiple approaches to constrain each parameter are 
discussed in the Supporting Materials and Methods. 
 
3.3.4 – Molecular Dynamics Simulations 
Molecular dynamics simulations were performed using GROMACS 5.0.6106 
starting from chain A of the crystal structure of Dys ABD1 (PDB 1DXX33), 
corresponding to residues 9-246 of human Dys (Uniprot P11532). Similarly, for Utr the 
starting structure was taken from chain A of the PDB 1QAG32 of human utrophin. For the 
latter, using the Uniprot P46939 sequence, both the N- and C-termini were elongated 
with PyMOL by 6 and 5 residues, respectively, so that the resulting sequence 25-261 
aligns well with the one simulated for dystrophin (Fig. 3.7). For Dys ABD1, amino acids 
S10 and S188 were mutated back to cysteine residues using CHARMMGUI107, and for 
both systems water seen in crystals was preserved. All histidine residues were set to 
neutral charge with hydrogen on the Nε, except for Utr ABD1 His 88 and 190, which 
were neutral with proton on Nδ. Periodic boundary conditions were implemented through 
a rhombic dodecahedron box with a box vector length of 11.6 nm. The system was 
solvated in TIP3P water108 and KCl was added to achieve electroneutrality and an ionic 
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strength of 150 mM. Covalent hydrogen bonds were constrained with the LINCS109 
algorithm, and the equations of motion were propagated with a time step of 2.0 fs. 
Electrostatic interactions were treated with the particle-mesh Ewald110 algorithm with a 
real cut-off and a grid spacing of approximately of 1.2 nm and 0.12 nm, respectively. Van 
der Waals interactions were switched off between 1.2 nm and 1.0 nm. A constant 
temperature of 300.0 K was maintained with the V-rescale algorithm111 applied to the 
protein and solvent groups independently, and a constant pressure of 1 atm was 
maintained with the Parrinello-Rahman barostat.112 Simulations were run using two 
flavors of the CHARMM force field family: CHARMM36113 and CHARMM22*114, 115. 
For each system (Dys and Utr), 5 simulations were run with che CHARMM36 force 
field, and 5 with the CHARMM22* force field, for a total of 20 independent simulations. 
Comparisons of structural parameters derived from each force field are summarized in 
Fig. 3.8-3.11. For both force fields, the system was initially minimized to remove bad 
contacts, and then it was equilibrated for 1 ns at constant volume and temperature, 
followed by 3 ns at constant pressure and temperature during which the harmonic 
restraints on the protein’s heavy atoms were gradually reduced from 239 kcal mol-1 nm-2 
to zero. At this point, for each force field 5 independent simulations were started by 
randomizing the atoms’ velocities, and continued for 500 ns, resulting in a total 
simulation time of 5 µs for the ten total trajectories for each system. Coordinates of the 
trajectories were saved every 5 ps and additional analyses (see Supporting Information) 
indicated that to improve statistics the trajectories obtained with the two force fields 
could be pooled together. The trajectories were processed with GROMACS, data analysis 
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and plotting was performed with the software R116, and structures were visualized with 
PyMOL117. 
Principal component analysis (PCA)118 was performed on the protein’s backbone 
atoms to identify the main conformational changes that characterize ABD1’s dynamics. 
To directly compare the conformational states of Dys and Utr, the principal components 
were calculated by pooling the trajectories of both systems together, and then each 
system’s trajectories were projected on the common principal components. Residue Q189 
for Dys was omitted from the analysis because sequence alignment of Dys to Utr (Fig. 
3.7) shows a gap in Utr in that position. The trajectories were then binned along the first 
two principal components, and the relative density of the histograms was used to 
calculate the free energy difference through the Boltzmann distribution. To identify 
flexible regions in the protein backbone, the conformations of the Cα of 4 consecutive 
residues were binned using the MK32K25 structural alphabet119 and the corresponding 
Shannon entropy was calculated using the method of Pandini et al120. 
As a proxy for the distance between the two spin labels on residues 120 and 239, 
we monitored the distance between the two Cα carbons of these residues. Additionally, 
solvent accessible surface area (SASA)121 was measured for the total protein, and 
separated in the hydrophobic and hydrophilic contributions. The differences in SASA 
between the open conformation of ABD1 and the closed conformations were plotted on 
the closed conformation’s representative structure using PyMOL. 
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3.4 – Results 
3.4.1 – Dys ABD1’s structure transitions from a closed to open state, but with significant 
structural disorder 
To test the hypothesis that the CH domains of Dys ABD1 undergo a 
conformational opening upon binding of F-actin, we performed DEER experiments on a 
spin labeled ABD1 fragment. Application of DEER allows us to make a direct 
comparison to existing structural data on the homologous Utr ABD1 fragment.37 Using 
site-directed mutagenesis, we removed all native cysteine residues in the Dys ABD1 
construct and engineered in new cysteines at residue positions 120 and 239, positions 
similar to those used in Utr ABD1 in ref. 59. Based on the domain-swapped dimer crystal 
structure previously determined for Dys ABD133, these residue locations would be 
suitable for detecting a change in interdomain distance upon F-actin association. 
After spin-labeling the protein, we measured interprobe distances with and 
without varying concentrations of F-actin. In the absence of F-actin, DEER 
measurements identified a short interprobe distance, indicating that the CH1 and CH2 
domains of Dys ABD1 are in a more compact closed state (Fig. 3.2, top). This is apparent 
in the DEER echo amplitude, which shows a rapid decay and mild oscillations in the time 
domain, both of which indicate a short interprobe distance. In samples containing F-actin, 
the DEER echo amplitude decays more slowly, indicating longer distances. The 
oscillations initially present in the absence of F-actin are dampened out in its presence, 
indicating actin-induced structural disorder (Fig. 3.2, middle and lower panels). 
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Figure 3.2.  DEER data on 80μM MSL-labeled Dys ABD1 (blue data sets) in the 
presence of increasing F-actin from top to bottom. Molar ratio of F-actin (FA) to Dys 
ABD1 is shown above time domain data. Utr ABD1 DEER reported previously in ref37. 
(red data sets) is overlaid for comparison. Left: time-domain decays. Right: derived 
distance distributions. Tikhonov distributions for Dys ABD1 (black dotted lines) were fit 
to two discrete Gaussian distributions (blue solid lines) and indicate that F-actin shifts 
interprobe distance toward a more open structural state but there is considerable structural 
disorder. Note that this contrasts with Utr ABD1’s Gaussian distributions (shown as red 
solid lines) which are ordered. Moreover, Utr ABD1’s structural opening is complete. For 
complete time domains see Fig. 3.12. To see figure in color go on-line. 
 
When comparing these structural results to the previously examined Utr ABD1, 
several features stand out. First, both ABDs share a common mechanism of opening upon 
binding to F-actin. Second, the Dys ABD1 contains much more structural disorder than 
65 
 
seen previously in Utr ABD1. This is evident in the mild or complete lack of oscillations 
present in the echo amplitude decay of Dys which, in Utr ABD1, were very well 
resolved. Lastly, unlike the Utr ABD1, Dys ABD1 does not undergo a complete shift to 
the open structural state. This is evident by the fact that a shorter interprobe distance is 
still sampled even in the presence of excess of actin. This latter observation is consistent 
with previous work examining the DysABD1 open-closed structural transition upon 
binding actin100; Pyrene excimer fluorescence using residues C10 and C188 indicated that 
Dys ABD1 occupied a closed conformation when bound to actin. This method, however, 
would not have been able to detect the open conformers identified in this study by DEER. 
Collectively, the pulsed EPR data identifies a common binding mode for Dys and Utr 
ABD1, but simultaneously highlights distinct structural dynamics in the ABD-actin 
interaction. 
3.4.2 – MD simulations characterize a compact & conformationally heterogeneous ABD1 
To gain atomistic insight into the factors affecting the compact vs. extended 
conformational equilibrium, we performed MD simulations starting from the Dys and Utr 
ABD1 crystal structures, both of which are in an open conformation.32, 33 Ten 500 ns 
simulations were independently run for each ABD, and in 18 out of 20 simulations the 
ABD structures similarly collapsed to compact conformations. The results show that not 
all simulations sampled the same conformation and a small number of stable compact 
conformations were identified  for both Dys and Utr using principal component analysis 
(PCA) (Fig. 3.3, minima B-F). The free energy profiles in Fig 3.3 show that for both Dys 
and Utr at least 5-6 distinct compact and one extended conformations exist. Moreover, 
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these conformations have similar energies and the different structures can easily 
interconvert into each other by overcoming small free energy barriers (3-4 kcal/mol). 
 
Figure 3.3. Free energy landscape of Dys ABD1 (A), and Utr ABD1 (B) projected on the 
first two principal components. The two principal components describe a “bending” 
motion of the two CH domains around a central swivel (PC1) that allows the extended-to-
compact transition, and the “revolution” motion of one CH domain around the other 
(PC2). A representative structure for each of the major conformational minima are also 
plotted. Structural heterogeneity correlates with the measured structural disorder present 
in DEER distributions and low unfolding free energy. To see figure in color go on-line. 
 
Using the method of Pandini et al.120, we calculated the backbone Shannon 
entropy as a proxy of its conformational flexibility and projected the calculated entropy 
on the structure (Fig 3.4 A). The entropy of the linker region spanning from Gly-130 to 
Asn-135 is comparable to that of the disordered N- and C-termini, indicating that this 
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region is characterized by a great degree of conformational flexibility, as recently 
suggested by Chakravarty et al.122. This suggests that the linker region closer to the CH2 
domain acts as a swivel, allowing the conformational transitions between compact and 
extended conformations, as well as the revolution of one CH domain around the other. 
This role is supported by monitoring the change in φ/ψ dihedral angles between the 
extended (minimum A in Fig 3.3 A) and a compact conformation (minimum F in Fig 3.3 
A), which highlights the very same region as the one in which dihedrals change the most 
(Fig. 3.13). 
 
Figure 3.4. Structural collapse of dystrophin and utrophin ABD1, derived from MD 
simulations. (A) Dys ABD1 Shannon entropy calculated for macrodiehedrals formed by 4 
consecutive Cα carbons. (B) SASA averaged over the ensemble of structures defining 
each minimum identified in Figure 3.3, with error bars representing one standard 
deviation. Representative closed structural states of (C) Dys and (D) Utr ABD1. 
Hydrophobic residues that promote closure are highlighted. To see figure in color go on-
line. 
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Next, we aimed at identifying the driving force inducing the transition to compact 
conformations. Upon further analysis, all compact structures display a smaller solvent 
accessible surface area when compared to the extended conformation (Fig. 3.4 B). 
Although some of the residues involved may vary in each different compact structure, we 
observed that a core of hydrophobic residues on the same face of the amphipathic linker 
helix and a cluster of residues on the CH2 domain are predominantly involved in 
hydrophobic interactions in all compact conformations (Fig 3.4 C and D, Fig. 3.14). Such 
a pattern could indicate that the closed structural states are stabilized in part by 
interactions involving hydrophobic side chains. A similar mechanism was recently 
proposed for the ABD of β-III-spectrin42, and it is also supported by the fact that the same 
hydrophobic interactions are present in the extended crystal structure of Dys ABD1 
(1DXX), although because of the dimeric nature of the crystal they are domain-swapped 
(Fig. 3.15).  
3.4.3 – Experimental validation of MD simulations  
To directly test the MD results that the distribution of closed conformers is 
promoted by hydrophobic contacts, differential scanning calorimetry (DSC) experiments 
were performed. The increase in a protein’s heat capacity (∆Cp) during an unfolding 
transition correlates directly with increased exposure of apolar amino acids, based 
empirically on the free energy of transfer between organic and aqueous phases 
(Supporting Materials and Methods, ). Comparison of this calculated ∆Cp with that 
experimentally measured by DSC indicates the extent of hydrophobic residue exposure to 
water in the folded state. We found that the measured value of ∆Cp for thermal unfolding 
of Dys ABD1 (4.09 ± 0.07 kcal/mol) was substantially less than the calculated value (4.7 
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kcal/mol) (Table 3.1).  This is consistent with the MD conclusion that the native state of 
Dys ABD1 has an unusually large fraction of hydrophobic residues exposed to solvent.  
Next, to compare the ensemble of conformations generated by MD simulations to 
the experimental data obtained by DEER, we plotted for Dys ABD1 the probability 
density of the distance between the Cα of Val-120 and Leu-239, the residue positions 
where spin labels were inserted (Fig. 3.16). The plot shows a broad peak centered at 1.2 
nm with a shoulder at 2.0 nm, corresponding to the closed conformations. The features of 
the peak match the features of the same peak in the DEER experiments in absence of 
actin (Fig 3.2). We characterized the two underlying distributions as both due to compact 
conformations, differing only by the relative orientation of the two CH domains (Fig. 
3.16). In the DEER data, the peak is centered at about 1 nm longer distance than in the 
data from the simulations. This could be explained by the fact that in the simulations the 
distance was mapped between the two Cα rather than from the ends of the long TEMPO 
spin label. In addition, the two mutations introduced to add the spin labels may somewhat 
interfere with the hydrophobic patch between the linker and the CH2 domain (in 
particular perturbing Val-120 and Phe-236 which is only 3 residues away from Leu-239). 
Yet, it was reassuring to notice that the change in distances metric was preserved. In fact, 
the DEER data indicates an increase of about 2.5 nm upon transition from the compact to 
the extended conformations (Fig. 3.2 top and bottom panels) and a similar trend is 
observed in the simulated data when considering the small shoulder at 4.0 nm, which 
represents the extended conformation. 
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Figure 3.5. Modeling of MD simulation-derived Dys ABD1 conformers on actin 
filament. When the CH1 domain of Dys ABD1 conformers in free energy minima of Fig. 
3.3 are aligned with the CH1 domain of β-III-spectrin ABD from a recent 6.9 Ǻ cyro-EM 
structure (6ANU), some of the structural models are devoid of steric clashes (green, 
yellow, red). The open conformation (magenta) is similarly free of steric clashes. While 
some closed conformations of Dys ABD1 exhibit significant steric clashes with actin 
(blue), the fact that others do not suggests there are binding-compatible closed states for 
Dys ABD1 in agreement with previous structural measurements using pyrene excimer 
fluorescence.100 To see figure in color go on-line. 
 
3.5 – Discussion 
The diverse biophysical methods employed in this study were geared towards 
identifying structural differences in Dys and Utr ABD1-actin complexes and 
understanding how they, in turn, may contribute to differences in function. We found 
that, similar to Utr, the Dys ABD1 can exist in two main structural states: a compact state 
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where the CH domains are in close apposition and a more extended open state that is 
stabilized by actin. Unlike our previous study of Utr ABD137, Dys ABD1 did not shift 
completely to its extended open state; a significant mole fraction of ABD1 continued to 
sample compact states even with an excess actin concentration (Fig. 3.2). Moreover, the 
Dys ABD1-actin complex is much more structurally heterogeneous than Utr ABD1. This 
indicates that the two protein domains, though homologous, may functionally diverge in 
part due to distinct structural dynamics.  
Support for the distinct structural dynamics come not only from DEER (Fig. 3.2) 
where the full-width half max of Dys ABD1 distance distributions far exceed that of Utr 
ABD1, but also MD simulations (Fig. 3.3 and Fig. 3.4). In the latter case, for instance, an 
overlay of structural states derived from Fig. 3.3 indicates that Dys and Utr ABD1 are 
sampling distinct conformational spaces. If the CH1 domains of each ABD1 are aligned 
in pairwise fashion and the positions of the linker and CH2 are examined, not a single 
pair of structural states from the free energy minima orient exactly the same way (Fig. 
3.17). Although we observed several general similarities, even in the most favorable of 
cases the orientation of the two CH domains were still distinct such that no structure for 
the Dys ABD1 could be mapped onto a structure for Utr ABD1. 
When considering how these distinct ABD1 structural dynamics could impact 
function, two possibilities come to mind: alteration of ABD1 affinity for actin and 
alteration of actin structural dynamics when bound to filaments. With regard to 
modulation of affinity, recent work on Dys and Utr ABD1 indicate that actin binding is 
largely mediated by the CH1 domain102, 123 as has been suggested in other binding studies 
of ABDs or through inference from CH2 domain mutations that increase affinity for 
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actin.60, 103 We used this evidence to justify aligning our simulation-derived Dys ABD1 
structures with that of the CH1 domain of β-III-spectrin in a recently reported cryo-EM 
structure and assessed if any of the stable conformers were capable of docking without 
steric hindrance (Fig. 3.5).103 From this analysis, we found that docking the open 
extended conformers from the MD simulations is compatible with binding because the 
linker and CH2 domain protrude and point away from actin, avoiding any potential steric 
clash. Steric clash was one of the main reasons originally proposed for ABDs needing to 
open upon binding.36 We also found, however, that while many of the closed compact 
conformers result in steric clashes between the CH2 domain and actin, at least some 
compact conformations for either Dys or Utr are compatible with binding to actin 
(structure B in Fig. 3.3 A for Dys ABD1, and structures B, D, and E in Fig. 3.3 B for Utr 
ABD1). This is in agreement with the recent work of Shams et al.124, which suggests that 
various binding modes between ABD1 and actin could be accessible. Therefore, the 
conformational ensembles computationally characterized could explain how both 
compact and extended conformations of ABD1 are sampled when bound to actin.  
The notion that Dys and Utr ABD1 closed structural states have high degeneracy 
and that some are potentially “binding competent” whereas others are not suggest that 
ABD1’s structural dynamics could directly impact affinity for actin. If, for example, the 
most stable closed conformers of ABD1 are those that give raise to steric clashes when 
binding to actin, shifting the equilibrium to a binding competent conformer of higher free 
energy will result in a reduced binding affinity. Alternatively, if multiple closed 
conformers are free of steric clashes and thus binding competent, affinity for actin would 
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be increased. In this way, the shifting of conformational equilibria in the structurally 
dynamic unbound state could play a role in fine-tuning affinity for actin.  
It is important to point out that the energetics at play in such a binding model are 
compatible with existing measurements of ABD1 affinity. In Dys ABD1, for instance, the 
ΔG of actin binding derived from reported Kd that range from 10-50 M123, 125 is an 
energetically favorable 6-7 kcal/mole. Our calculations show that the energy difference 
between the various closed and open ABD1 conformers should be smaller than this range 
(Fig. 3.3) and thus be capable of an actin-induced redistribution of the structurally 
dynamic ensemble. Unfortunately, the computational precision of the free energy profile 
constructed from our unbiased simulations does not allow any further extrapolation. 
While there appears to be more than one conformer in the ABD1 ensembles that is 
potentially binding competent (Fig. 3.5), in the absence of simulation data that includes 
actin filaments, no conclusions can be drawn about which conformation is the most stable 
when bound. As such, it is not possible to directly explain the differences in the 
experimentally detected spin label distances in Dys and Utr (Fig. 3.2) as due to the 
binding of one specific more stable conformer identified by MD simulations. However, 
DEER measurements indicate that it is primarily an open conformation for Utr and a 
heterogeneous mixture for Dys. Future work could potentially probe this structural 
heterogeneity further using pressure perturbation EPR methods.126 
With regard to how Dys and Utr differentially alter actin dynamics, the structural 
behavior measured by DEER provides insights into a mechanistic contribution (Fig. 3.2). 
When full-length Dys and Utr bind actin, they each restrict the amplitude of bending and 
twisting motions of the filament, although Utr does so to a much greater degree. Part of 
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the difference is probably explained by binding of each protein’s ABD299. Each ABD2 
varies in its proximity to ABD126, 27. However, another contributing factor may be 
distinct structural dynamics within each protein complex. Because actin itself can adopt 
many conformations upon twisting and bending127, binding of ABDs in general may 
impose on the filament’s conformational exploration. If bound ABDs differ, however, in 
their ability to conformationally adapt to actin fluctuations, they may consequently have 
distinct restrictive capacities. If these dynamic differences persist in their full-length 
structures, they may locally contribute to the overall global differences measured 
previously.98, 99 Additionally, if bound ABDs differ in the degree to which they can adapt 
to structural changes of actin, distinct ABD dynamics may also contribute to ABD’s 
ability to remain bound under mechanical stress experienced by the filament. The fact 
that the computationally characterized ensembles of Dys and Utr ABD1 have similar 
general features, but differ in the specific orientation of the CH domains, supports this as 
a viable adaptation mechanism.  
Overall, the results presented in this study agree well with previous work on Dys 
ABD1 and other ABDs from the spectrin superfamily and simultaneously provide new 
insights. In a prior study examining the question of whether or not the Dys ABD1 opens 
upon binding, for instance, pyrene excimer fluorescence data indicated that the ABD1 
could bind in a closed conformation.100 While these results could not determine the 
distribution of conformational states when bound to actin, they are in agreement with our 
current findings. We showed in Fig. 3.2 that even in a 4:1 excess of actin, about 50% of 
the ABD1 is bound in a compact conformation. However, what our results show in 
addition is that the remaining ~50% of the bound population is present in an extended 
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conformation, making our findings complementary to that of Singh et al.100. We have 
already pointed out that different experimental techniques can capture ABD domains in 
both compact and extended conformations. Such differences, when considered in 
conjunction with a flat free energy landscape of easily interconvertible conformers, 
suggest that ABDs are malleable proteins responsive to small external perturbations. A 
perturbation on the order of just 1 kcal/mole could shift the equilibrium from one 
conformation to another (Fig. 3.3).  
This proposed mechanism may not only contribute to our understanding of ABDs 
being found in a variety of conformations, but also the impact of disease-causing 
mutations. If the conformational ensembles of ABDs are easily perturbed, defects such as 
missense mutations could significantly alter the distribution of structural states. If such 
mutations redistributed the conformational ensemble in a way that more readily populates 
binding competent conformers, for instance through the mechanism discussed above, it 
could help explain the modest to significant gains in affinity observed in ABDs 
associated with disease.39, 42 In addition, mutation-induced redistribution may alter the 
conformational ensemble in such a way that there is a gain conformational adaptability 
that allow binding to persist despite structural fluctuations of the filament.  
Application of this generalized ABD model to DMD and BMD mutations in Dys 
requires some caution. Many DMD and BMD missense mutations that have been studied 
previously are mutations that have substituted CH domain core hydrophobic residues for 
charged or polar residues.33 When such mutations were studied in the isolated Dys ABD1 
fragment, the main affect seemed to be misfolding of the domain rather than change in 
binding affinity.128 Indeed, when many of the same missense mutations were examined in 
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full-length Dys, changes in binding affinity were modest or statistically insignificant.129 
This suggests that for DMD and BMD, missense mutations that perturb the core fold of 
ABD1 CH domains are promoting disease via a misfolding-induced degradation 
mechanism.130 For some missense mutations, perhaps those that are more superficially 
located within the ABD1 or those that do not misfold the ABD1 but perturb stability, a 
functional impact like that discussed above for ABDs in general may become relevant. 
However, without clear examples of DMD and BMD missense mutations that alter 
binding affinity while simultaneously preserving the ABD1 fold, this potential 
mechanism will remain speculative and bare most relevance to other ABDs in which 
missense mutation stability-structure-affinity relationships are better established.103   
One of the observations made here points to an interesting feature of Dys ABD1 
that will probably require further investigation in future studies. While DSC measurement 
of heat capacity helped validate the MD-suggested use of surface hydrophobicity in 
modulating closed conformer sampling, it also revealed a rather complex endothermic 
transition (Fig. 3.18). The absolute heat capacity of a protein is a measure of underlying 
structural diversity in the folded and unfolded states, but can also be used to evaluate the 
presence of intermediate states. It is not known whether the distribution of conformers 
identified for Dys ABD1 reflect a distribution of equivalent distinct states or arise as a 
distribution or sampling of partially folded intermediate states. We find that the diversity 
of open and closed conformers corresponds energetically to a two-state model comprised 
of a folded and unfolded state. The unfolded state retains a surprising amount of order, 
consistent with retaining hydrophobic contacts even under extreme conditions. This 
suggests that the energetic functional landscape of Dys ABD1 may be capable of 
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absorbing much more energy than anticipated from the distribution of open and closed 
conformers identified. However, further quantitative assessment of such a 
thermodynamic prediction will require application of additional biophysical techniques. 
 
3.6 – Conclusions 
We have probed Dys ABD1 dynamics with complementary experimental and 
computational techniques. We have characterized free ABD1 in solution as adopting a 
compact conformation. With computer simulations we have shown that both Dys and Utr 
ABD1 are conformationally malleable proteins for which low-energy compact and 
extended conformations are easily accessible through a flat free energy landscape. We 
have identified the region of the linker that grants conformational flexibility to the protein 
and the hydrophobic patches responsible for stabilizing the compact conformations. We 
have characterized the conformational ensemble of actin-bound Dys ABD1 as originating 
from an equal contribution of compact and extended structures. Finally, we have linked 
our findings and proposed a model for how unique structural dynamics of Dys and Utr 
ABD1 contribute to their distinct functions. 
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3.7 – Supporting Materials and Methods 
3.7.1 – Multifaceted approach to DSC analysis 
MD simulations revealed that surface exposed hydrophobic residues drive the 
open to closed conformational fluctuations of ABD1. The extent of hydrophobic and 
hydrophilic exposure is directly proportional to the change in heat capacity.131 
Differential scanning calorimetry (DSC) is a direct means to measure the change in heat 
capacity and relate it to the solvent exposed surface area.131-137 DSC analysis also 
provided a free energy of unfolding of 4.45 ± 0.07 kcal/mol for DysABD1. This energy 
sets an upper limit to the free energy difference between different folded conformations, 
as higher energies would start depleting the folded population in favor of the unfolded. 
Comparing the experimental to the maximal change in heat capacity, we determined the 
percent unfolding of Dys ABD1 to be 87% or, conversely, that 13% residual structure 
remains in the unfolded state. Because simulations have shown that surface exposed 
hydrophobic residues are present in Dys ABD1 and play a key role in defining its tertiary 
structure, it is consistent to think that the structure of this protein is more resilient to 
unfolding. That is, because the folded structure is relatively stable with exposed 
hydrophobic residues, the thermal unfolding, which coincides with the exposure of core 
hydrophobic residues, may bring a lesser perturbation to the structure than in other 
proteins that have lower content of exposed hydrophobic residues. As a result, a large 
portion of residual structure is then likely resultant of hydrophobic contacts recapitulating 
the role of hydrophobic contacts as a driving force for Dys ABD1 reconfiguration.  
MD revealed the Dys ABD1 ensemble of closed conformations is stabilized by 
hydrophobic interactions involving mainly the CH2 domain and the flexible linker. We 
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tested whether Dys ABD1 is enriched in hydrophobic residues that affect the change in 
heat capacity between the folded and unfolded states when compared to other 
proteins.  Specifically, calorimetric values were compared to predictive models relating 
changes in solvent exposed surface areas to changes in heat capacity using DSC. The last 
three columns of Table 3.1 contain thermodynamic values obtained by fitting our DSC 
data using three different methods, and in the first two columns are theoretical predictions 
obtained using models from Spolar131 and Freire132. Although each fitting method is 
discussed in detail in the following sections of the supplement, it is relevant to point out 
here that the Spolar131 method predicts the change in heat capacity from the molecular 
weight of the protein, whereas the Freire132 model utilizes the protein amino acid 
sequence.  
Table 3.1 shows that the change in heat capacity of Dys ABD1 upon unfolding 
fitted from DSC data is greater than theoretical prediction based on molecular weight 
using the method outlined by Spolar131, but it is smaller than the heat capacity predicted 
by Freire’s model that includes the protein’s sequence. These deviations are consistent 
with the high concentration of aromatic residues (~3 times expected for a protein of this 
size) while simultaneously having some of the aromatic residues already solvent exposed 
in the 1DXX crystal structure reported by PDB. 
 
3.7.2 – Text S1, Predicting ΔCp and ΔHTm from molecular weight and sequence 
Sequence based change in heat capacity prediction 
In a two-state unfolding process, the initial state is the folded state (or ensemble 
of states) and the final state is the unfolded state. The unfolded state is relatively, but not 
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completely, devoid of higher order structure. Thus, it is necessary to estimate the residual 
structure in the unfolded state to characterize the unfolding process. Using models for 
determining the absolute heat capacity of previously studied proteins, the maximum 
change in heat capacity for Dys ABD1 was compared to determine residual structure 
from the experimentally determined change in heat capacity.132 The maximum change in 
heat capacity was predicted to be 5.9 kcal/mol/°C.132-135 This overestimation reflects that 
hydration effect does not take the role of configurational entropy of the unfolded protein 
into consideration, as has been noted in reference138. Another oversimplification is that 
the geometry of Dys ABD1 is not globular.132 Adjustments were made to the absolute 
folded heat capacity based on the change in surface areas of a sphere (approximating 
globular geometry) and two smaller spheres of equal volume (approximating Dys ABD1 
geometry). This adjustment resulted in a predicted change in heat capacity of 4.7 
kcal/mol/°C. Then, by normalizing the experimental change in heat capacity to the 
theoretical maximum change in heat capacity we can determine the role of 
configurational entropy in the unfolded state. Analysis yielded 87% unfolding for Dys 
ABD1 and is calculated by the following equation. 
 
𝑢𝑛𝑓𝑜𝑙𝑑𝑒𝑑 =
∆𝐶𝑝,𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙(𝑇)
𝐶𝑝,𝑢(𝑇)−𝐶𝑝(𝑇)
∗ 100        Eq. 3.4 
 
Where 𝐶𝑝,𝑢(𝑇) and 𝐶𝑝,𝑓(𝑇) were determined using previously established models. The 
heat capacity of any amino acid residue or backbone species (x) has been estimated as a 
third order polynomial.132 
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𝐶𝑝,𝑥 = 𝐴𝑥 + 𝐵𝑥𝑇 + 𝐶𝑥𝑇
2 + 𝐷𝑥𝑇
3       Eq. 3.5 
 
The total heat capacity of the unfolded state will then be the additive heat capacities of all 
components 
 
𝐶𝑝,𝑢(𝑇) = ∑ 𝑛𝑥𝐶𝑝,𝑥 + (𝑁 − 1)𝐶𝑝,𝑏𝑏 + 𝐶𝑝,𝑁𝐻2 + 𝐶𝑝,𝐶𝑂𝑂𝐻
20
𝑥=1     Eq. 3.6 
𝐶𝑝,𝑓(𝑇) = (𝑎 + 𝑏𝑇)𝑀𝑊         Eq. 3.7 
 
Where the summation from 1 to 20 represents a summation over the 20 amino acid 
residue types, 𝐶𝑝,𝑏𝑏 represents the heat capacity of the backbone species, and the last two 
terms in equation 3.29 account for the N- and C- termini, respectively. All coefficients A, 
B, C, D, a, and b have been determined and tabulated.132  
 
Predictions based on Molecular Weight 
The overall change in heat capacity (ΔCp) was estimated from molecular weight, 
utilizing the fact that the change in hydrophobic and hydrophilic surface areas dictate 
changes in heat capacity and are linearly dependent on molecular weight for proteins 
spanning 4 kDa to 40 kDa given by the set of equations listed below131: 
 
∆𝐴𝑁𝑃 = 0.636𝑀𝑊 − 2120Å
2        Eq. 3.8 
∆𝐴𝑃 = 0.309𝑀𝑊 − 40Å
2         Eq. 3.9 
∆𝐶𝑃,𝐶𝑎𝑙𝑐 = −0.32∆𝐴𝑁𝑃 + 0.14∆𝐴𝑃𝑐𝑎𝑙𝑚𝑜𝑙
−1𝐾−1               Eq. 3.10 
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Where equations 3.8 and 3.9 calculate the expected change in exposed nonpolar and polar 
surfaces, respectively and are used in equation 3.10 to calculate the resulting change in 
heat capacity between folded and unfolded states. For Dys ABD1 which has a molecular 
weight of 27.355 kDa (determined via ExPASy ProtParam), the change in heat capacity 
was predicted to be 3.7 ± 0.7 (kcal/mol°C). Because this model is based on globular 
proteins, the values reported are interpreted as an upper estimate for the total change in 
heat capacity of a protein, because globular proteins are mostly spherical and therefore 
have the highest volume to surface area ratio. However, since the prediction based off of 
molecular weights assumes a normal distribution of amino acids (whereas, Dys ABD1 
has ~3x higher content of aromatic residues) Dys ABD1 is likely to deviate from this 
value. 
The enthalpy of unfolding was estimated with respect to the same work noting 
that enthalpy was similarly proportional to molecular weight and temperature given the 
following equation131, 
 
   ∆𝐻°𝑓𝑜𝑙𝑑(𝑇) = (−0.161𝑇𝑀𝑊) + 47.24𝑀𝑊 + 672.8𝑇 − 232010𝑐𝑎𝑙𝑔
−1           Eq. 3.11 
 
where, T is the transition temperature of the protein, and MW is the molecular weight of 
the protein. For Dys ABD1 the model yielded a value of 118.5 ± 0.4 kcal/mol at 55°C. 
Once again, the enthalpy predicted serves as an upper limit, as the predictive model was 
developed largely off globular proteins, whereas Dys ABD1 is non-globular. 
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3.7.3 – Text S2, Calorimetric features of the experimental endotherm 
To further narrow down the parameter space for the Gibbs-Helmholtz equation to 
model heat capacity it can be seen that the three necessary variables (ΔHTm, ΔCp, and Tm) 
all manifest in distinct parts of the endotherm (Fig. 3.18A). The enthalpy of transition is 
contained within the large spike in heat capacity represented by the shaded red region in 
the plot. The region has an upper boundary described by the raw instrumental readout, 
whereas the lower boundary is described by the shift in populations from the folded state 
to the unfolded state, which is represented by the sigmoidal baseline (i.e. the shift in 
equilibrium). Comparison of transition enthalpy between the first and second scans on the 
same sample allow for the determination of reversibility, which was 15%. The sigmoidal 
baseline is representative of the population shift from folded to unfolded (
𝑑𝜃𝑢
𝑑𝑇
) and when 
scaled by the change in heat capacity between the two states it gives the lower bound for 
the excess heat capacity. Then, the temperature at which the enthalpy equals half the 
complete excess enthalpy of transition (∆𝐻𝑇𝑚) is the melting point (Tm). This also 
corresponds to the point at which the baseline change in heat capacity takes its half-
maximal value. 
 
The change in heat capacity (ΔCp) 
 After baseline subtraction, the baselines should be parallel to the x-axis. The 
folded baseline was extrapolated beyond the transition to the same region used for the 
unfolded baseline definition. The difference in heat capacity is then the change in heat 
capacity (ΔCp) given by the following equation: 
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 ∆𝐶𝑝(𝑇) = 𝐶𝑝,𝑢(𝑇) − 𝐶𝑝,𝑓(𝑇)                            Eq. 3.12 
 
where the heat capacities on the right hand side of the equation are the heat capacities 
after baseline subtraction, thus 𝐶𝑝,𝑓(𝑇) = 0 by definition.  
 
The excess transition enthalpy (ΔHTm) 
The excess enthalpy of transition was analyzed utilizing the approach developed 
by Freire.132 The Enthalpy of transition (Fig. 3.18A) represents the area defined by 
endotherm and the baseline heat capacities of the two states. To determine the sigmoidal 
baseline, the total change in enthalpy (∆𝐻𝑡𝑜𝑡(𝑇)) was determined using Riemann sums. 
 
∆𝐻𝑡𝑜𝑡(𝑇) = ∑ 𝐶𝑝,𝑑𝑎𝑡𝑎(𝑇) − 𝐶𝑝,𝑓(𝑇)
𝑇
𝑇=𝑇𝐿                                 Eq. 3.13 
 
Where ∆𝐻𝑡𝑜𝑡(𝑇) describes the total change in enthalpy due to both the excess heat 
capacity (∆𝐻𝑇𝑚) and the basal heat capacity (𝐶𝑝,𝑏𝑎𝑠𝑎𝑙) defined by the lower transition 
temperature (TL) and T. The maximal change in enthalpy is the summation from the 
lower limit to the upper limit of the transition (TU): 
 
∆𝐻𝑚𝑎𝑥 = ∑ 𝐶𝑝,𝑑𝑎𝑡𝑎(𝑇) − 𝐶𝑝,𝑓(𝑇)
𝑇𝑈
𝑇=𝑇𝐿
                Eq. 3.14 
 
Normalizing ∆𝐻𝑡𝑜𝑡(𝑇)  to the total change in ΔCp (3.5 ± 0.3 kcal/mol°C) yields the 
following equation for approximating the basal heat capacity (Cp,basal) of the protein as a 
function of temperature: 
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𝐶𝑝,𝑏𝑎𝑠𝑎𝑙(𝑇) =
∆𝐻𝑡𝑜𝑡(𝑇)
∆𝐻𝑚𝑎𝑥
∗ ∆𝐶𝑝                            Eq. 3.15 
 
Then, the excess enthalpy is the difference between the total change in enthalpy (∆𝐻max ) 
and basal change in enthalpy: 
 
∆𝐻𝑇𝑚 = ∆𝐻𝑚𝑎𝑥 − ∆𝐻𝑏𝑎𝑠𝑎𝑙                            Eq. 3.16 
 
Which can be solved with the above described parameters as an area integral bounded by 
the experimental heat capacity and the basal heat capacity: 
 
∆𝐻𝑇𝑚 = ∫ 𝐶𝑝,𝑡𝑜𝑡(𝑇) − 𝐶𝑝,𝑏𝑎𝑠𝑎𝑙(𝑇)𝑑𝑇
𝑇𝑈
𝑇𝐿
                Eq. 3.17 
 
The sigmoidal baseline and ΔHTm will vary minimally on the definition of the 
temperature bounds (TU and TL).  
 
Melting temperature (Tm) 
 The melting temperature is the point along the transition at which the distribution 
between folded and unfolded populations is 1:1. Therefore, this lies at the temperature for 
which: 
 
𝛥𝐻(𝑇𝑚) =
𝛥𝐻𝑇𝑚
2
                             Eq. 3.18 
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Where 
 
∆𝐻𝑇𝑚
2
= ∫ (𝐶𝑝,𝑡𝑜𝑡(𝑇) − 𝐶𝑝,𝑏𝑎𝑠𝑎𝑙(𝑇))𝑑𝑇
𝑇𝑚
𝑇𝑈
                          Eq. 3.19 
 
And can be solved directly by finding the solution to the following equation: 
 
∆𝐻𝑇𝑚 = 2(∆𝐻𝑡𝑜𝑡(𝑇𝑚) − ∆𝐻𝑏𝑎𝑠𝑎𝑙(𝑇𝑚))                          Eq. 3.20 
 
Where  𝑇𝑚 will also correspond to the half max of ∆𝐻𝑏𝑎𝑠𝑎𝑙(𝑇). 
 
3.7.4 – Text S3, Nonlinear least squares regression  
The values from analysis of the calorimetric features (Text S2) and constraints 
from predictive models (Text S1), along with a comparison to the Van’t Hoff fit  strictly 
describe where in the three-dimensional parameter space to fit to the Gibbs-Helmholtz 
model. From this, the nonlinear regression analysis was performed with equation 3.31 
and run in R using a Gauss-Newton algorithm to minimize the squared residuals. This 
yielded the following model fit (Fig. 3.18B). The next sections describe how the fitting is 
performed. 
 
3.7.5 – Two-state model analysis of heat capacity 
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As a protein denatures in solution, thereby exposing hydrophobic residues buried 
within the interior of the protein, the heat capacity (Cp(T)) of the sample cell increases 
according to the following expression: 
 
 𝐶𝑝(𝑇) = 𝜃𝑢𝐻(𝑇)
𝑑
𝑑𝑇
= (𝜃𝑢)
𝑑
𝑑𝑇
𝐻(𝑇) + 𝜃𝑢(𝐻(𝑇))
𝑑
𝑑𝑇
                        Eq. 3.21 
 
For Dys ABD1, the simplest model that can be applied is a two-state model from the 
native/folded (𝜃𝑓) state to denatured/unfolded (𝜃𝑢) state as Dys ABD1 underwent thermal 
denaturation. This means that the occupancy of intermediate states is negligible, therefore 
simplifying an equilibrium expression to two discrete ensembles:  
 
𝐾 =
[𝑢]
[𝑓]
                    Eq. 3.22 
𝐾 = 𝑒(
−∆𝐺
𝑅𝑇
)
                    Eq. 3.23 
 
Where [u] and [f] are concentrations of folded and unfolded ensembles and K is the 
equilibrium constant between the two states. Because the entire population, [P], of the 
protein is distributed between the unfolded and folded state the total protein concentration 
and fraction (𝜃) of each state can be written as follows: 
[𝑃] = [𝑢] + [𝑓]                            Eq. 3.24 
𝜃𝑢 =
𝐾
𝐾+1
                    Eq. 3.25 
𝜃𝑁 =
1
𝐾+1
                    Eq. 3.26 
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The free energy may be represented as both a function of the temperature dependent 
enthalpic and entropic contributions (ΔH(T) and ΔS(T), respectively) and as a 
consequence of the two-state model the change in heat capacity (ΔCp) simplifies to a 
discrete value as shown in equation 3.30132, 135: 
∆𝐻(𝑇) = ∆𝐻𝑇𝑚 + ∫ 𝐶𝑝(𝑇)𝑑𝑇
𝑇
𝑇𝑚
                           Eq. 3.27 
∆𝐺(𝑇) = −𝑅𝑇𝑙𝑛(𝐾)                            Eq. 3.28 
∆𝐺(𝑇) = ∆𝐻(𝑇) − 𝑇∆𝑆(𝑇)                           Eq. 3.29 
∆𝐺(𝑇) = ∆𝐻𝑇𝑚(1 −
𝑇
𝑇𝑚
) + ∆𝐶𝑝(𝑇 − 𝑇𝑚 − 𝑇 (ln (
𝑇
𝑇𝑚
)))                       Eq. 3.30 
 
Where the limit as ∆𝐶𝑝 approaches 0 is the Van’t Hoff equation for free energy. By 
substituting equations 3.30 and 3.23 into equation 3.21 and differentiating with respect to 
temperature the final fit expression of heat capacity as a function of temperature is as 
follows: 
 
𝐶𝑝(𝑇) = 𝛥𝐻(𝑇)
(𝛥𝐶𝑝−
𝛥𝐶𝑝𝑇𝑚
𝑇
+
𝛥𝐻
𝑇
)
𝐾
𝑅𝑇
(𝐾+1)2
+
𝛥𝐶𝑝𝐾
𝐾+1
+ 𝐹𝐵𝐿              Eq. 3.31 
 
Where FBL (folded baseline) describes the initial baseline heat capacity of the folded 
state, which we model using either a first or second order polynomial. The difference 
between the endotherm and the baseline heat capacity is equivalent to the instantaneous 
rate of change of the fraction folded (or unfolded) with respect to temperature 
𝑑𝜃
𝑑𝑇
. 
Therefore, the two-state equilibrium can be modeled by three thermodynamic parameters: 
the excess enthalpy needed to transition a population from a folded to an unfolded state 
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(ΔHTm), the overall change in heat capacity between the folded and unfolded states (ΔCp), 
and the melting temperature (Tm). For a two-state transition model, the largest rate of 
change occurred at the melting temperature (
𝑑𝜃
𝑑𝑇𝑚
), where both 𝜃𝑓  and 𝜃𝑢 equal 0.5. The 
maximal rate of change of folded proteins relates to the overall enthalpy of the unfolding 
process in that, 
 
∆𝐻𝑉𝐻 = 4𝑅𝑇𝑚
2 (
𝑑𝜃𝑢
𝑑𝑇
)                  Eq. 3.32 
 
where ΔHVH is the Van’t Hoff enthalpy. Thus, through comparison of the Van’t Hoff, it is 
possible to determine the validity of a two-state model.135 For Dys ABD1, the Van’t Hoff 
enthalpy (110 kcal/mol) was not extremely different from the enthalpy determined via a 
nonlinear regression, NLS, model (118.5 ± 0.4 kcal/mol) described later in the 
supplement, thus supporting the use of a two-state model. However, the Van’t Hoff 
comparison is not sufficient for defining a two-state model. Further support for the two-
state model comes from the comparison of the changes in heat capacity calculated 
between the different folded conformers of ABD1, which varied by approximately 0.05 
kcal/mol°C between open conformers and approximately 0.1 kcal/mol°C between open 
and closed ensembles, which MD simulations characterized as having free energy 
differences smaller than a couple kcal/mol. Finally, error surface and confidence region 
mapping were used to estimate nonlinear confidence regions to address the uncertainty in 
the folded baseline as has been noted in protein folding energetics studied by DSC.139, 140 
 
3.7.6 – Text S4, Disorder Prediction Modeling 
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In order to extend our results to WT Dys ABD1, we first needed to assess the role 
of cloning material to the folding energetics. This was done using predictive models to 
determine how ordering within the construct would be affected by cloning material left 
behind after purification. Because the construct was separated from the 6x His tag using a 
TEV protease, it is expected that two extra residues, glycine and serine, were left over 
after TEV cleavage. Disorder calculations were compared between the WT sequence and 
the construct containing the extra two amino acids.141, 142 There is minimal predicted 
change in disorder with the addition of the two extra amino acids (Fig. 3.19). 
 
3.7.7 – Analysis of the Molecular Dynamics Trajectories 
In our simulations, two versions of the CHARMM force field were used because 
evidence shows that the standard CHARMM36 force field may not perform as well as the 
CHARMM22* force field when simulating intrinsically disordered protein.143 Although 
ABD1 is not an IDP, our calorimetric measurements indicated that it may be considered 
marginally stable. We chose to use the CHARMM22* force field to be able to capture 
any region of the protein that showed marginal stability. At the same time, we recognize 
that the CHARMM22* is a more specialized force field, and thus has not been field-
tested as extensively as CHARMM36. We performed additional analyses with the goal of 
testing whether significant differences in the secondary structure, backbone dynamics, 
and conformational space sampled arise between the two force fields. 
To evaluate differences in secondary structure sampled by the two force fields, 
Figure 3.8 shows a comparison of the secondary structure elements calculated with the 
DSSP algorithm.144 The figure shows that, for both Dys and Utr, in the flexible regions 
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CHARMM36 displays a higher α-helical content than CHARMM22*, which in turn 
displays a higher component of turn, bend, and coil.  
To evaluate difference in the backbone dynamics, Figure 3.9 shows a comparison 
of the backbone φ/ψ dihedral order parameter calculated accordingly to the method of 
van der Spoel and Berendsen.145 Dihedral angles autocorrelation functions were 
calculated over each individual 500 ns trajectory, and the mean of the φ/ψ order 
parameters was averaged over all 5 trajectories for a given system and force field. For 
each amino acid, t-test statistics was performed between the 2 sets of 5 trajectories to 
evaluate whether the observed backbone order parameters were significantly different 
between the two force fields. In Figure 3.9, all amino acids that resulted in a p-value 
lower than 0.05 are marked with a black dot. We notice that the majority of the amino 
acids showing a statistically significant difference are those belonging to ordered regions, 
for which a negligible absolute difference in the order parameter between the two force 
fields is present. The less ordered regions show larger differences between the two force 
fields, but the larger variability is present also among trajectories of the same force field. 
As a result, from these analyses it is not possible to establish whether the disordered 
regions are characterized by a statistically significant difference in dynamics between the 
two force fields. 
As an alternative approach to using the backbone order parameter to map the 
conformational flexibility of different regions of the protein we use the Shannon entropy 
as described in the main text.  Figure 3.10 shows a comparison of the Shannon Entropy 
for the two force fields, which suggests that the flexible linker region could experience a 
higher conformational dynamics in the CHARMM22* simulations. 
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The previous analyses showed some differences between the CHARMM36 and 
CHARMM22* trajectories both in terms of secondary structure and in terms of backbone 
conformational dynamics. To test whether these differences significantly affect the 
conformational space sampled by the trajectories, we used the root mean square deviation 
(RMSD) as a metric to test the difference between the various trajectories. In Figure 3.11 
(panels A and C) we have plotted the RMSD matrices between all the trajectories. In 
short, each frame of each trajectory is here compared (by calculating the RMSD) with 
each frame of each trajectory. The bottom-left quadrant compares the 5 CHARMM36 
trajectories with each other, and the top-right quadrant compares the 5 CHARMM22* 
trajectories. The other two quadrant identically compare the CHARMM36 trajectories 
with the CHARMM22* ones. The figure shows that for both Dys and Utr there are 
trajectories within the same force field that are similar to each other (for example Dys 
c36(2), c36(3), and c36(5)), as well as very dissimilar (for example Dys c36(1) with 
c36(4)). When comparing trajectories obtained with different force fields, we see a 
similar distribution of similar and dissimilar trajectories as those within the same force 
field, which suggests that the two force fields do not greatly differ in the conformational 
space sampled. To better exemplify this, we plotted (panels B and D) the probability 
density of the RMSD for each subset (within c36, within c22, and the cross-comparison 
c36-c22). Again, what we observe is that the distribution of the cross-comparison c36 vs 
c22 is similar to those within the c36 or within the c22 force fields. Together, these 
results support the view that the differences between the force fields highlighted by the 
secondary structure and backbone dynamics analyses do not significantly affect the 
conformational space sampled by the trajectories. In view of these observations, to 
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improve the statistics of our principal component analyses, we have pooled together the 
trajectories obtained with the two force fields. 
 
Figure 3.6. Spin labeling Dys ABD1 (120:239) with 4-maleimide-TEMPO. Shown are 
the double integrals of 100 μM TEMPOL standard (blue) and DysABD1 labeled with 
MSL (red). This sample was used to determine the spin concentration of Dys ABD1 
(120:239), where the ratio of max intensities from the double integral indicate a spin 
concentration of approximately 67.6 μM. When compared to the Bradford determined 
protein concentration of 80 μM, this corresponds to a labeling efficiency near 84%. 
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Dys 
#         
9 10 11 12 13 14 15 16 17 18 19 20 
Dys 
        
D C Y E R E D V Q K K T 
Utr 
        
R S D E H N D V Q K K T 
Utr 
#         
25 26 27 28 29 30 31 32 33 34 35 36 
 
Dys 
# 
21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 
Dys F T K W V N A Q F S K F G K Q H I E N L 
Utr F T K W I N A R F S K S G K P P I N D M 
Utr 
# 
37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 
 
Dys 
# 
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
Dys F S D L Q D G R R L L D L L E G L T G Q 
Utr F T D L K D G R K L L D L L E G L T G T 
Utr 
# 
57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 
 
Dys 
# 
61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 
Dys K L P K E K G S T R V H A L N N V N K A 
Utr S L P K E R G S T R V H A L N N V N R V 
Utr 
# 
77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 
 
Dys 
# 
81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 
Dys L R V L Q N N N V D L V N I G S T D I V 
Utr L Q V L H Q N N V E L V N I G G T D I V 
Utr 
# 
97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 
 
95 
 
Dys 
# 
101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 
Dys D G N H K L T L G L I W N I I L H W Q V 
Utr D G N H K L T L G L L W S I I L H W Q V 
Utr 
# 
117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 
 
Dys 
# 
121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 
Dys K N V M K N I M A G L Q Q T N S E K I L 
Utr K D V M K D V M S D L Q Q T N S E K I L 
Utr 
# 
137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 
 
Dys 
# 
141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 
Dys L S W V R Q S T R N Y P Q V N V I N F T 
Utr L S W V R Q T T R P Y S Q V N V L N F T 
Utr 
# 
157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 
 
Dys 
# 
161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 
Dys T S W S D G L A L N A L I H S H R P D L 
Utr T S W T D G L A F N A V L H R H K P D L 
Utr 
# 
177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 
 
Dys 
# 
181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 
Dys F D W N S V V C Q Q S A T Q R L E H A F 
Utr F S W D K V V K - M S P I E R L E H A F 
Utr 
# 
197 198 199 200 201 202 203 204 
 
205 206 207 208 209 210 211 212 213 214 215 
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Dys 
# 
201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 
Dys N I A R Y Q L G I E K L L D P E D V D T 
Utr S K A Q T Y L G I E K L L D P E D V A V 
Utr 
# 
216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 
 
Dys 
# 
221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 
Dys T Y P D K K S I L M Y I T S L F Q V L P 
Utr R L P D K K S I I M Y L T S L F E V L P 
Utr 
# 
236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 
 
Dys 
# 
241 242 243 244 245 246               
Dys Q Q V S I E               
Utr Q Q V T I D               
Utr 
# 
256 257 258 259 260 261               
 
Figure 3.7. Alignment of Dys and Utr ABD1 sequences. Green, yellow, and red shadings 
indicate conservative, semi-conservative, and non-conservative mutations. Cell border 
colors indicate the domains: CH1 (purple), linker (blue), CH2 (green). 
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Figure 3.8. Structure comparison between CHARM22* and CHARM36 force fields. 
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Figure 3.9. Dihedral order parameter. Black dots mark the amino acids for which a t-test 
between the order parameter of the two force fields resulted in a p-value of less than 0.05. 
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Figure 3.10. Shannon Entropy comparison between force fields. 
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Figure 3.11. (A, C): Pairwise RMSD matrices for the 5 CHARMM36 and the 5 
CHARMM22* trajectories. (B, D): Probability density plots of the RMSD from panels 
(A, C), calculated within a single force field (orange and gray lines), and across force 
fields (blue lines).  
101 
 
 
Figure 3.12. Double electron-electron resonance (DEER) on Dys ABD1 (120:239) at 
various actin concentrations. Shown here are the complete time domains of each 
background-corrected DEER waveform. The Fig. 3.2 shown in the main text shows the 
waveforms up to 1.6 μs to help emphasize the changes in waveform decay with 
increasing actin concentrations. 
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Figure 3.13. Dihedral angle analysis for Dys ABD1 extended state (top panel, 
conformation A in Figure 3.3) and for the most compact states based on SASA analysis 
(middle panel, conformation F in Figure 3.3). The bottom panel represents the difference 
between the dihedral angles of the two conformations. The red box highlights the linker 
region where the backbone is changing conformation, which overlaps with the region 
identified in Figure 3.4A. 
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Figure 3.14. Difference in solvent accessible surface area (SASA) between the main 
open conformer of Dys ABD1 (Group A) and each major closed conformer (Groups B-
F), where Groups A-F are those identified in Fig. 3.3 of the main text. Hydrophobic 
residues are shown as yellow bars whereas all other residues are gray. The specific 
residues pointed out in Fig. 3.4C of the main text are highlighted in the panels above with 
a light yellow strip.  
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Figure 3.15. Dys ABD1 crystal structure 1DXX showing the swapped domains between 
chains A and B. In spheres are the hydrophobic residues identified as forming 
interactions in the compact structures identified by MD simulations in Figure 3.4. 
 
I127 
105 
 
 
Figure 3.16. Probability density plot of the distance between the Cα atoms of the two 
spin labels V120 and L239 in Dys ABD1, calculated over the entire conformational 
ensemble. Representative structures for selected distances are also shown. 
 
  
V120-L239 Cα Distance (nm) 
106 
 
 
Figure 3.17. Overlap between Dys ABD1 and Utr ABD1 conformational ensembles. 
Structures were aligned using the CH1 domain as a reference (purple). Lighter cyan and 
green colors are used for Dys ABD1, darker colors for Utr ABD1. The two axes label the 
specific conformer as described in Figure 3.3 of Dys ABD1 (horizontally) and of Utr 
ABD1 (vertically). 
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Figure 3.18. Graph A illustrates the calorimetric features of the thermal denaturation of 
Dys ABD1 using averaged DSC data from Dys ABD1. The key features ΔH, Tm, and 
ΔCp are representative of the total area under the curve (shaded red), the temperature at 
the half integral, and the overall heat capacity baseline shift of the process, respectively. 
Graph B represents the averaged triplicate scans (where the width represents the standard 
deviation) in dark blue and the model fit in light blue. 
 
 
Figure 3.19. Theoretical calculations from the Uversky lab determining the likelihood of 
disorder throughout the Dys ABD1 construct.141, 142 This was utilized to provide a metric 
with which to determine the effect of cloning material left behind (which was a glycine 
and a serine after TEV cleavage) on the purified construct. The similarities between 
ABD1 with cloning remnants (orange) and without cloning remnants (blue) is predicted 
to be minimal based on these calculations.  
A B 
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Dys ABD1 
Prediction  
(Freire) 
Prediction 
(Spolar) Calorimetric 
Van’t 
Hoff NLS Fit 
ΔHTm (kcal/mole) NA 160 ± 30 142 ± 3 110 118.5 ± 0.4 
ΔCp  
(kcal/mole/°C) 
4.7 
3.7 ± 0.7 3.5 ± 0.5 NA 4.09 ± 0.07 
Tm (°C) NA NA 55.13± 0.02 NA 55.07±0.02 
ΔG(37°C) 
(kcal/mole) 
NA 
NA 6.1 ±0.4 NA 4.45 ± 0.07 
  
Table 3.1. List of fitted thermodynamic parameters for Dys ABD1 with associated errors. 
From left to right, the columns contain the list of thermodynamic values being 
represented, values from the nonlinear least squares (NLS) model fit, thermodynamic 
values taken from the calorimetric features of the raw data, excess enthalpy from the 
Van’t Hoff analysis, predictions for excess enthalpy and change in heat capacity based on 
molecular weight, and a prediction for the change in heat capacity based on differences in 
the predicted absolute heat capacities of the folded and unfolded states. Values that were 
not described by the given model are listed as ‘NA’. Errors for the Van’t Hoff enthalpy 
and Freire prediction model are not included. 
 
  
*This chapter was reproduced in its entirety with permission from the following article: 
Fealey ME, Binder BP, Uversky VN, Hinderliter A, Thomas DD. Structural impact of 
phosphorylation and dielectric constant variation on synaptotagmin’s IDR. Biophys J. 
2018 114:550-561. 
CHAPTER 4: STRUCTURAL IMPACT OF PHOSPHORYLATION AND 
DIELECTRIC CONSTANT VARIATION ON SYNAPTOTAGMIN’S 
INTRINSICALLY DISORDERED REGION* 
4.1 – Section Summary 
We used time-resolved Förster resonance energy transfer, circular dichroism, and 
molecular dynamics simulation to investigate the structural dependence of synaptotagmin 
1’s intrinsically disordered region (IDR) on phosphorylation and dielectric constant. We 
found that a peptide corresponding to the full-length IDR sequence, a ~60-residue strong 
polyampholyte, can sample structurally collapsed states in aqueous solution, consistent 
with its κ-predicted behavior, where κ is a sequence-dependent parameter that is used to 
predict IDR compaction. In implicit solvent simulations of this same sequence, lowering 
the dielectric constant to more closely mimic the environment near the surface of a lipid 
bilayer promoted further sampling of collapsed structures. We next examined the 
structural tendencies of central region residues of the IDR in isolation. We found that the 
exocytosis-modulating phosphorylation of Thr112 disrupts a local disorder-to-order 
transition induced by trifluoroethanol/water mixtures that decrease the solution dielectric 
constant and stabilize helical structure. Implicit solvent simulations on these same central 
region residues testing the impact of dielectric constant alone converge on a similar 
result, showing that helical structure is formed with higher probability at a reduced 
dielectric. In these helical conformers, lysine-aspartic acid salt bridges contribute to 
stabilization of transient secondary structure. In contrast, phosphorylation results in 
formation of salt bridges unsuitable for helix formation. Collectively, these results 
suggest a model in which phosphorylation and compaction of the IDR sequence regulate 
structural transitions that in turn modulate neuronal exocytosis.  
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4.2 – Introduction 
Synaptotagmin 1 (Syt 1) is the calcium ion (Ca2+) sensor for neurotransmitter 
release, chelating Ca2+ upon action potential-induced entry and consequently triggering 
fast synchronous release.146 The underlying mechanisms by which Syt 1 mediates this 
biological event remain incompletely understood. Our goal has been to investigate the 
allosteric network of Syt 1 to elucidate regulatory mechanisms that underlie controlled 
neurotransmitter release.49, 147, 148 Our group found that an intrinsically disordered region 
(IDR) within Syt 1 (residues ~80-141) exerts allosteric influence over the adjacent C2 
domain referred to as C2A (Fig. 4.1A). Until recently, this IDR had received little 
attention and its structural biology still represents a significant gap in our understanding 
of Syt 1 function. Because the Syt 1 IDR exerts allosteric influence over C2A, structural 
or disordered ensemble transitions that occur there may be important for modulating C2 
domain functions that in turn influence exocytosis.149 Additionally, the IDR was recently 
shown to bind to the pleckstrin homology (PH) domain of dynamin 1, implicating its 
sequence in an important protein-protein interaction of endocytosis.150 
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Figure. 4.1. Model of Syt 1 and amino acid sequence of its IDR. (A) Syt 1 consists of a 
short luminal domain (LD), a single transmembrane helix (TM), a ~60 residue IDR, and 
two calcium ion- and phospholipid-binding C2 domains in tandem, C2A and C2B. 
Approximate dielectric constants for the bilayer core (ε=2), interfacial region (ε=4-20), 
and bulk solution (ε=80) are shown to indicate environments the polyampholytic IDR 
may experience. (B) The IDR sequence (residues 80-141) is shown with the basic 
residues in blue and the acidic residues in red. The distribution of charged residues 
partially delineates the sequence into three segments as indicated. Above the sequence is 
the ANCHOR predicted probability for each residue potentially contributing to a binding 
site as described in ref. 151 and 152.The modeled peptide below the sequence shows the 
location for covalent attachment of acceptor dyes as well as location of the added 
tryptophan (yellow) used in FRET experiments. Thr112, the phosphorylation site 
examined in this study, is also indicated. 
 
When examining the amino acid sequence of this IDR to make initial structural 
predictions, it appears to be a strong polyampholyte with ~50% of its residues consisting 
of an almost equal number of oppositely charged amino acids (Fig. 4.1 B).153, 154 
However, the distribution of charged residues divides the IDR into three main segments: 
a highly positive N-terminal region (~80-96), a more sequence-diverse central region 
with dispersed lysine-aspartic acid repeat motifs (~97-120), and a highly negative C-
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terminal region (~121-141) (Fig. 4.1 B). Intrinsically disordered proteins (IDPs) that have 
a high degree of charge separation sample more compact structural states, and the degree 
of compactness can be predicted with the calculated κ. This κ varies from 0 (less 
compact) to 1 (most compact) and, in model 50-mer peptides consisting of an equal 
number of lysine and glutamic acid residues, correlates to radii of gyration (Rg) that range 
from 3.0 nm to 1.7 nm.155 When we performed this calculation for Syt 1’s IDR sequence, 
we determined a κ value of 0.22, suggesting that the IDR can sample more compact 
structural states whose Rg approaches 2.3 nm (Tables 4.3 and 4.4, Supporting Materials 
and Methods Chapter 4). Further application of the sequence-dependent analysis 
software, CIDER, places the Syt 1 IDR in a chimeric region of the IDP phase diagram, 
predicting exploration of both coil and hairpin structures (Fig. 4.9).156 Recently it was 
proposed that this IDR functions in Syt 1 as an “electrostatic zipper” that opens and 
closes to mediate docking of synaptic vesicles and fusion pore opening, respectively, 
though no distance measurement was made.157 Chimeric behavior of the IDR would be 
appropriate for such opening and closing and can be experimentally measured using 
Förster resonance energy transfer (FRET), an approach we have explored here (Fig. 4.1 
B). 
While the calculated κ term for the Syt 1 IDR probably stems from the N- and C-
terminal regions with high charge density, the central region has its charged residues 
more evenly distributed, suggestive of more local coil disorder. Within this central region 
there is a series of KD-repeats with the exception of a KT sequence at residue positions 
111 and 112. Many of these charged residues are in i,i+4 positions, suggesting they could 
stabilize helical secondary structure through salt bridge formation. Intriguingly, Thr112 is 
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a site of phosphorylation that was recently shown to promote PKC-mediated potentiation 
of synaptic transmission (Fig. 4.1 B).158 Addition of a phosphate at this site would 
complete a positive-negative repeat pattern in this central region of the IDR, impact the 
local electrostatics of the region, and probably alter its structural propensity. Furthermore, 
this central region contains a predicted binding site that is adjacent to Thr112 (Fig. 4.1 B), 
suggesting that phosphorylation of Thr112 could initiate a structural transition that 
modulates binding.151, 152 Such a mechanism could help explain how phosphorylation in 
vivo promotes synaptic plasticity. Collectively, this differential distribution of charged 
residues suggests that electrostatics serve more than one structural role in IDR-
modulation of neuronal exocytosis. 
The polyampholyte nature of this IDR is of further significance because it is part 
of an integral membrane protein. The lipid bilayer core and interfacial regions have low 
dielectric constants (ε=2-20) compared to bulk aqueous solution (ε=80), so the potential 
structural impact of charged residues in the IDR sequence is likely to be more 
pronounced in Syt 1’s native local environment (Fig. 4.1 A). In the current study, we 
aimed to answer the above questions in an attempt to establish basic principles of this 
IDR’s behavior.  
 
4.3 – Materials and Methods 
4.3.1 – Reagents 
Potassium chloride (KCl), sodium phosphate monobasic (NaH2PO4) and sodium 
phosphate dibasic (Na2HPO4) were obtained from ThermoFisher Scientific. 2,2,2-
trifluoroethanol (TFE) ≥99.0% was obtained from Sigma-Aldrich. N-[2-
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(dansylamino)ethyl]maleimide and N-(iodoacetaminoethyl)-1-naphthylamine-5-sulfonic 
acid (IAEDANS) acceptor labels were obtained from Sigma-Aldrich. Three peptides 
corresponding to the full-length Syt 1 IDR (residues 80-141) with a C-terminal 
tryptophan as well as the core region of the IDR with some of the acidic C-terminus 
(residues 97-130) in both unphosphorylated and phosphorylated form (phosphorylated at 
threonine 112) were obtained from Selleck Chemicals at a purity of 95% based both on 
mass spectrometry and HPLC. Numbering of residues assumes start codon methionine is 
removed. The amino acid sequences for each of the three peptides correspond to the 
following: (full-length IDR) KKCLFKKKNKKKGKEKGGKNAINMKDVKDLGKT- 
MKDQALKDDDAETGLTDGEEKEEPKEEEKW; (unphosphoryl-ated core of IDR) 
GKNAINMKDVKDLGKTMKDQALKDDDAETGLTDG; (phosphorylated core of 
IDR) GKNAINMKDVKDLGK(pT)MKDQALKDDDAETGLTDG. The core region 
peptides included a few residues from the acidic terminus of the IDR to help ensure 
adequate solubility. Despite this inclusion of C-terminal residues, these peptides are 
referred to as the “core region” throughout the manuscript. The peptides did not include 
N- or C-terminal caps in an attempt to avoid potential perturbations to helicity.159 
In the full-length IDR construct, the tryptophan was added to both enable UV 
measurement for concentration determination and also to act as a donor probe in time-
resolved FRET experiments. Use of tryptophan and dansyl was also chosen as a way of 
minimizing structural perturbation to system with fluorescent probes, only requiring 
addition of one residue and exploiting the single native cysteine. 
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4.3.2 – Tryptophan Lifetime FRET 
For the time-resolved FRET, we first reconstituted full-length IDR peptide in 10 
mM NaH2PO4/Na2HPO4 buffer with the pH adjusted to 7.4. Measuring the A280 and 
using a calculated extinction coefficient of 5600 cm-1M-1, the concentration of peptide 
was determined. A 4-fold excess of maleimide-dansyl (in the case of the full-length 
synthetic peptide) or AEDANS (in the case of the recombinant full-length IDR) acceptor 
probe that had been reconstituted in dimethylformamide (DMF) was then added to the 
peptide solution and allowed to incubate with the full-length IDR for 3 hours at room 
temperature (~23 °C) in the presence of 1 mM tris(2-carboxyethyl)phosphine (TCEP) 
reducing agent to prevent cysteine cross-linking. During the reconstitution of full-length 
IDR, the peptide forms a dimer that is in equilibrium with its monomeric form. To isolate 
the acceptor-labeled monomer for FRET and simultaneously separate labeled peptide 
from free dye, we subjected the peptide solution to size exclusion chromatography using 
a pre-packed S100 sephadex column from G&E. Because of the large molecular weight 
difference between the peptide dimer (~14 kDa), peptide monomer (~7 kDa) and free 
maleimide-dansyl probe (~370 Da), all three species can be resolved into separate 
fractions. The elution fractions containing just acceptor-labeled full-length IDR peptide 
were identified by UV absorption, pooled, and concentrated using an Amicon Ultra-4 
centrifugal filter unit from Millipore whose molecular weight cut-off was 3 kDa. The 
final concentration of full-length peptide as well as the extent of labeling with maleimide-
dansyl were determined with UV absorption using the approach described by 
Gustiananda et al.160. In this approach, the peptide concentration is determined by 
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measuring the donor-acceptor peptide and subtracting the contribution from dansyl with a 
correction factor previously described161: 
 
[IDR peptide] = (A280 – (A331x0.386))/5500     Eq. 4.1 
[maleimide-dansyl] = A331/4000       Eq. 4.2 
  
The ratio of [IDR peptide] and [maleimide-dansyl] enables an assessment of labeling 
efficiency and for the full-length IDR peptide, this ratio was near unity indicating 
complete labeling. This seemed reasonable considering the IDR is unfolded, allowing for 
the cysteine to be well exposed to free acceptor dye in bulk solution. 
Tryptophan lifetimes were measured on a custom made spectrometer from 
Fluorescence Innovations147, 162, which uses an Nd:Yag laser for excitation of 
pyrromethene 597 with a 532 nm wavelength. The emission from pyrromethene passes 
through a doubling crystal to create a 295 nm wavelength specific for tryptophan 
excitation. Syt 1 IDR with a C-terminal tryptophan was synthesized (or expressed 
recombinantly) and subjected to lifetime measurements at 23°C in the absence and 
presence of dansyl (or AEDANS in the case of the recombinant IDR) acceptor probe 
irreversibly linked to the N-terminal cysteine residue present in the natural sequence (Fig. 
4.1 B). Tryptophan emission from samples at concentrations of 1-3 μM was monitored at 
340 nm. 
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Tryptophan waveforms with and without covalently attached acceptor dye were 
fit to multiexponential decays using a custom-made fitting program FargoFit.163 The 
general description of the waveform is a sum of exponentials: 
 
F(t) = ∑ ai e-t/τini=1 ,          Eq. 4.3 
 
where ai represents the amplitude of each i
th component, n represents the number of 
components, and τi is the fluorescence lifetime. The tryptophan waveforms were 
sufficiently described by two exponentials (Fig. 4.2 A). To determine the distance R 
between tryptophan and dansyl probes, amplitude-weighted average lifetimes τ were 
calculated and subsequently used to determine the efficiency of energy transfer (E) which 
was then used in a rearranged Förster equation with 2.1 nm for the tryptophan-dansyl R0: 
 
E = 1 - τDA/τD,  R = R0(1/E – 1)1/6       Eq. 4.4 
 
4.3.3 – Circular Dichroism 
Peptides were reconstituted in buffer containing 10 mM sodium phosphate (pH 
7.4), and stock solution concentrations were determined using BCA microplates and UV 
absorption (for full-length peptides). TFE was added at incremental percentages v/v over 
a range of 0-60%. Each raw data set of absorption had a corresponding buffer scan 
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subtracted from it to remove any absorption contributions from buffer or TFE co-solvent. 
Resulting data sets were plotted as mean residue ellipticity (MRE) according to the 
following equation: 
 
MRE = θx(MW/(N – 1))/lc ,        Eq. 4.5 
 
where [θ] is raw ellipticity, MW is the molecular weight of the peptide, N is the number 
of residues, l is the cuvette path length, and c is the peptide concentration in mg/mL. 
Concentrations of core region peptide samples ranged from 18-20 μM for all experiments 
whereas full-length IDR peptides were at a concentration of 10 μM. To extract the free 
energy of folding for Syt 1 IDR peptides, a simultaneous non-linear least squares fit of 
198 nm and 222 nm wavelengths was performed (mathematical derivation in Supporting 
Materials and Methods Chapter 4). Four replicate measurements of TFE gradients for 
each Syt 1 IDR peptide were individually fit and then averaged to determine standard 
deviations. Estimates of helicity were obtained by fitting data sets to linear combinations 
of α-helix, β-sheet, and random coil secondary structures as described previously.13, 164  
4.3.4 – Atomistic MD simulation of Syt 1 IDR 
Peptides corresponding to both the full-length Syt 1 IDR and the core region were 
generated in Discovery Studio 2.0. Molecular Dynamics (MD) simulations were 
performed with NAMD 2.9165 using the CHARMM36 force field166, the Generalized 
Born Implicit Solvent (GBIS) model167, and 2-fs time steps. Peptide termini were left 
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charged to mimic the state of the peptides used in CD experiments. The peptide systems 
were maintained at constant temperature with a Langevin thermostat (298 K). Peptides 
corresponding to residues 80-141 in the unphosphorylated state or residues 97-129 of the 
Syt 1 IDR with and without phosphorylation at Thr112, were subjected to energy 
minimization and gradually warmed up over a period of 200 ps prior to equilibration. All 
systems subsequently achieved RMSD convergence within 50 ns (Fig. 4.10). We 
performed a total of eight different simulations. For the full-length Syt 1 IDR sequence, 
the peptide was subjected to two different salt concentrations (10 mM and 100 mM) at 
two GBIS solvent dielectric constants (ε = 80 and ε = 20). For the core region residues 
alone, we simulated the peptide with and without phosphorylation of Thr112 at the two 
dielectric constant values described above at a salt concentration of 100 mM. A ε value of 
80 was used to mimic an aqueous solution environment, while a value of 20 was used to 
mimic the upper limit of the membrane interfacial region.168, 169 The full-length IDR 
peptide was simulated at ε = 80 for 970 ns with either a 10 mM salt concentration or a 
100 mM salt concentration. At ε = 20, the full-length peptide was simulated for 480 ns 
and 760 ns at salt concentrations of 10 mM and 100 mM, respectively.  The 
unphosphorylated core region peptide was simulated with ε = 20 for 1 μs and with ε = 80 
for 1.08 µs. The phosphorylated core region peptide was simulated with ε = 20 for 1.0 μs 
and with ε = 80 for 1.1 µs. Trajectories were analyzed using VMD 1.9.1.170 The program 
STRIDE, included within VMD, was used to monitor secondary structure throughout 
each trajectory.171 When calculating the probability of existing in different types of 
secondary structure (coil, beta sheet, turn, and helix), we combine 310-helicies with α-
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helices under the assumption that 310-helical structure is an on-path transition point 
between coil and α–helix.172 
4.3.5 – Protein Purification 
For FRET studies on the recombinant IDR construct, a nucleotide sequence 
encoding residues 80-141 with a C-terminal tryptophan followed by a His-tag, was 
cloned into a pET28a vector and subsequently transformed into BL21 E. coli using the 
New England BioLabs heat-shock protocol. Transformed cells were plated onto a 
kanamycin-containing agar plate with an antibiotic concentration of 50 μg/mL and 
subsequent colonies were used to generate inoculate for large-scale bacterial growth and 
protein expression, induced with 1 mM IPTG. After 12 hours at 25 °C, cells were 
harvested by centrifugation. Cell pellets were resuspended in 20 mM MOPS, 200 mM 
KCl, 4 M urea, 1 mM PMSF at pH 7.4 (4 °C), then lysed by sonication. The resulting 
lysate was treated with DNAse and 1 mM MgCl2 and allowed to stir at 4 °C for 1 hour, 
followed by centrifugation to remove cellular debris. The supernatant was passed through 
a ThermoScientific Nalgene prefilter plus GFP sterile filter with a pore size of 0.2 μm to 
remove further particulate matter. The filtered solution was then slurried with TALON 
metal affinity resin buffered in 20 mM MOPS, 200 mM KCl, 4 M urea, pH 7.4. The 
slurry was gently stirred at 4 °C for 2 hours, then transferred into a column to remove 
unbound protein and nucleic acid. Settled resin was subsequently rinsed with four column 
volumes of buffer containing 20 mM MOPS, 200 mM KCl, 4 M urea, and 10 mM 
imidazole (to remove non-specifically bound proteins) at pH 7.4. Resin was then rinsed 
with a high salt buffer (20 mM MOPS, 1 M KCl, 4 M urea, 10 mM imidazole at pH 7.4) 
to separate nucleic acid bound to linker region peptide (specifically, the region containing 
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a high number of lysine residues). The resin was then rinsed with four column volumes of 
buffer containing 20 mM MOPS, 200 mM KCl, 4 M urea, and 10 mM imidazole at pH 
7.4. The linker region protein was then eluted with buffer containing 20 mM MOPS, 100 
mM KCl, 4 M urea and 300 mM imidazole at pH 7.4. Fractions of eluted protein were 
run on SDS-PAGE and pure fractions whose 260 nm/280 nm ratio was <0.7 (which 
indicates >95% purity with respect to nucleic acid contamination) were pooled and 
concentrated. Syt 1 IDR was then dialyzed against 4 liters of buffer containing 10 mM 
sodium phosphate at pH 7.4 four times, each with an equilibration time of 6 hours to 
ensure complete exchange. The Syt IDR was then subjected to size-exclusion 
chromatography as described above for the Syt IDR synthesized peptide to isolate 
monomers. 
 
4.4 – Results 
4.4.1 – Full-length IDR peptide can sample compact structural states in aqueous solution 
To first test the hypothesis that the Syt 1 IDR can sample compact structural states 
consistent with an “electrostatic zipper”, we used tryptophan (Trp)-dansyl FRET, placing 
the aromatic amino acid at the C-terminus of an IDR peptide and dansyl at the N- 
terminus using the sequence’s single native cysteine for irreversible attachment (Fig. 4.1 
B). The Trp-dansyl probe pair has an R0 of 2.1 nm, a value suitable for detecting IDR 
compaction based on the κ prediction if it occurs. We measured the Trp lifetime decay 
with and without acceptor dansyl and found the lifetime to be shortened by proximity of 
the acceptor probe. When fit to bi-exponential functions (Fig. 4.2 A), it was found that the 
122 
 
Trp and dansyl probes were a mean distance of 2.40±0.05 nm apart (Fig. 4.2 B), which 
represents the average inter-probe distance but only for compact conformers detected by 
this dye pair. 
 
 
Figure. 4.2. Sampling of a structurally collapsed state by the Syt 1 IDR in aqueous 
solution. (A) Determining the number of lifetimes needed to fit tryptophan decays 
without (blue) and with (red) acceptor dyes. In both cases, two lifetimes were considered 
necessary and sufficient (asterisk). (B) Time-resolved FRET measurement of Syt 1 IDR 
synthesized peptide showing Trp-dansyl undergoing energy transfer in 10 mM sodium 
phosphate buffered to a pH of 7.4. Blue: donor-only.  Red: donor-acceptor. Error bars: 
SD of 4 replicates. Black: instrument response function (IRF). The distance derived from 
the change in average lifetime (τD = 1.53±0.11, τDA = 1.06±0.10) is 2.40±0.05 nm (Eq. 
4.4). Shown below the time-resolved data are residuals of fitting to bi-exponential 
functions. (C) A similar FRET result was obtained from a recombinantly expressed Syt 1 
IDR construct that was labeled with AEDANS acceptor. The slight increase in FRET in 
the recombinant IDR is thought to be due to inclusion of a his-tag, which tend to promote 
compaction in IDPs.173  
 
Given the ~60 residue separation between the two probes, such a measurement 
indicates that the IDR peptide can sample compact structural states in aqueous solution, 
though this measurement cannot differentiate between hairpin and globular structures. 
Additionally, by using our minimally perturbing probe pair, we are not able to measure 
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occupation of conformers adopted beyond a ~3.4 nm inter-probe distance, where FRET 
efficiency between Trp-Dansyl is below 5%. Thus, to complement our FRET 
measurements characterizing the structural behavior of the IDR in an aqueous 
environment with low salt, we next performed MD simulations on a peptide 
corresponding to the full-length Syt 1 IDR sequence (residues 80-141). We used an 
implicit solvent model with a dielectric constant of ε = 80 and a 10 mM salt 
concentration. The simulated IDR structure sampled a wide range of conformers under 
these conditions as indicated by its fluctuating Rg during the trajectory (Fig. 4.3A). 
Intriguingly, while FRET indicates that sampling of compact conformers does occur (Fig. 
4.2), MD simulations suggest that compact conformers are not the dominant structural 
species in the overall aqueous environment ensemble (Fig. 4.3B). On average, the IDR 
sequence samples extended coils more frequently (Fig. 4.3C). Collectively, FRET and 
MD results correlate with the IDR’s predicted behavior based on amino acid sequence 
alone and is consistent with the previously proposed “electrostatic zipper” model in 
which the IDR samples both open (extended) and closed (compact) conformers.156, 157  
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Figure. 4.3. MD simulation of the full-length Syt 1 IDR (residues 80-141) with an 
implicit solvent (ε=80) and salt concentration of 10 mM. (A) Radius of gyration (Rg) as a 
function of simulation time indicates the IDR sequence samples both extended and 
compact states. Dotted line indicates average Rg. (B) Inter-residue distance (<Rj-i>) 
between first (i) and each subsequent (j) residue (Cαj-Cαi) in the Syt 1 IDR plotted as a 
function of simulation time. Plots suggest weak long-range interactions promote 
sampling of more compact conformations. However, compact conformers are not the 
dominant structural species in an aqueous environment as indicated by the location of the 
average inter-residue distances (black diamonds). (C) Representative conformers of 
different Rg. Structures, N- to C-terminus, are color-coded blue to red. 
 
4.4.2 – TFE-water mixtures promote partial helicity in core IDR residues 
Next, to assess the structural potential of the more sequence-diverse central 
region, we used circular dichroism and the helix-promoting co-solvent trifluoroethanol 
(TFE) (Fig. 4.4 and Fig. 4.11). Several of the residues in the central region, because they 
have hydrophobic side chains, would likely have low free energy barriers to desolvation, 
which often occurs upon protein-protein binding. This, coupled with the core region’s 
predicted binding site and phosphorylation (Fig. 4.1 B), make it a potential site of 
ordering. Moreover, TFE/water mixtures allow for creation of low dielectric 
environments that more closely mimic that found near a lipid bilayer surface. For these 
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reasons, TFE is a useful perturbing agent to study structural transitions of a membrane-
localized polyampholyte IDR.174 In the unphosphorylated state, increasing TFE 
concentration results in partial folding into helical structure (Fig. 4.4 A). This transition 
exhibits 2-state behavior exemplified by the isodichroic point (vertical dotted line). When 
we fit the transition to a 2-state model (Fig. 4.4 D, Supporting Material and Methods) we 
measured a folding free energy (ΔG0) of 1.0±0.2 kcal/mole (Table 4.1).  
 
 
Figure. 4.4. Impact of Thr112 phosphorylation on Syt 1 IDR core region 
(GKNAINMKDVKDLGKTMKDQALKDDDAETGLTDG). (A) MRE of 
unphosphorylated Syt 1 IDR core and (B) MRE of phosphorylated Syt 1 IDR core as a 
function of increasing TFE (0-60% v/v going from red to violet) in 10 mM sodium 
phosphate at a pH of 7.4. (C) Fitting of absorption profiles to linear combinations of α-
helix, β-sheet and random coil in each IDR construct at a maximal TFE concentration of 
60% v/v. (D) Simultaneous fitting of the 198 nm coil minimum (solid circles, dark line) 
and 222 nm (open circles, lighter line) signals during folding transition for 
unphosphorylated (purple), phosphorylated (green) and full-length (orange) peptides. (E) 
Comparison of 222 nm/200 nm ratio from full-length (orange), unphosphorylated core 
(purple) and phosphorylated core (green). Removal of flanking charge shifts IDR from a 
pre-molten globule-like (PMG-like) state to a more coil-like state and phosphorylation 
accentuates this effect. Figure modified from reference175. 
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To assess the impact of phosphorylation, we repeated the TFE titration with a 
phosphorylated peptide (phosphothreonine, pThr112) of identical sequence (Fig. 4.4 B). 
This approach of using TFE-induced folding has been successfully applied in other 
disordered systems to discern differences in folding propensity upon residue 
phosphorylation.176, 177 Upon inclusion of the post-translational modification, TFE-
induced folding was somewhat restricted as evident in the absorption profile (Fig. 4.4 B, 
Fig. 4.11). When the structural transition was fit to a 2-state model as before, a ΔG0 of 
0.36±0.09 kcal/mole was found (Fig. 4.4 D) indicating that phosphorylation increases the 
ease with which helical structure forms with increasing TFE concentration (the ΔΔG0 is 
equal to -0.6±0.2 kcal/mole). However, when we quantified the helical content of 
unphosphorylated and phosphorylated peptides in the presence of maximal TFE (Fig. 4.4 
C), the phosphorylated peptide did not reach the same level of helicity as that of the 
unphosphorylated peptide (Table 4.2), giving rise to an apparent lowering of the folding 
free energy. Collectively, these findings indicate that phosphorylation interferes with 
TFE-induced helix formation in the core region residues. 
 m-value 
(cal/mol·TFE) 
ΔG0 
(cal/mol) 
[θ]U 
(198nm) 
[θ]F 
(198nm) 
[θ]U 
(222nm) 
[θ]F 
(222nm) 
Unphosphorylated -55±2 1000±200 -12±1 -4.9±0.2 -0.8±0.2 -4.3±0.2 
Phosphorylated -48±4 360±90 -14.9±0.9 -7.3±0.9 -1.1±0.5 -4.2±0.7 
Full-length IDR -82±20 1500±300 -9.3±0.5 -3.6±0.3 -2.1±0.4 -4.8±0.2 
 
Table 4.1. Fit parameters from TFE-induced folding of Syt 1 IDR constructs. 
When examining the CD absorption profile of IDPs, another useful parameter in 
assessing structure is the 222 nm/200 nm ratio, which can help discern whether or not a 
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particular IDP is in a more compact pre-molten globule state or in a disordered coil 
state.175, 178 When we compare the full-length Syt 1 IDR with the unphosphorylated and 
phosphorylated core region peptides, a trend becomes apparent (Fig. 4.4 E).  
In the full-length IDR, the 222 nm/200 nm ratio is consistent with its predicted 
chimeric behavior existing in a region of space between purely coil and purely pre-
molten globule, which is consistent with the FRET measurement of compactness (Fig. 
4.2) and MD simulation sampling of extended coils (Fig. 4.3). However, when the 
flanking positive and negative regions are largely removed to generate a peptide that 
includes core region residues, the 222 nm/200 nm ratio is shifted more definitively in the 
direction of coil disorder and phosphorylation shifts the ratio further still (Fig. 4.4 E). 
This indicates that the central region, where positive and negative charges are more 
evenly distributed, imparts more coil behavior and phosphorylation enhances that 
behavior. However, with the flanking densely positive and densely negative regions, 
structural states intermediate between pre-molten globule and coil are preferred.  
This suggests that, if the central region transitions to structural ensembles 
containing more ordered elements, the flanking charged regions that promote sampling of 
compact structural states may exert regulatory control over accessibility of those core 
region conformers. TFE-induced folding of full-length Syt 1 IDR has a larger ΔG0 of 
1.5±0.3 kcal/mole compared to the unphosphorylated core peptide, which supports the 
hypothesis that flanking basic and acidic termini can limit core region folding (Fig. 4.4 D, 
orange; Table 4.1). Also consistent with this hypothesis is the observation that estimated 
helical content of the full-length peptide is statistically indistinguishable from that of the 
unphosphorylated core peptide (fraction helical in 60% v/v TFE, full-length 0.45±0.02 vs 
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core 0.42±0.01). However, because we did not measure TFE-induced folding of the 
flanking basic and acidic regions in isolation, we cannot conclusively say the core region 
residues are the only residues that become helical in the full-length IDR peptide. 
Regardless, mechanisms where structural compaction in IDPs limit accessibility of 
internal regions of sequence have been proposed in other systems179, 180 and may still bear 
relevance to the Syt 1 IDR structure within the context of the whole protein embedded in 
a synaptic vesicle. 
 Fraction 
helix 
(experiment) 
Fraction total 
helix (MD 
sim) 
Fraction α-helix  
(MD sim) 
Fraction 310-helix  
(MD sim) 
Unphosphorylated 0.42±0.01 0.16 0.12 0.04 
Phosphorylated 0.37±0.03 0.09 0.04 0.05 
 
Table 4.2. Estimated helical content of unphosphorylated and phosphorylated Syt 1 IDR 
core regions under maximum (60% v/v) TFE concentration (experiment) or lowest 
(ε=20) dielectric constant (MD sim). 
 
4.4.3 – Implicit solvent simulations show increased helicity in unphosphorylated core 
residues upon reducing dielectric constant 
While CD provides global information on Syt 1 IDR core region structure, we 
also sought atomistic details from MD simulation similar to our FRET experiments.165, 166 
In the in vitro studies, both unphosphorylated and phosphorylated peptides formed helical 
structures in the lower dielectric environments of TFE-water mixtures (Fig. 4.4). While 
TFE is known to stabilize helical structure181, 182, helical conformers would be a 
reasonable form of secondary structure for this IDR to adopt. Several of its residues have 
high to intermediate helical propensity.183, 184 Moreover, several oppositely charged 
residues in the core region are positioned in i, i+4 locations, suggesting a role for salt 
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bridges in the stabilization of helical structure. In the low dielectric environment of the 
interfacial region of the bilayer, there should be a higher propensity to form such salt 
bridges. We tested this hypothesis using an implicit solvent, first simulating the IDR core 
region at ε=80 (similar to that of water) and then with ε=20 (closer to that of the 
interfacial region). In both simulations, salt concentration was 100 mM to more closely 
mimic in vivo conditions. At ε=80, the unphosphorylated peptide largely occupied coil or 
turn secondary structure (Fig. 4.5 A and Table 4.5), consistent with CD measurements of 
the synthetic peptide (Fig. 4.4). When the unphosphorylated peptide was simulated again 
with ε=20, there was a large increase in the probability of helical conformers (Fig. 4.5 B 
and Table 4.5). When examining the 1.0 µsec trajectory, the helical conformers formed 
were often stabilized by lysine-aspartic acid salt bridges (Fig. 4.5 C). In particular, K111 
and D115 as well as K104 and D108 were among the longer-lived interactions within 
continuous helices (Fig. 4.5 D) though several other electrostatic interactions were also 
observed (Fig. 4.5 E), not all of which were helix stabilizing. 
 
4.4.4 – Implicit solvent simulations indicate Thr112 phosphorylation disrupts formation 
of helical conformers in IDR core residues 
To assess the impact of phosphorylation on the structural propensity of the IDR 
core residues, we repeated the implicit solvent simulations on a phosphorylated peptide 
of identical sequence. At ε=80 and 100 mM salt, the peptide was largely disordered and 
residual helical content was minimal (Fig. 4.6 A and Table 4.5). When the phosphorylated 
peptide was simulated at ε=20, helical structure formed but to a lesser degree compared 
to the unphosphorylated peptide (Fig. 4.6 B and Table 4.5) which is consistent with CD 
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data (Fig. 4.4). This difference is more pronounced when the total helical content is 
separated back into α- and 310-helices. The unphosphorylated peptide’s total helical 
content is largely dominated by α-helix (Table 4.2). In the phosphorylated peptide, the 
ratio of α- to 310-helices is closer to 50:50 with a slight preference toward the 310-helix 
(Table 4.2). 
 
Figure. 4.5. Simulated structural ensemble of unphosphorylated Syt 1 IDR core region. 
(A) Representative conformers of the peptide at a dielectric constant of 80 with secondary 
structure probability per residue is shown below (histogram). (B) Representative 
conformers of the peptide at a dielectric constant of 20 and secondary structure 
probability per residue shown below (histogram). Note increase in helical probability. (C) 
Close-up of example salt bridge that forms to stabilize helix in low dielectric 
environment. (D) IDR core region sequence showing sample salt bridge interactions 
found in helices at a dielectric constant of ε=20. Residues highlighted in purple occupy 
helical secondary structure. (E) Heat map showing change in all salt bridge interactions in 
going from dielectric 80 to dielectric 20. An increased frequency of interaction between 
two charged residues is indicated by gradations of blue whereas decreased interactions 
are indicated by gradations of red. Note increased frequency of i, i+3 and i, i+4 contacts. 
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The region of highest helicity in the unphosphorylated peptide was significantly 
disrupted by phosphorylation, as indicated by a sharp rise in turn/coil secondary 
structures in the residues immediately adjacent to and including Thr112 (Fig. 4.6 A and 
B). Similar to the unphosphorylated peptide under ε=20 simulation conditions, several 
salt bridges were prevalent during the course of the 1.0 µsec trajectory. In this case, 
however, the salt bridges involved the phosphate and several different lysine residues, 
none of which were in optimal positions for stabilizing helical structure (Fig. 4.6 C and 
D). For example, K111 (i, i+1), K107 (i, i+5), K104 (i, i+8) and K98 (i, i+14) all form 
salt bridges with the phosphate (Fig. 4.6 E). In addition to these unfavorable 
intramolecular interactions, phosphothreonine itself is thought to have a lower helical 
propensity which may further contribute to reduced helix formation.185 Moreover, in 
other model helical peptides, phosphorylation events that are centrally localized in the 
helix are more destabilizing to structure.186 
After examining unphosphorylated and phosphorylated peptides individually, we 
next considered them simultaneously as part of a thermodynamic cycle for the core 
region structural states (Fig. 4.7). Using the simulation-derived secondary structure 
probabilities, we calculated energetics for structural transitions that could then be 
compared to those derived from CD. Overall, the energetic trends were similar to those 
extracted from TFE folding experiments. Transitioning from high to low dielectric 
constant was energetically favorable for both unphosphorylated and phosphorylated 
states. However, like the CD experiments, the phosphorylated peptide had a more 
energetically favorable transition (∆∆GU→F = -0.88 kcal/mole) despite having less overall 
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helicity in each dielectric environment. In both dielectric environments, phosphorylation 
was energetically unfavorable for helix formation. 
 
 
Figure. 4.6. Structural ensemble of phosphorylated Syt 1 IDR core. (A) Representative 
conformers of the peptide at a dielectric constant of 80. Secondary structure probability 
per residue is shown below (histogram). Note reduced helicity compared to 
unphosphorylated peptide. (B) Representative conformers of the peptide at a dielectric 
constant of 20. Secondary structure probability per residue is shown below (histogram). 
Note that residues 107-118, which formed a continuous helix in the unphosphorylated 
peptide, is disrupted by coil secondary structure immediately adjacent to phosphorylation 
site. (C) Close-up of example salt bridge that distorts peptide backbone and limits helix 
formation in low dielectric environment. (D) IDR core region sequence showing salt 
bridge interactions inhibitory toward helices at a dielectric constant of ε=20. Green 
residues are those that occupy helical conformers during the trajectory. (E) Heat map 
showing change in salt bridge interactions in going from dielectric 80 to dielectric 20. An 
increased frequency of interaction between two charged residues is indicated by 
gradations of blue whereas decreased interactions are indicated by gradations of red. 
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Figure. 4.7. Simulation-derived thermodynamic cycle of structural states adopted by Syt 
1 IDR core region (residues 97-129). Folding free energies of each structural state 
(Unphos80, Phos80, Unphos20, Phos20) were determined by applying the equation ∆G = 
-RTln(fH/fNH), where fH is the fraction of helical conformers and fNH is the fraction of 
non-helical conformers. The free energy changes associated with transitioning between 
each state were then calculated and are shown in the figure above. Note that for both 
unphosphorylated and phosphorylated peptides, lowering the dielectric constant is 
favorable toward helix formation. The fraction of helical content is shown parenthetically 
below each structural state. At a given dielectric constant, phosphorylation is generally 
unfavorable toward helix formation. Note that the apparent ∆∆G computed from MD 
structural data is of similar magnitude to that derived from CD. 
 
4.4.5 – Sampling compact structural states in full-length IDR simulations can limit core 
region folding 
After obtaining data on full-length IDR compaction and helix formation in the 
core region residues separately, we next considered how sampling of compact structural 
states may influence core region helix propensity. We simulated the full-length IDR 
sequence at ε=80 and ε=20 at high (100 mM) and low (10 mM) salt concentrations and 
compared their structural behaviors. As suggested by the CD TFE-folding data, inclusion 
of the flanking N- and C-terminal regions seem to reduce probability of core region helix 
formation (Fig. 4.8A). This conclusion stems in part from comparison of the helix 
probability seen for the core region alone (Fig. 4.5A) with the same core region residues 
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within the full-length sequence. Comparison of core region and full-length peptides at 
ε=20 was less supportive in this regard (Fig. 4.8B). However, when full-length IDR 
peptides at ε=80 and ε=20 are examined at high and low salt concentrations, the 
correlation becomes more apparent. At ε=80 and 100 mM salt, there is a decrease in the 
sampling of compact structural states (Fig. 4.12) which coincides with a modest increase 
in helix probability in the core region residues (Fig. 4.13). The decrease in sampling of 
compact structural states is still subtle at ε=80 (Fig. 4.8C-E), which may in part explain 
why we did not measure a significantly different change in FRET efficiency under 
increasing salt concentration (Fig. 4.14A). This same salt-induce change was, however, 
more pronounced in simulations performed at ε=20 (Fig. 4.12 and 4.13). In general, the 
IDR more readily samples compact/hairpin structural states at ε=20 as evidenced by Rg 
and polymer chain behaviors (Fig. 4.8C-E). 
While salt influences compaction at ε=20, another likely competitor for 
intramolecular interactions within the IDR is intermolecular interactions with the lipid 
bilayer. Previous EPR spin label accessibility measurements indicate that the basic N-
terminal region can partially penetrate into a POPC:POPS lipid bilayer when 
reconstituted.187 This suggests that the basic N-terminus is the IDR region most likely 
responsible for direct lipid binding. To assess this potential contribution, we measured 
membrane binding of IDR peptides representing either the full-length IDR sequence or 
core region (residues 97-130) to large unilamellar vesicles whose lipid composition 
mimics that of a synaptic vesicle. Consistent with our hypothesis, only the full-length 
IDR peptide that includes the basic N-terminus was found to bind membrane (Fig. 4.14B 
and Fig. 4.14C, Supporting Materials and Methods Chapter 4). Though the core region 
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undergoes structural changes when the full-length IDR is associated with a synaptic 
vesicle mimic49, these co-sedimentation results suggest that the basic N-terminus is 
largely responsible for lipid binding. Because of this binding and the high local 
concentration of acidic phospholipids normally experienced by Syt 1 in the bilayer, lipid 
binding may be able to compete with intramolecular association of N- and C-terminal 
regions. Collectively, the simulations of the full-length IDR and binding results point to 
the possibility of a structural interplay between IDR compaction and occupation of 
transient helical conformers in the core region residues. 
 
 
Figure. 4.8. Structural impact of dielectric constant and salt on full-length Syt 1 IDR. 
Comparison of core region helix propensity in full-length (black histograms) and core 
region (purple or green histograms) peptides at (A) ε = 80 and (B) ε = 20 when salt 
concentration is 100 mM. The full-length IDR shows (C) variable Rg depending on 
simulation conditions where L and H represent 10 mM and 100 mM salt. Inset shows 
average Rg for entire trajectory. The average inter-residue distance for all conditions is 
shown in (D) along with representative conformers in (E). Structures in (E), N- to C-
terminus, are color-coded blue to red. 
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4.5 – Discussion 
In the current study, we probed the structural propensity of Syt 1’s IDR, 
examining the dependence on dielectric constant and phosphorylation. These are 
important goals because, in the former case, the type of intrinsic disorder exploited by Syt 
1 (strong polyampholyte) is naturally subjected to a low dielectric environment by virtue 
of being embedded in a lipid bilayer. This makes the impact of electrostatics more 
pronounced, enhancing any effect charged residues exert on local protein structure. In the 
latter case, phosphorylation at Thr112 has been shown to potentiate synaptic transmission 
in hippocampal neurons158, but a molecular rationale for this cellular change is lacking. 
With regard to dielectric constant, we found both through experiment (Fig. 4.4) 
and simulation (Fig. 4.5 and Fig. 4.6) that reduced dielectric constant promotes helix 
formation in core region residues. These results are of biological interest because we 
previously reported that the IDR remains largely disordered when associated with a lipid 
bilayer.49 While we could not rule out the possibility of the IDR peptide undergoing 
oligomerization on the membrane surface, which could alter structural propensity, 
another possibility for lack of structure is lipid-induced unfolding. While the bilayer 
provides a constant low dielectric environment that should promote folding in the core 
region of the IDR, other chemical factors undoubtedly still influence secondary structure. 
The vesicles we used previously were composed of nine lipid species in specific mole 
fractions designed to mimic the outer leaflet of the native organelle. IDR interaction with 
this cocktail of lipid headgroups may favor a more disordered state as part of a regulatory 
mechanism. Many IDPs and IDRs that interact with membranes are sensitive to lipid 
composition and have their secondary structure altered by different lipid mixtures.188 In 
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the single-pass integral membrane protein phospholamban, for example, this type of lipid 
modulation of structure has been directly linked to altered functionality. In response to 
cationic phospholipids, phospholamban’s cytoplasmic domain becomes more disordered 
and this structural shift consequently decreases the protein’s inhibitory potency towards 
the sarcoplasmic reticulum Ca2+-ATPase (SERCA) that it normally regulates.189 
Another possible explanation for the full-length IDR being more disordered when 
associated with a membrane could relate to an increased tendency to sample compact 
structural states (Fig. 4.8). Increased population of compact states due to low dielectric 
constant was inversely correlated with core region helix formation. This suggests that, in 
addition to possible lipid-regulation of folding, there may also be suppression of structure 
from intramolecular interactions between basic and acidic termini. 
Another finding of biological interest in this study is the site of apparent helix 
formation (Fig. 4.5 and Fig. 4.6). The position where helical structure forms is intriguing 
because it correlates with a disorder-based predicted binding site (Fig. 4.1). In a study by 
de Jong et al158, residues 109-116 were identified as being inhibitory toward synaptic 
release when unphosphorylated and permissive when phosphorylated. Our results suggest 
a potential structural model for this altered function. In the absence of phosphorylation, 
these residues (which form part of a predicted binding site) have a tendency to form an α-
helix which may be necessary for association with an as yet unidentified partner. When 
phosphorylated, however, there is a local disruption of helix formation that may then 
limit binding. This mode of regulation for binding interactions is common. There are 
examples in other IDP systems where single phosphorylation events similarly break 
helices190 or, in extreme cases, sequester a partially helical binding site into a different 
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form of secondary structure.191 In some instances, phosphorylation does not have a 
significant impact on secondary structure, but rather shifts local and global disordered 
ensembles to regulate interactions.179 And in other cytoplasmic regions of integral 
membrane proteins, phosphorylation can rearrange salt bridge interaction networks to 
switch local structure.177 Alternatively, a core region helix may form part of an interaction 
surface that contributes to Syt oligomerization, in which case helix disruption could alter 
the oligomeric state.187 These possibilities are also worth considering in the context of 
other synaptotagmin isoforms. In synaptotagmin 7, for instance, phosphorylation of 
Ser103 (a residue in its putative IDR) also potentiates exocytosis, in this case, of 
insulin.192 Such a similarity suggests that findings on Syt 1’s IDR may help inform future 
study of other synaptotagmin IDR isoforms. 
The structural differences between unphosphorylated and phosphorylated core 
region residues in Syt 1 also provide potential insight into a recent report of the IDR 
interacting with the PH domain of dynamin 1, a GTPase known for facilitating fission of 
vesicles that are being endocytosed.150 That study showed that a T112E missense 
mutation in the IDR abolishes the binding interaction, suggesting that phosphorylation is 
a regulatory mechanism for the interaction. However, that study also showed that deletion 
of residues 117-119 (ALK) or 111-119 (KTMKDQALK) did not disrupt binding of the 
IDR to the PH domain. Given that the KTMKDQALK residues are among those that 
adopt helical conformers in the absence of phosphorylation, the binding interaction with 
dynamin’s PH domain may not involve a specific structured helix in the Syt 1 IDR, but 
instead rely on a mechanism involving local electrostatic interactions.  
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On a more global level, the full-length IDR seems to sample collapsed structures 
(Fig. 4.2 and Fig. 4.8), consistent with both computational predictions155, 156 and effects 
of site-directed mutagenesis on the basic and acidic regions of the IDR in vesicle-vesicle 
docking/fusion assays.157 The other two sites of phosphorylation within the IDR (Thr125 
and Thr128), are located in the acidic C-terminal region, suggesting their placement 
could enhance compaction.193, 194 This may be particularly relevant in a low dielectric 
environment like that near the membrane surface, which already enhances occupation of 
compact conformations (Fig. 4.8). 
When comparing the CD and MD estimates of helical structure in lowest 
dielectric environments, there are differences in the absolute fractions determined by each 
method. While CD and MD do not quantitatively converge, they both indicate that 
phosphorylation is inhibitory toward helix formation. The lack of quantitative agreement 
is not surprising, since the MD simulations consider only the change in dielectric 
constant, ignoring other helix-stabilizing properties of TFE that involve alterations of 
peptide-water interactions which would likely require explicit treatment of both TFE and 
water.195-197 
 
4.6 – Conclusions 
We examined the structural impact of dielectric constant and phosphorylation on 
Syt 1’s IDR. The general sequestration of positive and negative residues at the N- and C-
termini promotes sampling of collapsed structural states in aqueous solution (Fig. 4.2) 
although compact states are more minor compared to extended coil states (Fig. 4.3). The 
more sequence-diverse core region of the IDR, where charge is more uniformly 
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distributed, can form short helices when subjected to TFE (Fig. 4.4) or a simulated low 
dielectric environment (Fig. 4.5). Phosphorylation at Thr112, however, disrupts this 
helical tendency both folding experiments in TFE and in implicit solvent simulations 
(Fig. 4.4 and Fig. 4.6). In addition to phosphorylation alteration of folding (Fig. 4.7), the 
helical propensity of these same core region residues may also be limited in the full-
length sequence as compact structural states are sampled (Fig. 4.8). Collectively, these 
results argue that the Syt 1 IDR is influenced by the low dielectric environment near the 
membrane surface and that altered charge distribution through post-translational 
modification can exert local alterations to its structural propensity. 
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4.7 – Supporting Material 
4.7.1 – Calculation of Compaction Predictor κ  
Polyampholytes are a class of intrinsically disordered proteins that have a high 
frequency of positively and negatively charged amino acids. The Syt 1 IDR falls into this 
category with ~56% of the amino acids being charged. In the predictive framework 
developed by Das and Pappu155, a polyampholyte IDP will adopt linear/extended or 
compact/globular random coils, depending on the distribution of charged side chains in 
sequence. The physical observable for measurement of compaction in this model is radius 
of gyration Rg, which is correlated with a computable predictive parameter called κ. The 
κ term depends on two main terms: σ, the overall charge asymmetry, and σi, the local 
charge asymmetry within a “blob” of linear sequence (usually 5 or 6 residues). How κ 
was calculated and used to predict the possible compactness of the Syt 1 IDR is shown 
below (Table 4.3 and Table 4.4). The fraction of positive (f+) and negative (f-) within 
each 5 or 6 residue i-th blob was used to determine σi: 
 
σi = (f+ - f-)i2/(f+ + f-)i         Eq. 4.6 
 
Each blob’s charge asymmetry was compared to the IDR’s overall charge asymmetry 
(Eq. 4.7) to determine the squared deviation (δ) using Eq. 4.8: 
 
σ = (f+ - f-)2/(f+ + f-)         Eq. 4.7 
δ = ∑ (𝜎𝑖 − 𝜎)
2/𝑁𝑏𝑙𝑜𝑏Nblobi=1         Eq. 4.8 
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Where Nblob is the number of blobs in the IDR sequence. Next, δ was determined for a 
rearranged primary sequence of the IDR amino acids that represents the maximum 
possible charge segregation. This value (δmax = 0.503) was then used to calculate κ, the 
parameter used to predict degree of compaction based on Figure 2 from155: 
 
κ = (δ/δmax)          Eq. 4.9 
 
4.7.2 – IDR peptide binding to large unilamellar vesicles (LUVs) 
To test if the IDR core region bound LUVs whose lipid composition mimicked 
that of a synaptic vesicle, we prepared liposomes using our previously developed lipid 
cocktail. This lipid composition was designed to mimic the outer leaflet of a synaptic 
vesicle organelle: 1-stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (18:0-18:1 PE); 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (16:0-18:1 PE); 1-stearoyl-2-
docosahexaenoyl-sn-glycero-3-phosphoethanolamine (18:0-22:6 PE); 1-stearoyl-2-
docosahexaenoyl-sn-glycero-3-phosphoserine (18:0-22:6 PS); 1-stearoyl-2-oleoyl-sn-
glycero-3-phosphoserine (18:0-18:1 PS); 1-stearoyl-2-arachidonoyl-sn-glycero-3-
phospho-(1’-myo-inositol-4’,5’-bisphosphate) (18:0-20:4 PI(4,5)P2); 1,2-dioleoyl-sn-
glycero-3-phospho-(1’-myo-inositol-4’,5’-bisphosphate) (18:1-18:1 PI(4,5)P2); 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol (16:0-18:1 PI); cholesterol. For further 
details preparation, see references49, 198. 
Co-sedimentation with synaptic vesicle mimic LUVs were performed by 
incubating 15 μM of either the full-length IDR (a synthetic peptide corresponding to 
residues 80-156) or the IDR core with part of the acidic C-terminus (residues 97-130) 
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with LUVs for 30 minutes at 22 °C. The concentration of LUVs for each sample ranged 
from 0-6 mM and total sample volume was 60 μL. After incubation, samples were 
subsequently spun down in a TLA 100 rotor for 1 hour at 22 °C to pellet LUVs and 
bound peptide. Depletion of peptide from the resultant supernatants was then used to 
assess membrane binding, where 20 μL aliquots were taken from the supernatants and 
run on SDS-PAGE (Fig. 4.14). 
 
4.7.3 – Nonlinear fitting to two-state folding model 
To determine the free energy of folding, we fit CD signal change to a two-state 
folding model. In a two-state model, there is equilibrium between unfolded (U) and 
folded (F) states of the protein: 
 
Keq = [U]/[F]                   Eq. 4.10 
 
The equilibrium constant is directly related to free energy through the Gibbs equation 
(Eq. 4.11): 
 
ΔG = -RTln(Keq)                  Eq. 4.11 
 
In cases where protein folding equilibria are monitored as a function of osmolyte, 
co-solvent (such as trifluoroethanol, TFE), or denaturant it can be assumed that the 
equilibrium between unfolded and folded states is linearly dependent on the added solute. 
This is an assumption of the linear extrapolation method199 which we employ here: 
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ΔG%TFEv/v = m x (%TFE v/v) + ΔG0                Eq. 4.12 
 
Where ΔG%TFEv/v is the free energy of the folded-unfolded equilibrium at some specified 
volume percentage of TFE, m is the proportionality constant by which the folding 
equilibrium free energy changes with addition of TFE, and ΔG0 is the equilibrium folding 
free energy in the absence of any TFE. In the case of circular dichroism measurements, 
there is a change in absorption of circularly polarized light with a change in structure. 
This signal change, when plotted as a function of % TFE v/v, creates a sigmoidal 
transition from which the fraction of unfolded species (fU) can be represented: 
 
fU = ([θ]%TFEv/v – [θ]min)/([θ]max – [θ]min)               Eq. 4.13 
 
Where [θ]%TFEv/v is the absorption of circularly polarized at different volume percentages 
of TFE, [θ]min is the absorption in the absence of TFE where there is no folded structure, 
and [θ]max is the absorption where there is constant helical structure with addition of TFE. 
By calculating fU at all volume percentages of TFE, equilibrium constants (Keq, %TFE) and 
folding free energies (ΔG%TFEv/v) can be calculated for each data point: 
 
Keq, %TFE = fU/(1-fU)                  Eq. 4.14 
ΔG%TFEv/v = -RTln(Keq, %TFE)                 Eq. 4.15 
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A plot of ΔG%TFEv/v from Eq. 4.15 versus % TFE v/v yields a linear correlation upon 
which linear regression analysis can be performed to obtain the slope (m) and intercept 
(ΔG0) of Eq. 4.12 above.  
While the above approach provides the desired value for the folded-unfolded 
equilibrium in the absence of TFE, we further analyzed the data with a non-linear least 
squares regression fitting of the raw data so that we could simultaneously fit two 
wavelengths reporting on the transition (198 nm and 222 nm) to a single set of m-values 
and ΔG0. The signal measured by circular dichroism is dependent on the fraction of 
unfolded protein. To model the folding transition, we use the following expression to 
describe the experimental data: 
 
[θ]fit = fU x ([θ]F – [θ]U) + [θ]U                Eq. 4.16 
 
Where [θ]fit is the modeled signal, [θ]F is the absorption for maximally folded protein, 
and [θ]U is the absorption for unfolded protein. In the non-linear least squares regression 
fitting, both [θ]F and [θ]U are fit parameters. However, absorption values taken directly 
from the raw data both in the absence of TFE (for [θ]U) and when there is no additional 
gain of folded structure upon addition of TFE (for [θ]F) can be used as close starting 
values. These parameters did not change substantially during the fitting process (Table 
4.1). Since fU is directly related to the folded-unfolded equilibrium constant (Eq. 4.14) 
and the equilibrium constant is related to free energy in the presence of TFE (Eq. 4.15) 
which in turn is linearly related to % TFE v/v (Eq. 4.12), then simple rearrangement and 
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substitution of equations will give a modified expression for [θ]fit in terms of the four fit 
parameters used for non-linear regression: 
 
[θ]fit = ((e-(m*(%TFEv/v)+ΔG0)/(RT))/(e-(m*(%TFEv/v)+ΔG0)/(RT) + 1)) x ([θ]F – [θ]U) + [θ]U     Eq. 4.17 
 
With Eq. 4.17 used to calculate the theoretical absorption of circularly polarized 
light as a function of % TFE v/v, we used the solver function of Excel to minimize the 
sum of the square differences between experimental and calculated fit values by 
manipulating the four parameters of m, ΔG0, [θ]F and [θ]U in a manner similar to that 
described previously.147, 162 In addition to using absorption values from the raw data for 
[θ]F and [θ]U as described above, we also used m and ΔG0 parameters obtained from the 
initial linear regression analysis of the linear-extrapolation method. Using these four 
starting parameters in Eq. 4.17 already does a reasonable job of describing the data. 
However, application of solver for further error minimization improves the total sum of 
the square differences between raw and fit values. After fitting the raw data sets, both the 
data and fit were normalized for side-by-side comparison in the main text.  
147 
 
 
Figure 4.9. Position of Syt 1 IDR in sequence charge-dependent phase diagram of 
structural states. Note that location of the Syt 1 IDR, indicated by Seq 1 data point, 
suggests it likely samples coil and/or hairpin-like structural states in an environment 
whose dielectric constant is similar to water. 
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Figure 4.10. RMSD of Syt 1 IDR constructs used in MD simulations. Core region 
peptides (residues 97-129) in unphosphorylated (purple) and phosphorylated (green) 
states and at dielectric constants of both ε=80 and ε=20 are shown in top four panels. The 
full-length peptides (residues 80-141) at dielectric constant and salt concentration of ε=80 
and 10 mM (blue), ε=80 and 100 mM (green), ε=20 and 10 mM (red), ε=20 and 100 mM 
(orange) are shown in the bottom four panels. Note that each peptide reaches equilibrium 
rapidly.  
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Figure 4.11. TFE-induced folding of Syt1 IDR. The left column shows partial folding of 
the IDR core residues (97-130) with Thr112 phosphorylated. Note its restricted transition. 
The middle column shows partial folding of IDR core residues (97-130) with Thr112 in 
its unphosphorylated state. The right column shows partial folding of the full length IDR 
(residues 80-140). Note that the top three panels in this column are replicates of the 
synthesized peptide and the bottom panel is the recombinantly expressed IDR that 
includes a C-terminal his-tag. Violet to red corresponds to a 0-60% v/v TFE range in 
increments of 3%. 
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Figure 4.12. Simulated inter-residue distances of full-length Syt 1 IDR under varied 
dielectric constant and salt conditions during the course of each trajectory. Black 
diamonds indicate the average structure. 
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Figure 4.13. Helix probability histograms (determined as described in main text) for full-
length Syt 1 IDR sequence. Black arrows for all four histograms indicate approximate 
core residue region. In all cases, arrows align with 0.1 on the probability axis to aid 
comparison. Also noteworthy is that, under all four conditions, helical content in the 
acidic C-terminus was markedly low. 
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Figure 4.14. Potential factors influencing full-length IDR compaction. (A) FRET 
efficiency was not significantly affected by salt. (B) Core region Syt 1 IDR 
(representative of n=2) as a synthetic peptide in a co-sedimentation assay with synaptic 
vesicle mimic LUVs. (C) Full-length Syt 1 IDR (left, representative of n=3) as a synthetic 
peptide in a co-sedimentation assay with synaptic vesicle mimic LUVs and (right) the 
resultant binding curve (KD = 169±82 μM). Collectively, the presence of either peptide in 
the supernatant indicates that the peptide containing the polybasic N-terminus is binding 
competent. This suggests that the basic N-terminus, in addition to transiently interacting 
with the negative C-terminus of the IDR sequence, also interacts with acidic lipids in a 
synaptic vesicle membrane and likely has two competing interactions (lipid – 
intermolecular; negative C-terminus – intramolecular) that could influence propensity to 
exist in compact structural state. 
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Table 4.3. Calculated kappa for blob g=5. 
For g = 5 
i + - f+ f- σi (σi - σ)2 ∑Nblob # of blobs δ κg=5 
1 2 0 0.4 0 0.400 0.157 6.927 58 0.119 0.238 
2 2 0 0.4 0 0.400 0.157  
3 2 0 0.4 0 0.400 0.157 
4 3 0 0.6 0 0.600 0.355 
5 3 0 0.6 0 0.600 0.355 
6 4 0 0.8 0 0.800 0.633 
7 4 0 0.8 0 0.800 0.633 
8 4 0 0.8 0 0.800 0.633 
9 3 0 0.6 0 0.600 0.355 
10 4 0 0.8 0 0.800 0.633 
11 3 1 0.6 0.2 0.200 0.038 
12 3 1 0.6 0.2 0.200 0.038 
13 2 1 0.4 0.2 0.067 0.004 
14 2 1 0.4 0.2 0.067 0.004 
15 2 1 0.4 0.2 0.067 0.004 
16 2 0 0.4 0 0.400 0.157 
17 1 0 0.2 0 0.200 0.038 
18 1 0 0.2 0 0.200 0.038 
19 1 0 0.2 0 0.200 0.038 
20 0 0 0 0   
21 1 0 0.2 0 0.200 0.038 
22 1 1 0.2 0.2 0.000 0.000 
23 1 1 0.2 0.2 0.000 0.000 
24 2 1 0.4 0.2 0.067 0.004 
25 2 2 0.4 0.4 0.000 0.000 
26 1 2 0.2 0.4 0.067 0.004 
27 1 1 0.2 0.2 0.000 0.000 
28 2 1 0.4 0.2 0.067 0.004 
29 1 1 0.2 0.2 0.000 0.000 
30 1 0 0.2 0 0.200 0.038 
31 2 0 0.4 0 0.400 0.157 
32 2 1 0.4 0.2 0.067 0.004 
33 1 1 0.2 0.2 0.000 0.000 
34 1 1 0.2 0.2 0.000 0.000 
35 1 1 0.2 0.2 0.000 0.000 
36 1 1 0.2 0.2 0.000 0.000 
37 1 1 0.2 0.2 0.000 0.000 
38 1 2 0.2 0.4 0.067 0.004 
39 1 3 0.2 0.6 0.200 0.038 
40 1 3 0.2 0.6 0.200 0.038 
41 0 4 0 0.8 0.800 0.633 
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42 0 3 0 0.6 0.600 0.355 
43 0 2 0 0.4 0.400 0.157 
44 0 1 0 0.2 0.200 0.038 
45 0 1 0 0.2 0.200 0.038 
46 0 1 0 0.2 0.200 0.038 
47 0 1 0 0.2 0.200 0.038 
48 0 2 0 0.4 0.400 0.157 
49 0 3 0 0.6 0.600 0.355 
50 1 3 0.2 0.6 0.200 0.038 
51 1 3 0.2 0.6 0.200 0.038 
52 1 4 0.2 0.8 0.360 0.127 
53 1 3 0.2 0.6 0.200 0.038 
54 2 2 0.4 0.4 0.000 0.000 
55 1 3 0.2 0.6 0.200 0.038 
56 1 3 0.2 0.6 0.200 0.038 
57 1 3 0.2 0.6 0.200 0.038 
58 2 3 0.4 0.6 0.040 0.001 
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Table 4.4. Calculated kappa for g=6. 
 
for g=6 
i + - f+ f- σi (σi - σ)2 ∑Nblob # of blobs δ κg=6 
1 3 0 0.500 0.000 0.500 0.246 6.170 57 0.108 0.215 
2 3 0 0.500 0.000 0.500 0.246  
3 3 0 0.500 0.000 0.500 0.246 
4 3 0 0.500 0.000 0.500 0.246 
5 4 0 0.667 0.000 0.667 0.439 
6 5 0 0.833 0.000 0.833 0.688 
7 5 0 0.833 0.000 0.833 0.688 
8 4 0 0.667 0.000 0.667 0.439 
9 4 0 0.667 0.000 0.667 0.439 
10 4 1 0.667 0.167 0.300 0.088 
11 4 1 0.667 0.167 0.300 0.088 
12 3 1 0.500 0.167 0.167 0.026 
13 2 1 0.333 0.167 0.056 0.003 
14 3 1 0.500 0.167 0.167 0.026 
15 2 1 0.333 0.167 0.056 0.003 
16 2 0 0.333 0.000 0.333 0.108 
17 1 0 0.167 0.000 0.167 0.026 
18 1 0 0.167 0.000 0.167 0.026 
19 1 0 0.167 0.000 0.167 0.026 
20 1 0 0.167 0.000 0.167 0.026 
21 1 1 0.167 0.167 0.000 2.E-05 
22 1 1 0.167 0.167 0.000 2.E-05 
23 2 1 0.333 0.167 0.056 0.003 
24 2 2 0.333 0.333 0.000 2.E-05 
25 2 2 0.333 0.333 0.000 2.E-05 
26 1 2 0.167 0.333 0.056 0.003 
27 2 1 0.333 0.167 0.056 0.003 
28 2 1 0.333 0.167 0.056 0.003 
29 1 1 0.167 0.167 0.000 2.E-05 
30 2 0 0.333 0.000 0.333 0.108 
31 2 1 0.333 0.167 0.056 0.003 
32 2 1 0.333 0.167 0.056 0.003 
33 1 1 0.167 0.167 0.000 2.E-05 
34 1 1 0.167 0.167 0.000 2.E-05 
35 2 1 0.333 0.167 0.056 0.003 
36 1 2 0.167 0.333 0.056 0.003 
37 1 2 0.167 0.333 0.056 0.003 
38 1 3 0.167 0.500 0.167 0.026 
39 1 3 0.167 0.500 0.167 0.026 
40 1 4 0.167 0.667 0.300 0.088 
41 0 4 0.000 0.667 0.667 0.439 
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42 0 3 0.000 0.500 0.500 0.246 
43 0 2 0.000 0.333 0.333 0.108 
44 0 1 0.000 0.167 0.167 0.026 
45 0 2 0.000 0.333 0.333 0.108 
46 0 1 0.000 0.167 0.167 0.026 
47 0 2 0.000 0.333 0.333 0.108 
48 0 3 0.000 0.500 0.500 0.246 
49 1 3 0.167 0.500 0.167 0.026 
50 1 4 0.167 0.667 0.300 0.088 
51 1 4 0.167 0.667 0.300 0.088 
52 1 4 0.167 0.667 0.300 0.088 
53 2 3 0.333 0.500 0.033 0.001 
54 2 3 0.333 0.500 0.033 0.001 
55 1 4 0.167 0.667 0.300 0.088 
56 1 4 0.167 0.667 0.300 0.088 
57 2 3 0.333 0.500 0.033 0.001 
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Table 4.5. MD-derived secondary structure for Syt 1 IDR core region. Turn (T), β-sheet 
(B), helix (H) and coil (C) are shown as fractions for each residue. 
 
 Unphosphorylated Dielec80 Unphosphorylated Dielec20 Phosphorylated Dielec80 Phosphorylated Dielec20 
Res T B H C T B H C T B H C T B H C 
97 
0.120 0.000 0.000 0.880 0.104 0.000 0.000 0.896 0.126 0.000 0.000 0.874 0.270 0.000 0.000 0.730 
98 
0.229 0.000 0.005 0.766 0.208 0.027 0.008 0.751 0.244 0.002 0.003 0.750 0.320 0.001 0.003 0.676 
99 
0.359 0.000 0.020 0.621 0.380 0.027 0.040 0.505 0.379 0.002 0.014 0.605 0.652 0.002 0.006 0.340 
100 
0.457 0.000 0.083 0.460 0.547 0.000 0.144 0.305 0.500 0.000 0.064 0.435 0.676 0.084 0.039 0.202 
101 
0.442 0.000 0.097 0.460 0.551 0.000 0.173 0.277 0.484 0.000 0.077 0.438 0.686 0.099 0.045 0.169 
102 
0.443 0.000 0.104 0.454 0.540 0.000 0.194 0.265 0.486 0.000 0.078 0.436 0.711 0.089 0.064 0.135 
103 
0.519 0.000 0.092 0.389 0.559 0.000 0.185 0.253 0.550 0.000 0.045 0.405 0.614 0.118 0.061 0.208 
104 
0.445 0.000 0.093 0.462 0.404 0.024 0.179 0.348 0.474 0.002 0.030 0.494 0.682 0.107 0.052 0.159 
105 
0.394 0.000 0.089 0.517 0.355 0.024 0.194 0.419 0.448 0.002 0.035 0.515 0.604 0.000 0.048 0.348 
106 
0.418 0.000 0.128 0.454 0.361 0.000 0.307 0.331 0.482 0.000 0.059 0.459 0.664 0.084 0.034 0.218 
107 
0.352 0.000 0.153 0.495 0.355 0.000 0.335 0.310 0.440 0.000 0.073 0.487 0.612 0.094 0.181 0.113 
108 
0.342 0.000 0.158 0.499 0.412 0.000 0.327 0.261 0.414 0.000 0.065 0.522 0.228 0.193 0.170 0.409 
109 
0.354 0.000 0.149 0.497 0.373 0.000 0.336 0.287 0.359 0.000 0.044 0.597 0.234 0.115 0.174 0.478 
110 
0.486 0.000 0.102 0.412 0.458 0.000 0.287 0.252 0.331 0.000 0.009 0.660 0.220 0.000 0.000 0.780 
111 
0.448 0.001 0.141 0.411 0.445 0.006 0.295 0.253 0.193 0.000 0.007 0.799 0.087 0.000 0.033 0.879 
112 
0.448 0.001 0.147 0.404 0.422 0.010 0.285 0.282 0.160 0.000 0.010 0.830 0.502 0.000 0.123 0.374 
113 
0.520 0.000 0.162 0.317 0.485 0.011 0.288 0.215 0.324 0.000 0.026 0.650 0.612 0.000 0.221 0.167 
114 
0.527 0.000 0.203 0.270 0.484 0.010 0.323 0.182 0.462 0.000 0.057 0.482 0.621 0.000 0.343 0.035 
115 
0.520 0.000 0.226 0.255 0.531 0.000 0.324 0.146 0.492 0.000 0.086 0.421 0.578 0.000 0.398 0.024 
116 
0.525 0.001 0.205 0.269 0.516 0.000 0.295 0.190 0.522 0.000 0.083 0.395 0.591 0.000 0.350 0.059 
117 
0.482 0.001 0.122 0.395 0.501 0.011 0.124 0.362 0.484 0.000 0.053 0.464 0.623 0.000 0.120 0.258 
118 
0.380 0.000 0.058 0.562 0.388 0.015 0.060 0.534 0.384 0.000 0.022 0.593 0.393 0.000 0.018 0.589 
119 
0.284 0.000 0.019 0.697 0.309 0.013 0.024 0.652 0.296 0.000 0.008 0.696 0.243 0.000 0.007 0.750 
120 
0.228 0.000 0.022 0.750 0.257 0.005 0.052 0.685 0.242 0.000 0.011 0.747 0.330 0.000 0.013 0.658 
121 
0.190 0.000 0.024 0.787 0.237 0.000 0.070 0.693 0.211 0.000 0.017 0.773 0.305 0.000 0.067 0.628 
122 
0.220 0.000 0.026 0.754 0.268 0.000 0.073 0.659 0.237 0.000 0.019 0.744 0.349 0.000 0.084 0.567 
123 
0.335 0.000 0.023 0.642 0.363 0.000 0.061 0.574 0.333 0.000 0.016 0.650 0.446 0.005 0.091 0.459 
124 
0.309 0.000 0.019 0.672 0.350 0.000 0.056 0.593 0.312 0.000 0.016 0.672 0.467 0.006 0.079 0.449 
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125 
0.308 0.000 0.016 0.676 0.338 0.001 0.040 0.620 0.312 0.000 0.013 0.676 0.420 0.003 0.060 0.518 
126 
0.260 0.000 0.009 0.731 0.288 0.000 0.018 0.691 0.255 0.000 0.006 0.739 0.349 0.000 0.021 0.630 
127 
0.122 0.000 0.004 0.875 0.146 0.000 0.008 0.845 0.126 0.000 0.002 0.872 0.150 0.000 0.005 0.846 
128 
0.057 0.000 0.000 0.943 0.067 0.000 0.000 0.932 0.053 0.000 0.000 0.947 0.065 0.000 0.000 0.935 
129 
0.001 0.000 0.000 0.999 0.001 0.000 0.000 0.999 0.001 0.000 0.000 0.999 0.001 0.000 0.000 0.999 
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CHAPTER 5: FUTURE DIRECTIONS 
5.1 – Actin-binding domains 
 The results presented in Chapters 2 and 3 of this thesis provide several potential 
avenues for future studies. One of the first is exploration of the N-terminal residues 
upstream the CH1 domain. In Chapter 2, the truncation of the 50 N-terminal disordered 
region abolished binding. This finding is intriguing, because the ABD is typically defined 
as consisting of the tandem CH domains. Yet, in this example, the CH domains are 
present but no binding occurs. This opens the question about how significantly the N-
terminal residues of other ABDs in the spectrin superfamily contribute to their respective 
binding affinities. Similar truncation experiments could address this. Another facet to this 
question is post-translational modifications. The N-terminal residues sometimes contain 
phosphorylation sites within the sequence. If the N-terminal sequence contributes to the 
actin-binding interface and PTMs occur there, is affinity being tuned up or down? Some 
research groups have already begun probing this question with simulation approaches200, 
but it is well known that phosphorylation is typically an on/off switch for tuning 
functions. 
 Another possible question to explore is whether or not the βIII-spectrin mutation 
could be used to help in the generation of more high-resolution cryo-EM models, but for 
other ABDs. The wild-type affinity of the βIII-spectrin ABD was too low to decorate 
filaments and generate a model. Other ABDs may face similar problems, but if their 
affinities could be increased through introduction of mutations that increase affinity by 
perturbing the closed-open equilibrium (but the not fold) of CH domains, perhaps high-
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resolution models would become attainable. Indeed, a more recent cryo-EM structural 
study201 that generated ABD-actin models of even higher resolution than that of βIII-
spectrin utilized ABD mutants that had elevated affinity. Those structural models also 
stabilized F-actin with phalloidin, which may contribute to improved resolution in the 
model. Either way, the cryo-EM models could reveal more information on ABD-actin 
interactions, particularly the N-terminal residues, which might otherwise be difficult to 
study structurally when bound to actin filaments. 
5.2 – The IDR of synaptotagmin 1 
 For Chapter 4, the results of the study are of interest because they suggest that 
structural modifications outside the C2 domains are biologically relevant to the function 
of the protein. How, exactly, is still not known and will require design of exploratory 
experiments to generate new hypotheses. It is possible that the structural change is having 
an allosteric effect that impacts Ca2+-sensing, but it also seems plausible that this region 
of synaptotagmin might form a binding site for some other exocytosis effector protein. 
Ultimately, this topic will be something I will explore during my postdoc.  
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